Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007164	s-igakeli	— (—)	34914	42212	100.00%	Distribution not available
3007164	p-iga	g/l (g/l)	33572	52076	0.11%
3007164	s-iga	g/l (g/l)	29562	35542	0.05%
3007164	p-iga	— (—)	8750	11104	100.00%	Distribution not available
3007164	s-iga	— (—)	2759	3218	100.00%	Distribution not available
3007164	p-iga	g/l_______ (g/l)	444	508	0.00%
3007164	s-immunoglobuliinia	g/l (g/l)	416	426	0.00%
3007164	immunoglobuliinia	g/l (g/l)	216	219	0.00%
3007164	iga	g/l (g/l)	140	156	0.00%
3007164	s-iga	G/L (g/l)	76	76	0.00%
3007164	s-iga	g/l_______ (g/l)	23	23	0.00%
3007164	s-immunoglobuliinia	g/l_______ (g/l)	21	21	0.00%
3007164	keliakia,immunoglobuliinia	g/l (g/l)	8	8	0.00%	Distribution not available
3007164	p-immunoglobuliinia(pi)	g/l (g/l)	5	5	0.00%	Distribution not available
3007164	s-immunoglobuliinia(paketti)	g/l (g/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Symptoms and signs concerning food and fluid intake

1969

8432

3.12

322.31

1.7

1.4

2.38

2.36

g/l

0.11

1159

4877

Diseases of the eye and adnexa

13013

46236

1.54

321.49

1.6

1.4

2.30

2.28

g/l

0.36

8465

30448

Chronic kidney disease

4098

21757

2.08

320.46

2.0

1.5

2.86

2.59

g/l

8.68

2811

12441

Sciatica+with lumbago

7846

45537

1.70

320.04

1.5

2.34

2.39

g/l

1.16

4935

28883

Finngen Rheumatological endpoints

15007

62236

1.48

319.00

1.6

1.5

2.45

2.29

g/l

17.68

9903

39438

Sleep apnoea

13884

63430

1.50

317.03

1.6

1.5

2.51

2.40

g/l

8.80

8826

39887

Nausea and vomiting

4262

23508

2.06

315.10

1.8

1.5

2.34

2.32

g/l

0.27

2675

14059

Conjunctivitis

12675

73796

1.52

312.74

1.6

1.5

2.23

2.29

g/l

3.55

7757

46823

Other disorders of urethra and urinary system

10783

52324

1.57

311.34

1.6

1.5

2.37

2.33

g/l

0.76

6629

32550

Psychiatric diseases

14528

52817

1.49

310.42

1.5

2.41

2.36

g/l

2.06

8876

34121

Any mental disorder

16449

61072

1.45

309.67

1.6

1.5

2.43

2.35

g/l

4.09

9819

39687

Other and unspecified polyneuropathies, also in other diseases

2765

13717

2.48

309.28

1.9

1.5

2.66

2.59

g/l

0.61

1660

8256

Migraine

9744

47803

1.85

307.65

1.5

2.06

2.22

g/l

22.61

6318

30542

Other anxiety disorders

9073

47420

1.92

307.65

1.6

1.4

2.18

2.25

g/l

3.67

5206

31736

All anxiety disorders

11807

57584

1.85

307.65

1.6

1.5

2.21

2.29

g/l

5.52

6903

38272

Mood [affective] disorders

17557

74358

1.70

307.65

1.5

2.31

2.36

g/l

2.92

10231

48055

Renal failure

6213

31953

1.86

307.65

2.0

1.5

2.96

2.57

g/l

19.39

4211

18521

Asthma-related infections

9966

61986

1.78

307.65

1.7

1.5

2.37

2.33

g/l

0.81

6559

38485

L04AX Other immunosuppressants

10172

58714

2.08

307.65

2.2

1.4

2.50

2.33

g/l

9.78

7305

36140

Other and unspecified dermatitis

8594

54113

1.82

307.65

1.6

1.5

2.45

2.35

g/l

4.59

5554

33542

Asthma, unspecified (mode), excluding more controls

8695

36657

1.95

307.65

1.6

1.4

2.44

2.29

g/l

6.80

5422

22588

Symptoms and signs involving the skin and subcutaneous tissue

11234

74714

1.57

307.65

1.6

1.5

2.27

2.37

g/l

5.66

7021

46775

Type 1 diabetes, wide definition, subgroup 1

4271

20044

2.86

307.65

1.7

1.5

2.46

2.23

g/l

11.17

2275

12989

Diverticular disease of intestine

10752

37036

2.07

307.65

1.6

1.5

2.56

2.53

g/l

0.54

6193

23275

Diarrhoea and gastroenteritis of presumed infectious origin

11665

70216

1.65

307.65

1.7

1.5

2.35

2.34

g/l

0.27

7419

44344

Bacterial infection, other or unspecified, including avohilmo

8469

45010

1.72

307.65

2.0

1.4

2.65

2.41

g/l

11.88

5809

26514

Anaemias

5652

12748

4.10

307.65

1.8

1.3

2.43

2.11

g/l

23.41

3815

8751

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

18138

72493

1.83

307.65

1.6

1.5

2.31

2.37

g/l

2.99

11595

45438

Acute upper respiratory infections of multiple and unspecified sites

12801

63554

1.63

307.65

1.7

1.4

2.25

2.35

g/l

7.56

8435

39898

Gastrointestinal diseases

10802

29010

2.16

307.65

1.6

1.3

2.27

2.16

g/l

7.01

7066

18455

Bacterial Sepsis

6470

33148

1.81

307.65

1.9

1.5

2.84

2.48

g/l

22.76

4338

19401

Pain in throat and chest

14188

54526

1.72

307.65

1.6

1.4

2.36

2.32

g/l

1.46

8769

34734

Certain infectious and parasitic diseases

15812

54717

1.59

307.65

1.7

1.4

2.37

2.28

g/l

6.30

10185

34226

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6049

15924

2.17

307.65

1.5

1.3

2.30

2.23

g/l

2.25

3986

10259

Sub-endpoint used in defining T1D endpoints

4856

26251

2.18

307.65

1.7

1.5

2.53

2.36

g/l

7.32

2651

16850

Low back pain

13357

57386

1.78

307.65

1.6

1.4

2.35

2.34

g/l

0.14

8274

36569

Myalgia

4212

23437

2.18

307.65

1.6

1.5

2.22

2.30

g/l

2.28

2493

15009

Headache

12271

55515

1.99

307.65

1.6

1.4

2.17

2.31

g/l

15.80

7747

34736

Pain in limb

14269

57642

1.78

307.65

1.6

1.5

2.35

2.34

g/l

0.44

8583

36800

Malaise and fatigue

8414

38531

1.97

307.65

1.7

1.4

2.53

2.38

g/l

6.24

5216

23218

Mood disorders

17578

74379

1.70

307.65

1.5

2.31

2.36

g/l

2.82

10246

48070

Constipation

15151

62687

1.88

307.65

1.6

1.5

2.44

2.38

g/l

2.20

8941

39453

Codeine or tramadol medication

18316

69024

1.59

307.65

1.6

1.5

2.39

2.36

g/l

1.32

11465

44126

Symptoms and signs involving the circulatory and respiratory systems

17095

56667

1.68

307.65

1.6

1.4

2.31

2.30

g/l

0.26

11130

36103

Metabolic disorders

14430

60447

1.57

307.65

1.6

1.5

2.50

2.35

g/l

12.13

8914

38487

Hypothyroidism, strict autoimmune

11622

48628

1.76

307.65

1.5

1.4

2.29

2.30

g/l

0.09

7289

29954

Multiple myeloma, including Hilmo

1021

2572

7.71

307.65

8.0

1.3

3.31

2.75

g/l

1.71

903

1436

Disorders of thyroid, IBD co-morbidities

3074

9705

2.62

307.65

1.6

1.3

2.19

2.17

g/l

0.33

1918

6398

Diseases of the skin and subcutaneous tissue

15735

54255

1.59

307.65

1.6

1.4

2.43

2.31

g/l

8.80

9990

34385

Other systemic involvement of connective tissue

4666

24645

2.35

307.65

1.8

1.5

2.44

2.37

g/l

1.46

3181

14619

ILD medications

21224

66931

1.98

307.65

1.8

1.3

2.45

2.30

g/l

17.88

14844

40542

Caries of dentine

3552

17024

2.43

307.65

2.1

1.4

2.67

2.45

g/l

5.42

2339

11319

Acute upper respiratory infections

16797

70678

1.56

307.65

1.7

1.4

2.30

2.38

g/l

5.76

10862

43759

Other dorsopathies, not elsewhere classified

16480

59377

1.58

307.65

1.5

2.34

2.33

g/l

0.16

10471

37815

Other joint disorders

14337

53848

1.51

307.65

1.5

2.28

g/l

0.07

9299

34458

Behavioural syndromes associated with physiological disturbances and physical factors

15964

73478

1.64

307.65

1.5

2.25

2.36

g/l

12.15

10072

46438

Insulin medication

9138

48283

1.77

307.65

1.7

1.5

2.80

2.37

g/l

53.37

5467

30089

Asthma (diagnoses ohter than nonallergic)

14430

80389

1.61

307.65

1.6

1.5

2.39

2.33

g/l

2.54

9199

50399

Insulin, fast-acting

6268

33112

2.33

307.65

1.7

1.5

2.71

2.40

g/l

21.82

3611

20896

First line medication for Crohn's disease

20121

65774

1.88

307.65

1.8

1.3

2.42

2.31

g/l

9.17

14061

39971

Dental caries

4014

19145

2.37

307.65

2.1

1.4

2.66

2.44

g/l

5.13

2636

12714

Dorsalgia

16555

59144

1.64

307.65

1.6

1.4

2.37

2.34

g/l

1.23

10410

37671

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

14480

82001

1.50

307.65

1.7

1.5

2.28

2.35

g/l

4.21

9326

51494

Pain in joint

10900

33990

2.35

307.65

1.6

1.4

2.30

2.39

g/l

5.57

6636

21721

18035

65406

1.52

307.65

1.7

1.4

2.35

2.36

g/l

0.33

11625

40445

Autoimmune diseases related-to ILD

15807

76748

2.02

307.65

1.7

1.4

2.47

2.33

g/l

12.70

10831

47500

Pain, not elsewhere classified

4799

26579

2.15

307.65

1.7

1.4

2.26

2.33

g/l

1.89

3097

16363

Nutritional anaemias

8391

43793

2.18

307.65

1.7

1.5

2.65

2.40

g/l

15.91

5253

26244

Depression or dysthymia

10712

33764

1.98

307.65

1.5

2.42

2.41

g/l

0.21

6444

21808

Other anaemias

7089

32291

2.51

307.65

1.9

1.5

2.83

2.51

g/l

13.26

4557

18760

Polyarthropathies

10778

44194

1.76

307.65

1.7

1.5

2.66

2.34

g/l

32.23

7225

28161

Abdominal and pelvic pain

16650

51782

1.81

307.65

1.6

1.4

2.34

2.36

g/l

0.32

10634

32685

Iron deficiency anaemia

7461

38843

2.29

307.65

1.7

1.5

2.63

2.39

g/l

14.84

4724

23274

Other and unspecified anaemias

7041

32037

2.52

307.65

1.9

1.5

2.83

2.51

g/l

12.88

4528

18616

Codes for special purposes

8487

56224

1.69

307.65

1.8

1.5

2.34

2.35

g/l

0.10

5649

35200

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1730

3649

4.34

307.65

2.1

1.4

2.74

2.41

g/l

6.26

1279

2191

ILD medications: prednisolone, methylprednisolone, prednisone

19846

65031

1.96

307.65

1.7

1.3

2.45

2.31

g/l

14.29

13814

39361

Implicit viral Sepsis, including avohilmo

4742

26526

2.10

307.65

1.9

1.5

2.51

2.38

g/l

2.67

3063

15679

Lower back pain or/and sciatica

17741

76502

1.59

307.65

1.6

1.5

2.36

g/l

0.02

11061

48552

Nonalcoholic fatty liver disease

2465

8680

5.05

307.65

1.8

1.5

2.82

2.38

g/l

21.46

1941

5538

Excluding asthma or asthma-COPD overlap

12340

41371

1.64

307.65

1.6

1.4

2.38

2.32

g/l

2.03

7910

25726

Bronchitis

17555

76125

1.51

307.65

1.7

1.4

2.32

2.36

g/l

1.59

11455

47457

Inflammatory bowel disease treatment related agents

21335

69950

1.96

307.65

1.7

1.4

2.45

2.32

g/l

14.78

14956

42609

Provisional assignment of new diseases of uncertain etiology

8484

56172

1.69

307.65

1.8

1.5

2.34

2.35

g/l

0.10

5646

35170

Noninfective enteritis and colitis

8729

48192

2.21

307.65

1.7

1.5

2.37

2.33

g/l

1.07

5907

30138

Dermatitis and eczema

19303

75475

1.70

307.65

1.6

1.5

2.39

2.35

g/l

1.97

12284

47494

Pain (limb, back, neck, head abdominally)

11492

34757

1.85

307.65

1.6

1.4

2.36

2.39

g/l

1.03

7296

22155

Asthma, hospital admissions , main diagnosis only

13170

81111

1.55

307.65

1.6

1.5

2.36

2.33

g/l

0.82

8601

50774

Insulin, combination of fast acting with intermediate-acting or long-acting

9142

52574

1.78

307.65

1.7

1.5

2.80

2.44

g/l

38.76

5468

32608

Selective serotonin reuptake inhibitors

15663

55603

1.60

307.65

1.5

2.36

2.38

g/l

0.54

9420

35914

L04AA Selective immunosuppressants

4019

20992

2.46

307.65

2.1

1.5

2.49

2.34

g/l

5.04

3034

13108

Asthma, including avohilmo

19326

75834

1.53

307.65

1.6

1.5

2.37

2.34

g/l

0.67

12520

47563

Dermatitis

10146

63808

1.76

307.65

1.6

1.5

2.47

2.36

g/l

5.40

6548

39697

Exposure to unspecified factor

16161

81112

1.47

307.65

1.6

1.5

2.42

2.33

g/l

4.97

9271

52075

Budesonide

2698

12494

2.87

307.65

1.8

1.4

2.35

2.31

g/l

0.46

1868

7686

7849

48468

1.87

307.65

1.7

1.5

2.30

2.29

g/l

0.35

5207

30392

Infections, IBD-co-morbidities

2677

7271

3.24

307.65

1.9

1.4

2.38

2.25

g/l

2.39

1839

4744

Other soft tissue disorders, not elsewhere classified

16532

59146

1.81

307.65

1.6

1.5

2.34

2.33

g/l

0.26

10184

37832

ILD medications: immunosuppressive drugs

13078

59773

2.48

307.65

2.2

1.3

2.50

2.31

g/l

16.89

9566

36148

Asthma, hospital admission 2, infections

9966

61986

1.78

307.65

1.7

1.5

2.37

2.33

g/l

0.81

6559

38485

Gastro-oesophageal reflux disease

11797

56633

2.06

307.65

1.6

1.5

2.38

2.37

g/l

0.15

7048

35753

Cirrhosis of liver, NAS

1208

3550

6.34

307.65

1.9

1.5

4.49

2.50

g/l

83.10

1071

2115

Parasetamol

12025

39894

1.68

307.65

1.5

1.4

2.31

2.30

g/l

0.33

7882

25659

Episodal and paroxysmal disorders

17734

63905

1.53

307.65

1.5

2.28

2.34

g/l

3.48

11256

40389

Soft tissue disorders

16705

59743

1.57

307.65

1.5

2.32

2.33

g/l

0.48

10601

38212

Autoimmune diseases excluding thyroid diseases, strict definition

19613

58210

2.16

307.65

1.7

1.4

2.52

2.30

g/l

35.97

13052

36388

Hypothyroidism, levothyroxine purchases

4965

13181

2.58

307.65

1.6

1.3

2.18

2.13

g/l

1.41

3281

9204

Tramadol

12952

47996

1.83

307.65

1.7

1.4

2.51

2.35

g/l

12.63

7982

30666

Abnormal findings on examination of blood, without diagnosis

7043

36216

2.05

307.65

2.0

1.5

2.71

2.53

g/l

7.55

5115

22120

Asthma (mode)

13064

41282

1.89

307.65

1.6

1.4

2.38

2.32

g/l

2.44

8527

25644

Any reimbursement code in KELA

10482

33937

1.74

307.65

1.6

1.3

2.27

2.15

g/l

10.31

6874

21872

Intestinal infectious diseases, including avohilmo, including avohilmo

20136

71112

1.78

307.65

1.6

1.5

2.33

2.37

g/l

1.54

12694

44635

Hypothyreosis and Thyroxine purchase for inclusion criteria

14337

67560

1.52

307.65

1.5

2.29

2.35

g/l

4.13

8976

42367

COPD/asthma/ILD related infections

16071

57691

1.52

307.65

1.7

1.4

2.37

2.32

g/l

1.78

10422

35518

Other diseases of intestines

20094

65056

2.00

307.65

1.6

1.5

2.32

g/l

0.01

12726

41918

Codeine

15592

55467

1.69

307.65

1.5

1.4

2.36

2.30

g/l

3.36

9821

35632

Oral corticosteroids

19182

66474

1.95

307.65

1.7

1.4

2.46

2.34

g/l

11.77

13489

40500

Autoimmune diseases

20627

60309

2.01

307.65

1.7

1.4

2.43

2.29

g/l

17.02

13516

37608

Chronic lower respiratory diseases

19077

75040

1.44

307.65

1.6

1.5

2.40

2.32

g/l

5.64

12442

47078

Autoimmune diseases excluding thyroid diseases

20184

59828

2.16

307.65

1.7

1.4

2.52

2.29

g/l

36.51

13424

37333

Bacterial infection, other or unspecified

7616

40817

1.76

307.65

2.0

1.4

2.64

2.44

g/l

7.70

5246

23852

Diseases of oesophagus, stomach and duodenum

19002

67545

1.91

307.65

1.6

1.5

2.50

2.33

g/l

20.49

11760

43115

Other special examinations and investigations of persons without complaint or reported diagnosis

10150

30913

1.86

307.65

1.6

1.4

2.36

2.38

g/l

0.40

6736

20064

Osteopathies and chondropathies

8820

51820

1.77

307.65

1.9

1.5

2.47

2.39

g/l

2.35

5516

31637

Asthma (only as main-diagnosis), excluding more controls

12014

39358

1.93

307.65

1.6

1.3

2.36

2.29

g/l

3.15

7964

24477

Systemic connective tissue disorders

6119

32238

2.36

307.65

1.8

1.5

2.40

2.39

g/l

0.14

4235

19133

Oedema, not elsewhere classified

4855

26722

2.05

307.65

1.7

1.4

2.60

2.43

g/l

5.46

2973

15789

Coeliac disease

2484

11190

3.20

307.65

1.9

1.5

2.32

2.27

g/l

0.74

1514

6897

Chronic gastritis

3828

19405

2.35

307.65

1.6

1.5

2.67

2.52

g/l

2.87

2023

11340

Asthma, excluding more controls

12921

39358

1.93

307.65

1.6

1.3

2.39

2.29

g/l

5.26

8474

24477

Anxiety disorders, excluding more controls

14401

58221

1.80

307.65

1.6

1.5

2.27

2.33

g/l

3.36

8538

38065

Implicit bacterial Sepsis, including avohilmo

6263

31717

1.85

307.65

1.9

1.5

2.86

2.49

g/l

22.19

4106

18466

Multiple myeloma

660

1475

9.43

307.65

7.9

1.3

3.31

2.79

g/l

0.96

586

824

Other diseases of upper respiratory tract

16715

63903

1.47

307.65

1.6

1.5

2.29

2.41

g/l

9.60

10395

40021

Diseases of the digestive system

7139

40584

2.04

307.65

1.7

1.5

2.70

2.45

g/l

13.75

4532

24514

Examination and observation for other reasons

11329

30791

2.52

307.65

1.6

1.4

2.36

2.38

g/l

0.31

6578

19980

Intestinal infectious diseases

15812

80326

1.62

307.65

1.7

1.5

2.34

2.35

g/l

0.10

10076

50496

Disorders of the thyroid gland

14768

68358

1.53

307.65

1.5

2.29

2.36

g/l

4.42

9309

43093

Osteoporosis

4072

19628

2.31

307.65

1.9

1.5

2.58

2.47

g/l

1.56

2490

10803

Other diseases of urinary system

15155

61148

1.51

307.65

1.6

1.5

2.35

2.36

g/l

0.31

9554

38567

Dysphagia

3647

19036

2.26

307.65

1.7

1.5

2.43

2.48

g/l

0.70

2168

11282

Follow-up examination after treatment for conditions other than malignant neoplasms

6702

26859

1.87

307.65

1.5

1.4

2.32

2.36

g/l

0.76

3760

17287

Spondylopathies

10965

44542

1.59

307.65

1.6

1.5

2.51

2.45

g/l

1.83

6925

28036

Implicit Sepsis, including avohilmo

12288

61678

1.56

307.65

1.7

1.4

2.64

2.34

g/l

30.72

7696

38014

Persons encountering health services in other circumstances, wide

19035

65361

1.66

307.65

1.6

1.4

2.44

2.35

g/l

6.04

11861

41572

Persons encountering health services for other counselling and medical advice, not elsewhere classified

18897

65273

1.73

307.65

1.6

1.4

2.42

2.34

g/l

3.98

11703

41532

Hypothyroidism (congenital or acquired)

5014

13244

2.60

307.65

1.6

1.3

2.18

2.13

g/l

1.56

3309

9250

Dorsopathies

16386

59887

1.50

307.65

1.5

2.33

g/l

0.01

10537

38053

Cough

6776

37205

1.97

307.65

1.7

1.4

2.34

2.33

g/l

0.11

4250

22871

Insulin, intermediate and long-acting

8416

48599

1.93

307.65

1.7

1.5

2.82

2.45

g/l

38.69

4943

30145

Conjunctivitis (acute, non atopic), including avohilmo

16043

69211

1.53

307.65

1.5

2.30

2.38

g/l

5.63

10010

43932

Insulin, fast-acting or short human

6281

33784

2.26

307.65

1.7

1.5

2.70

2.42

g/l

19.32

3618

21352

Chronic rhinitis, nasopharyngitis and pharyngitis

5573

32526

2.04

307.65

1.6

1.5

2.23

2.37

g/l

6.89

3335

20602

Special screening examination for infectious and parasitic diseases

4718

18563

2.21

307.65

1.5

1.3

2.20

2.26

g/l

1.69

2637

12948

Mood disorders, excluding more controls

15841

60207

1.74

307.65

1.5

2.34

2.35

g/l

0.50

9230

39246

Chronic sinusitis

6844

42341

1.86

307.65

1.7

1.5

2.28

2.41

g/l

5.59

4457

26924

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

18763

69921

2.16

307.65

1.9

1.4

2.54

2.31

g/l

28.13

12480

43209

Other functional intestinal disorders

8120

38244

2.32

307.65

1.7

1.5

2.28

2.37

g/l

2.77

4952

23638

Cystitis

13492

55172

1.61

307.65

1.5

2.28

2.33

g/l

2.15

8537

34406

Dyspnoea

13795

70258

1.55

307.65

1.7

1.5

2.49

2.37

g/l

7.37

8878

43726

Depression medications

5662

14034

2.44

307.65

1.5

1.3

2.21

2.13

g/l

3.01

3677

9844

Spondylosis

7499

37361

1.74

307.65

1.5

2.42

2.51

g/l

3.14

4593

23170

COPD/asthma related infections

16071

57691

1.52

307.65

1.7

1.4

2.37

2.32

g/l

1.78

10422

35518

Diseases of the musculoskeletal system and connective tissue

9166

29682

1.72

307.65

1.6

1.4

2.26

2.22

g/l

1.07

5989

18992

Implicit Sepsis

11171

56026

1.62

307.65

1.8

1.4

2.70

2.37

g/l

30.48

7032

34107

Sleep apnoea, including avohilmo

14966

65873

1.49

307.65

1.5

2.47

2.38

g/l

5.64

9586

41432

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2592

10148

3.57

307.65

1.8

1.5

4.55

2.46

g/l

185.07

2163

6152

Other systemic involvement of connective tissue (FG)

4564

22153

2.54

307.65

1.8

1.5

2.44

2.33

g/l

3.44

3113

13032

Medical observation and evaluation for suspected diseases and conditions

10941

30912

2.07

307.65

1.6

1.4

2.34

2.38

g/l

1.09

6876

20064

Sleep disorders

15310

71991

1.63

307.65

1.5

2.25

2.36

g/l

12.02

9711

45669

Diaphragmatic hernia

5203

30206

2.01

307.65

1.6

1.5

2.48

2.50

g/l

0.32

2920

18081

Anxiety (asthma-related co-morbidities)

11488

53672

1.90

307.65

1.6

1.5

2.22

2.27

g/l

2.37

6732

35893

Liquid cancers, including Hilmo

5729

26159

2.34

307.65

3.1

1.4

2.35

2.56

g/l

3.99

4529

15283

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1120

2774

8.08

307.65

4.6

1.3

3.40

2.74

g/l

4.46

941

1532

Multiple myeloma and malignant plasma cell neoplasms

1050

2873

6.95

307.65

7.8

1.4

3.31

2.66

g/l

2.26

927

1650

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

660

1475

9.43

307.65

7.9

1.3

3.31

2.79

g/l

0.96

586

824

Irritable bowel syndrome

6505

26101

3.62

307.65

1.6

1.4

2.14

2.29

g/l

11.97

3973

16610

Mycoses, including avohilmo

14913

81158

1.54

307.65

1.5

2.32

2.35

g/l

1.24

9410

51343

Liquid cancers

5168

22135

2.84

307.65

3.3

1.4

2.33

2.58

g/l

4.70

4143

12812

Fever of other and unknown origin

9743

48588

2.02

307.65

2.0

1.4

2.43

2.34

g/l

2.98

6956

29931

COPD differential diagnosis

12281

41297

1.64

307.65

1.6

1.4

2.38

2.32

g/l

1.95

7875

25653

13990

57691

1.55

307.65

1.8

1.4

2.46

2.32

g/l

8.17

9213

35518

GASTRO-related operations

14261

41760

1.95

307.65

1.6

1.3

2.35

2.19

g/l

17.16

9432

25836

Asthma, unspecified (mode)

8868

38217

1.91

307.65

1.6

1.4

2.45

2.32

g/l

5.46

5511

23523

Other pulmonary diagnosis

12390

41371

1.65

307.65

1.6

1.4

2.38

2.32

g/l

1.94

7954

25726

Abnormalities of breathing

15231

56498

1.73

307.65

1.6

1.4

2.38

2.30

g/l

4.16

9998

35976

Other specific joint derangements/joint disorders

13284

52811

1.79

307.65

1.6

1.5

2.28

g/l

0.01

8293

33851

Certain infectious and parasitic diseases, including avohilmo

11204

35866

1.73

307.65

1.6

1.4

2.37

2.32

g/l

2.09

7198

22354

Inflammatory bowel disease

5433

31490

2.07

307.65

1.7

1.5

2.44

2.35

g/l

3.17

3910

20194

General examination and investigation of persons without complaint and reported diagnosis

9665

30902

1.80

307.65

1.6

1.4

2.34

2.38

g/l

1.07

6678

20061

Collagenous colitis

1828

7536

3.59

307.65

1.8

1.5

2.34

2.39

g/l

0.34

1163

4599

Neurotic, stress-related and somatoform disorders

15793

70859

1.74

307.65

1.6

1.5

2.25

2.34

g/l

8.34

9389

45861

General symptoms and signs

18741

58480

1.81

307.65

1.6

1.4

2.37

2.33

g/l

1.36

12348

36628

Hypothyroidism and >3 levothyroxin purchases

4965

13181

2.58

307.65

1.6

1.3

2.18

2.13

g/l

1.41

3281

9204

Other headache syndromes

7117

44081

1.86

307.65

1.6

1.5

2.17

2.31

g/l

9.57

4322

27812

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9550

54649

1.69

307.65

1.7

1.5

2.62

2.46

g/l

9.15

6422

32839

Polyneuropathies and other disorders of the peripheral nervous system

3172

16156

2.39

307.65

1.9

1.5

2.64

2.58

g/l

0.64

1955

9750

Implicit bacterial Sepsis

5612

28819

1.88

307.65

1.9

1.5

2.88

2.51

g/l

19.85

3719

16655

ILD differential diagnosis

12269

41282

1.64

307.65

1.6

1.4

2.38

2.32

g/l

1.98

7867

25644

Disorders of conjunctiva

13821

77085

1.53

307.65

1.6

1.5

2.25

2.32

g/l

4.39

8454

48868

Second line medication for Crohn's disease

10680

60801

2.12

307.65

2.2

1.4

2.49

2.33

g/l

10.26

7688

37490

Sleep disorders (combined)

18088

64443

1.62

307.65

1.5

2.37

2.35

g/l

0.43

11341

40535

Used for control exclusion in common control thyroid runs

19379

56137

2.01

307.65

1.6

1.4

2.40

2.30

g/l

9.50

12736

35116

Symptoms and signs involving the digestive system and abdomen

16829

51788

1.83

307.65

1.6

1.4

2.41

2.36

g/l

1.96

10808

32688

Type 1 diabetes, wide definition

4347

21056

2.70

307.65

1.7

1.5

2.45

2.25

g/l

9.92

2311

13623

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

13990

57691

1.55

307.65

1.8

1.4

2.46

2.32

g/l

8.17

9213

35518

Atopic dermatitis

10388

57134

1.62

307.65

1.5

2.24

g/l

0.01

6568

36878

Asthma (only as main-diagnosis)

12249

40997

1.90

307.65

1.6

1.4

2.37

2.32

g/l

1.98

8098

25464

Benign neoplasm: Colon

7760

42874

1.95

307.65

1.6

1.5

2.60

2.57

g/l

0.43

4475

25662

Reimbursement for rheumatic diseases

9453

57563

1.90

307.65

1.7

1.5

2.55

2.34

g/l

20.89

6692

34967

Benign neoplasm of colon, rectum, anus and anal canal

9302

46724

1.93

307.65

1.6

1.5

2.58

2.55

g/l

0.46

5384

28207

Primary_lymphoid and hematopoietic malignant neoplasms

4332

17752

3.31

307.65

3.6

1.4

2.29

2.58

g/l

4.66

3600

10143

Other noninfective gastroenteritis and colitis

4587

23331

2.50

307.65

1.8

1.5

2.28

2.31

g/l

0.50

2935

14245

Neurological diseases

14129

49011

1.59

307.65

1.6

1.4

2.26

2.31

g/l

2.24

9097

31284

Opioids

16277

56667

1.64

307.65

1.6

1.4

2.37

2.30

g/l

4.36

10484

36414

Neurological diseases, wide definition

5414

14521

2.18

307.65

1.5

1.4

2.17

2.11

g/l

1.79

3543

9615

Diseases of liver

7497

29742

3.62

307.65

1.8

1.5

3.26

2.36

g/l

154.90

5916

17982

Persons encountering health services for examination and investigation

9617

30913

1.71

307.65

1.5

1.4

2.38

g/l

0.12

6128

20064

Any gastric operation

14261

41760

1.95

307.65

1.6

1.3

2.35

2.19

g/l

17.16

9432

25836

Type 1 diabetes

4792

23792

2.57

307.65

1.7

1.5

2.51

2.27

g/l

14.00

2608

15376

Aplastic and other anaemias

7533

34486

2.42

307.65

1.9

1.5

2.82

2.50

g/l

13.90

4870

20065

Asthma

13247

40997

1.90

307.65

1.6

1.4

2.40

2.32

g/l

3.63

8660

25464

Fibrosis and cirrhosis of liver

1752

5304

5.97

307.65

1.9

1.5

3.94

2.41

g/l

82.99

1522

3120

Functional dyspepsia

4672

24463

2.36

307.65

1.6

1.5

2.26

2.33

g/l

1.75

2839

15233

Recurrent or chronic depression

7379

26480

2.33

307.65

1.5

1.4

2.27

2.33

g/l

1.63

4592

17579

Depression

16792

72886

1.75

307.65

1.6

1.5

2.29

2.35

g/l

3.48

9842

47248

Insomnia

15098

72439

1.61

307.65

1.4

1.5

2.24

2.35

g/l

11.69

9615

46005

Endocrine, nutritional and metabolic diseases

13855

45103

1.73

307.65

1.6

1.4

2.35

2.20

g/l

14.56

8741

29618

Disorders of gallbladder, biliary tract and pancreas

14656

65297

1.52

307.65

1.7

1.5

2.56

2.38

g/l

20.32

9579

40630

Other and unspecified iron deficiency

6313

30981

2.57

307.65

1.7

1.5

2.57

2.36

g/l

10.29

3961

18595

Hypothyroidism, other/unspecified

13872

64810

1.54

307.65

1.5

2.28

2.36

g/l

4.78

8689

40727

Other diseases of liver

4014

15445

3.96

307.65

1.8

1.5

2.82

2.31

g/l

41.62

3114

9461

Anxiety disorders

15895

71132

1.74

307.65

1.6

1.5

2.25

2.34

g/l

8.35

9452

46003

Other antidepressants

16869

55099

1.75

307.65

1.5

2.39

g/l

0.11

10338

35683

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

13698

67322

1.49

307.19

1.7

1.4

2.60

2.30

g/l

35.38

8603

42126

Obesity related asthma

5397

33110

1.89

305.05

1.6

1.5

2.50

2.39

g/l

3.47

3471

20654

Benzodiazepine use

15439

77478

1.45

303.35

1.6

1.5

2.38

2.37

g/l

0.20

9111

49632

Other disorders of lacrimal gland

5774

36136

1.85

302.17

1.7

1.5

2.33

2.38

g/l

1.11

3571

22173

5-aminosalicylic acid

3559

19483

2.21

302.16

1.8

1.4

2.44

2.32

g/l

3.39

2562

12248

Disorders of eyelid, lacrimal system and orbit

13023

69385

1.49

299.24

1.6

1.5

2.35

2.39

g/l

1.42

7923

43519

Abnormalities of heart beat

5478

32617

1.85

298.44

1.6

1.4

2.34

2.35

g/l

0.07

3386

20144

ILD medications: azathioprine

2598

12905

2.58

298.33

2.0

1.4

2.47

2.28

g/l

5.77

2008

7812

Other bacterial intestinal infections, including avohilmo

3681

20382

2.15

297.80

1.7

1.5

2.40

2.42

g/l

0.21

2320

12566

Insulin, fast-acting (human)

2543

12586

2.60

296.00

1.7

1.4

2.40

2.32

g/l

1.79

1380

8390

IBD patients in KELA-register

3938

22538

2.12

293.39

1.8

1.5

2.45

2.33

g/l

4.60

2894

14642

Other diseases of anus and rectum

4141

23604

1.99

289.90

1.6

1.5

2.50

2.48

g/l

0.15

2517

14386

All chronic kidney diseases

7633

40349

1.67

287.78

1.9

1.5

2.73

2.41

g/l

23.96

5145

24052

Hernia of abdominal wall, postoperative

2569

12486

2.40

286.85

1.6

1.3

2.62

2.37

g/l

6.17

1584

7377

Other gastritis (incl. Duodenitis)

3117

16469

2.24

286.56

1.7

1.5

2.75

2.49

g/l

6.80

1994

9955

Other nutritional deficiencies

10762

70383

1.54

286.46

1.6

1.5

2.53

2.29

g/l

30.64

6796

44860

Covid-19 confirmed case

5491

34245

1.83

285.09

1.9

1.5

2.43

g/l

0.05

3702

20947

Asthma-related pneumonia or sepsis

5282

32482

1.84

283.77

1.8

1.5

2.50

2.42

g/l

1.33

3502

19400

Asthma, hospital admissions 3, pneumonia

5282

32482

1.84

283.77

1.8

1.5

2.50

2.42

g/l

1.33

3502

19400

Asthma-related pneumonia

5267

32380

1.84

283.30

1.8

1.5

2.50

2.42

g/l

1.32

3491

19344

Azathioprine

2598

13189

2.51

281.68

2.0

1.4

2.47

2.28

g/l

5.90

2008

8065

Noninfectious colitis NAS

2425

12048

2.60

280.57

1.9

1.5

2.27

2.33

g/l

1.04

1580

7471

Other intervertebral disc disorders

11895

50914

1.51

280.38

1.5

1.4

2.38

2.40

g/l

0.27

7450

32438

Viral Sepsis

3198

17238

2.22

280.36

2.1

1.5

2.50

2.39

g/l

1.55

2162

10167

Implicit viral Sepsis

3190

17207

2.21

279.02

2.1

1.5

2.50

2.39

g/l

1.55

2156

10149

Disorders of lipoprotein metabolism and other lipidaemias

11233

48630

1.52

277.22

1.5

2.51

2.44

g/l

2.60

6476

30677

Disorders of lacrimal system

6743

43780

1.71

276.28

1.7

1.5

2.32

2.36

g/l

0.93

4187

26856

Acute sinusitis

8571

53866

1.61

275.33

1.8

1.4

2.24

2.32

g/l

3.76

5716

34339

Shoulder lesions

10447

44070

1.54

274.47

1.5

2.40

2.45

g/l

1.90

6484

28103

Type 1 diabetes, definitions combined

2076

9962

2.94

273.91

1.7

1.5

2.26

2.11

g/l

3.78

1056

6561

Other/unspecified dorsalgia

5644

35262

1.78

273.81

1.7

1.5

2.42

2.37

g/l

0.75

3376

22090

Type 1 diabetes, strict (exclude DM2)

2064

9897

2.95

273.20

1.7

1.5

2.26

2.11

g/l

3.78

1050

6518

Other bacterial diseases

13668

67049

1.45

273.01

1.9

1.4

2.66

2.34

g/l

39.56

9161

41326

Disease of hard tissues of teeth, NOS

7333

25028

1.68

272.09

1.5

1.4

2.37

2.47

g/l

3.82

4309

16300

Caries of enamel

14971

73795

1.44

272.01

1.5

2.27

2.36

g/l

7.61

8898

47477

Rheumatoid arthritis

4569

24181

1.91

271.99

1.6

1.5

2.66

2.41

g/l

11.19

3083

14732

Arthropathies

14418

54053

1.45

271.89

1.5

2.32

2.27

g/l

1.96

9405

34561

Enlarged lymph nodes

2591

13193

2.41

271.38

2.0

1.4

2.24

2.35

g/l

2.16

1943

8032

Inflammatory bowel disease, strict (require KELA)

3938

23074

2.06

271.06

1.8

1.5

2.45

2.32

g/l

4.74

2894

15023

Condition for Implicit Sepsis (Organ dysfunction codes)

12459

63165

1.48

270.85

1.7

1.4

2.64

2.33

g/l

31.99

7795

39119

Ulcerative colitis

3966

23198

2.03

270.54

1.8

1.5

2.45

2.36

g/l

2.58

2816

14879

Influenza and pneumonia

16470

77480

1.41

270.16

1.8

1.4

2.45

2.30

g/l

12.22

10881

48365

Complications of surgical and medical care, not elsewhere classified

14785

74250

1.43

266.78

1.6

1.5

2.44

2.37

g/l

3.65

9317

46768

Dentofacial anomalies [including malocclusion]

11646

66736

1.50

266.58

1.5

2.12

2.30

g/l

31.16

7496

42581

Candidiasis, including avohilmo

5112

32207

1.86

265.49

1.6

1.5

2.31

2.28

g/l

0.46

3224

20035

Persons encountering health services in other circumstances

6472

42241

1.71

264.02

1.6

1.4

2.41

2.31

g/l

4.33

4259

26784

Other bacterial diseases, including avohilmo

15202

71714

1.42

263.73

1.8

1.4

2.61

2.29

g/l

47.04

10157

44495

Pain and other conditions associated with female genital organs and menstrual cycle

4007

19795

2.06

263.65

1.5

1.4

2.04

2.13

g/l

4.08

2488

12676

Non-Hodgkin lymphoma, all, including Hilmo

1924

8842

2.74

262.51

2.6

1.4

2.01

2.63

g/l

26.49

1565

5026

Other diseases of hard tissues of teeth

7456

25467

1.65

259.85

1.5

1.4

2.40

2.47

g/l

1.57

4406

16524

Haemorrhoids and perianal venous thrombosis

4509

26992

1.86

259.59

1.5

2.37

2.50

g/l

4.53

2831

16564

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

13779

60948

1.44

258.71

1.6

1.5

2.68

2.30

g/l

72.24

8265

38605

All kidney diseases

14931

75788

1.42

258.65

1.7

1.4

2.57

2.29

g/l

40.40

9690

47439

Immunodeficiency with predominantly antibody defects

727

2198

8.84

258.52

5.1

1.5

1.34

2.29

g/l

36.66

540

1371

Hypothyroidism, drug reimbursement

2297

7686

2.51

257.34

1.6

1.3

2.25

2.15

g/l

2.05

1435

5288

Other specified/unspecified arthritis

4105

24441

1.95

256.65

1.7

1.5

2.53

2.36

g/l

4.34

2711

15172

Type 1 diabetes, strict definition, subgroup 1

1719

7943

3.24

254.89

1.7

1.5

2.21

2.07

g/l

3.63

853

5277

Other arthritis (FG)

4658

28751

1.86

253.53

1.7

1.5

2.54

2.35

g/l

6.77

3086

17608

Type 1 diabetes, strict definition

1784

8400

3.13

251.79

1.7

1.5

2.21

2.08

g/l

3.25

884

5597

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7533

49791

1.61

250.50

1.6

1.5

2.34

2.45

g/l

4.22

4819

31737

Nerve, nerve root and plexus disorders

15521

71124

1.40

249.03

1.6

1.5

2.39

2.40

g/l

0.11

9732

45066

Antihypertensive medication - note that there are other indications

10696

40309

1.52

247.83

1.6

1.4

2.23

2.14

g/l

6.44

7157

26132

Other disorders of skin and subcutaneous tissue

10340

63229

1.50

247.42

1.7

1.5

2.54

2.40

g/l

7.19

6498

38982

Disturbances of skin sensation

4616

28841

1.88

247.39

1.6

1.5

2.21

2.31

g/l

3.61

2811

18685

Certain disorders involving the immune mechanism

2955

16331

2.22

247.02

2.7

1.5

2.24

2.41

g/l

4.21

2124

10201

Diabetes mellitus

15492

68346

1.40

246.16

1.6

1.5

2.60

2.27

g/l

68.81

9459

43539

Abnormal findings on diagnostic imaging of lung

6079

37760

1.68

245.93

1.7

1.5

2.71

2.57

g/l

4.24

4030

22052

Symptoms and signs involving cognition, perception, emotional state and behaviour

14365

72809

1.41

245.66

1.5

2.38

2.37

g/l

0.27

8532

46514

Heart failure, not strict

9559

45652

1.53

244.97

1.8

1.5

2.89

2.42

g/l

54.98

6269

27125

Other diseases of blood and blood-forming organs, wide

3314

18962

2.10

244.48

2.2

1.5

2.28

2.45

g/l

4.69

2449

11515

Nonorganic sleeping disorders, excluding more controls

3558

20790

2.04

244.34

1.6

1.4

2.21

2.23

g/l

0.34

2112

14100

Disorders of other endocrine glands

6931

46536

1.65

243.44

1.7

1.5

2.28

2.30

g/l

0.34

4339

28856

Diseases of the respiratory system

9632

34012

1.54

243.24

1.6

1.4

2.34

2.33

g/l

0.25

6101

20846

Immunodeficiencies

1037

3884

4.61

242.89

4.3

1.5

1.54

2.30

g/l

35.65

768

2393

Acute renal failure

2882

15625

2.15

242.78

2.1

1.5

3.03

2.58

g/l

10.69

2017

9088

Hypothyroidism, strict autoimmune, 3 medication purchases required

12641

63459

1.45

242.68

1.5

2.30

2.34

g/l

1.30

7873

39700

Pure hypercholesterolaemia

9881

44756

1.51

242.65

1.5

2.53

2.47

g/l

1.56

5521

27959

Cardiovascular diseases

10743

41374

1.51

241.61

1.6

1.4

2.25

2.11

g/l

13.90

7277

26936

Pneumonia, organism unspecified

13732

71245

1.42

241.04

1.8

1.4

2.50

2.32

g/l

13.78

9074

44203

Pneumonias (Asthma/COPD co-morbidities)

15419

77397

1.39

240.39

1.8

1.4

2.48

2.31

g/l

14.24

10173

48319

Primary Sclerosing Cholangitis, IBD and UDCA required

610

1697

9.27

239.84

3.3

1.5

2.55

2.24

g/l

3.66

564

1036

Genitourinary diseases

8256

28362

1.58

239.52

1.6

1.5

2.39

2.38

g/l

0.17

5419

18351

Biological medication for rheuma

3184

18326

2.16

238.55

1.7

1.5

2.66

2.25

g/l

27.38

2338

11939

Triptan medication for migraine, single purchase ok

12330

62554

1.46

238.17

1.5

2.10

2.31

g/l

41.62

8167

39745

Migraine, single triptan purchase ok & required. ICD-code if available is included

12330

62554

1.46

238.17

1.5

2.10

2.31

g/l

41.62

8167

39745

Other diseases of intestine

2152

10652

2.43

238.04

1.7

1.5

2.61

2.55

g/l

0.61

1262

6560

Autoimmune hepatitis, wide definition

924

3202

4.53

237.76

2.1

1.4

2.70

2.36

g/l

5.38

734

1956

All pneumoniae

15503

77575

1.39

237.75

1.8

1.4

2.47

2.31

g/l

14.20

10222

48465

Urinary track infection

10185

36811

1.53

237.65

1.5

1.4

2.16

2.14

g/l

0.52

6449

22882

Persons encountering health services for specific procedures and health care

16410

75030

1.38

235.99

1.7

1.4

2.42

2.31

g/l

7.13

10375

47432

Diseases of oral cavity, salivary glands and jaws

7396

25552

1.61

235.83

1.5

1.4

2.47

g/l

0.05

4452

16568

Coxibs

3892

11695

1.95

235.48

1.5

2.33

2.42

g/l

2.05

2467

7408

Cholelithiasis

11708

59170

1.45

235.07

1.6

1.5

2.48

2.38

g/l

6.13

7479

36463

Other disorders of fluid, electrolyte and acid-base balance

4112

23398

1.87

234.68

1.8

1.5

2.95

2.54

g/l

15.58

2669

13784

Symptoms and signs involving the nervous and musculoskeletal systems

8419

59787

1.55

234.46

1.6

1.5

2.29

2.40

g/l

5.82

5537

36694

Cholelithiasis, broad definition with cholecystitis

12136

60126

1.44

234.28

1.6

1.5

2.50

2.38

g/l

7.99

7764

37117

Diabetes, insulin treatment (Kela reimbursement)

14418

65337

1.40

233.99

1.6

1.5

2.69

2.33

g/l

68.36

8655

41265

Diabetes, varying definitions

15333

68311

1.39

233.55

1.6

1.5

2.61

2.27

g/l

68.86

9377

43490

Sicca syndrome [Sjögren]

1530

6907

3.12

232.15

2.0

1.5

2.60

2.34

g/l

5.94

1052

4134

Fibromyalgia

1781

8523

2.82

231.52

1.7

1.4

2.15

2.23

g/l

1.13

1086

5522

Transplanted organ and tissue status

1682

7854

2.88

230.84

3.0

1.5

2.37

2.38

g/l

0.02

1353

4780

Haemorrhage from respiratory passages

4394

23863

1.81

230.40

1.7

1.5

2.71

2.52

g/l

5.84

2758

14192

Complications of procedures, not elsewhere classified

11802

71062

1.44

230.30

1.6

1.5

2.44

2.38

g/l

2.49

7452

44618

Renal tubulo-interstitial diseases

12738

70446

1.42

229.60

1.8

1.5

2.65

2.31

g/l

40.78

8274

43507

Alcoholic liver disease

1464

6362

2.96

228.50

1.7

1.5

5.15

2.50

g/l

134.57

1173

3877

Explicit Sepsis, including avohilmo

6106

36956

1.65

226.75

2.0

1.5

2.77

2.40

g/l

23.04

4317

21906

Personality disorders, excluding more controls

4255

26488

1.86

225.98

1.5

1.4

2.23

g/l

0.00

2358

18267

Undetermined asthma, excluding more controls

2093

10560

2.42

222.85

1.8

1.3

2.34

2.30

g/l

0.27

1341

6361

Explicit Sepsis

5953

36160

1.65

222.31

2.0

1.5

2.77

2.40

g/l

22.01

4220

21394

Other symptoms and signs involving the digestive system and abdomen

2614

14259

2.19

221.55

1.8

1.4

2.30

2.33

g/l

0.22

1693

8482

Dizziness and giddiness

10717

61671

1.46

221.47

1.5

2.32

2.40

g/l

3.35

6394

38979

Weight loss

1731

8308

2.76

220.97

1.7

1.5

2.38

2.41

g/l

0.24

1015

4955

Septicaemia

5550

33269

1.68

220.82

2.0

1.5

2.82

2.45

g/l

19.42

3932

19193

Other arthrosis

6909

31579

1.60

217.88

1.5

2.45

2.47

g/l

0.24

4030

19861

Other reaction to severe stress, and adjustment disorders

6058

41202

1.66

217.69

1.7

1.4

2.22

2.24

g/l

0.51

3742

27526

Abnormal weight loss

1593

7449

2.86

217.42

1.6

1.5

2.41

2.46

g/l

0.35

934

4435

Abnormal serum enzyme levels

3624

20886

1.89

217.06

1.8

1.5

2.57

2.69

g/l

2.63

2679

12801

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

14910

77068

1.38

216.22

1.8

1.4

2.49

2.31

g/l

15.13

9814

48101

Migraine with aura

4479

28738

1.82

215.74

1.5

1.4

2.04

2.18

g/l

9.18

2855

18553

Factors influencing health status and contact with health services

3919

11471

1.87

215.73

1.6

1.3

2.48

2.43

g/l

0.69

2490

7703

Undetermined asthma

2093

10692

2.38

215.47

1.8

1.3

2.34

2.31

g/l

0.18

1341

6475

Asthma/COPD (KELA code 203)

14496

74921

1.38

215.23

1.5

2.37

2.32

g/l

2.09

9422

47003

L04AD Calcineurin inhibitors

1895

9580

2.63

214.63

2.5

1.5

2.53

2.34

g/l

3.54

1480

5977

Hypertensive diseases (excluding secondary)

7944

32499

1.56

214.27

1.6

1.4

2.47

2.20

g/l

28.52

5208

21103

Coagulation defects, purpura and other haemorrhagic conditions

3019

17490

2.07

214.05

2.0

1.5

2.51

2.36

g/l

3.03

2160

10844

Vasomotor and allergic rhinitis

6212

41623

1.64

212.98

1.6

1.5

2.22

2.28

g/l

2.00

3938

26732

Complications of medical and surgical care

10472

70107

1.45

212.50

1.7

1.5

2.46

2.38

g/l

2.70

6483

43833

Temporomandibular joint disorders, including avohilmo

7707

53484

1.56

212.12

1.6

1.5

2.09

2.22

g/l

10.08

4911

34318

Other septicaemia, including avohilmo

5010

30520

1.70

212.06

2.0

1.5

2.84

2.46

g/l

18.97

3552

17497

Lumbar disc prolapse

8964

47998

1.50

211.45

1.5

2.37

2.41

g/l

1.09

5704

30549

Gout

3129

15315

1.96

211.26

1.9

1.5

3.00

2.71

g/l

5.03

2083

9084

Hyperkinetic disorders, excluding more controls

2706

14339

2.21

211.20

1.6

1.4

1.96

2.03

g/l

2.49

1681

9951

Hypertension, essential

10841

45397

1.45

210.18

1.6

1.5

2.55

2.31

g/l

25.82

6966

29203

Vocal cord dysfunction

2031

8957

2.35

210.11

1.6

1.4

2.28

2.18

g/l

1.68

1290

5837

Cardiac arrhythmias

9285

43284

1.50

209.93

1.6

1.4

2.36

2.19

g/l

12.97

6049

28119

Benign neoplasms

14746

62088

1.37

209.39

1.6

1.5

2.35

g/l

0.13

9554

40037

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1229

5171

3.16

208.95

2.4

1.5

3.32

2.53

g/l

13.47

959

2955

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

8930

62741

1.50

208.49

1.5

2.23

2.25

g/l

0.60

5406

39864

Other septicaemia

4883

29831

1.71

208.39

2.0

1.5

2.84

2.46

g/l

18.25

3468

17087

Diabetes medication

15431

70366

1.36

208.20

1.6

1.5

2.61

2.29

g/l

64.76

9321

44770

Visual disturbances and blindness

7589

54042

1.54

207.77

1.6

1.5

2.26

2.39

g/l

6.96

4499

33267

ILD, hospital admission 2, with pulmonary infections

1373

6008

2.85

207.42

2.1

1.4

2.79

2.61

g/l

1.93

1031

3362

Use of hypnotics and sedatives

15154

67535

1.36

204.71

1.6

1.5

2.43

2.39

g/l

1.32

9255

43222

Cholecystectomy

9707

61155

1.45

200.24

1.5

2.40

2.41

g/l

0.03

6194

37682

Rotator cuff syndrome

7972

39108

1.51

200.10

1.5

2.43

2.50

g/l

2.21

4993

24692

Allergic conjunctivitis

9289

66415

1.48

200.04

1.5

2.23

2.25

g/l

0.39

5636

42194

Other acute lower respiratory infections

7828

53591

1.52

200.01

1.8

1.5

2.36

g/l

0.07

5057

33372

Crohn disease

2217

12031

2.31

199.43

1.8

1.5

2.50

2.30

g/l

6.50

1662

7748

Type 2 diabetes, wide definition

10321

48388

1.44

197.58

1.6

1.5

2.82

2.37

g/l

63.84

6392

29896

Syncope and collapse

5929

33609

1.60

197.39

1.6

1.4

2.48

2.42

g/l

1.18

3498

20094

Migraine without aura

3775

23851

1.88

196.93

1.6

1.4

2.04

2.13

g/l

3.08

2450

15585

Visual disturbances

7084

50441

1.55

196.22

1.6

1.5

2.24

2.38

g/l

8.50

4218

31166

Purpura and other haemorrhagic conditions

2109

11281

2.32

195.40

2.2

1.5

2.63

2.41

g/l

3.82

1579

6926

Primary biliary cholangitis, wide definition

532

1509

7.02

194.79

2.1

1.4

2.77

2.35

g/l

4.29

450

866

ILD, hospital admissions

1968

10178

2.32

194.22

2.0

1.5

2.80

2.62

g/l

2.59

1441

5891

Symptoms and signs involving the urinary system

10295

58187

1.43

193.75

1.6

1.5

2.51

2.42

g/l

3.43

6299

35972

Other interstitial pulmonary diseases

1983

10293

2.30

193.18

2.0

1.5

2.81

2.63

g/l

2.79

1453

5941

Interstitial lung disease

1983

10294

2.30

193.13

2.0

1.5

2.81

2.63

g/l

2.75

1453

5951

Interstitial lung disease endpoints

1983

10294

2.30

193.13

2.0

1.5

2.81

2.63

g/l

2.75

1453

5951

Gingivitis and periodontal diseases

14091

56516

1.37

192.13

1.5

2.42

2.36

g/l

2.11

8436

36613

Symptoms and signs involving speech and voice

4681

30901

1.71

191.99

1.6

1.5

2.34

2.41

g/l

1.26

2771

18863

Rheumatoid arthritis, including avohilmo

5154

34677

1.66

191.89

1.6

1.5

2.62

2.40

g/l

10.18

3465

20726

Other diseases of lip and oral mucosa

6178

43180

1.59

191.40

1.6

1.5

2.34

2.37

g/l

0.56

3714

26813

Generalized anxiety disorder

3112

18891

1.99

190.40

1.5

1.4

2.15

g/l

0.01

1787

12765

Other inflammatory liver diseases

1133

4867

3.25

189.52

2.0

1.5

2.68

2.33

g/l

7.09

890

2933

Urticaria and erythema

5783

40113

1.62

189.51

1.7

1.5

2.27

2.25

g/l

0.26

3695

25272

Acetic acid derivatives and related substances

3645

11238

1.85

189.40

1.5

2.37

2.44

g/l

1.07

2266

7113

Obesity and other hyperalimentation

9699

68647

1.44

188.21

1.5

2.57

2.29

g/l

32.79

6069

43874

Seropositive rheumatoid arthritis

3337

20249

1.87

187.79

1.7

1.5

2.73

2.40

g/l

15.07

2294

11764

Continuous positive airway pressure

2440

11209

2.08

187.14

1.7

1.5

2.62

2.33

g/l

4.90

1464

6924

Obesity

9657

68476

1.44

186.98

1.5

2.58

2.29

g/l

33.09

6037

43763

Other respiratory diseases principally affecting the interstitium

2245

12253

2.14

186.13

2.0

1.5

2.79

2.62

g/l

2.71

1638

7097

Tumor necrosis factor alpha inhibitors

2776

16490

2.06

185.73

1.7

1.5

2.63

2.24

g/l

24.98

2032

10736

Allergic asthma (mode), excluding more controls

3794

23465

1.79

184.75

1.6

1.3

2.27

2.20

g/l

2.11

2518

14942

Oesophageal varices

746

2638

4.34

184.64

2.0

1.6

4.82

2.60

g/l

53.28

623

1597

Non-selective monoamine reuptake inhibitors

4759

30256

1.67

184.50

1.5

2.41

2.45

g/l

0.74

2776

18746

Inflammatory diseases of female pelvic organs

10246

53229

1.44

184.46

1.5

2.15

2.18

g/l

0.91

6323

33147

Neoplasms

12072

48560

1.39

183.72

1.7

1.4

2.25

2.28

g/l

1.20

8110

31391

Other inflammation of eyelid, including avohilmo

7221

52304

1.52

183.40

1.6

1.5

2.22

2.27

g/l

1.62

4476

33500

Spinal stenosis

5919

29942

1.57

181.70

1.6

1.5

2.55

2.59

g/l

0.60

3524

17859

Chronic hepatitis, not elsewhere classified

714

2533

4.77

181.69

2.2

1.5

3.02

2.25

g/l

14.19

588

1518

Other heart diseases, wide

13746

65269

1.36

180.62

1.6

1.5

2.41

2.28

g/l

11.79

8965

41412

Allergic asthma (mode)

3795

23619

1.78

180.16

1.6

1.4

2.27

2.21

g/l

1.65

2519

15053

Dental operations

7686

28159

1.50

179.77

1.5

1.4

2.49

2.48

g/l

0.08

4696

17958

Cholangitis (primary sclerosing, PSC)

1036

4341

3.23

179.23

2.6

1.5

2.64

2.45

g/l

2.05

864

2586

Disorders of synovium and tendon

7617

46927

1.49

179.09

1.5

2.28

2.37

g/l

4.27

4811

30005

Acute bronchitis

5729

39047

1.58

177.23

1.9

1.5

2.38

g/l

0.03

3628

23981

ILD, hospital admissions 1, main diag only

1764

9080

2.34

177.16

2.0

1.5

2.82

2.63

g/l

2.76

1287

5280

Voice disturbances

3843

24809

1.77

176.59

1.6

1.5

2.28

2.38

g/l

2.27

2287

15263

Cardiovascular diseases (excluding rheumatic etc)

10556

45951

1.42

176.28

1.6

1.4

2.33

2.13

g/l

22.51

7109

29830

Cholangitis (primary sclerosing, PSC), with reimbursement 202

499

1502

8.17

176.21

3.3

1.5

2.57

2.25

g/l

4.16

457

914

Other bacterial intestinal infections

2498

14364

2.02

175.96

1.8

1.5

2.44

2.46

g/l

0.14

1650

8703

Somatoform disorder

2598

15275

2.04

175.87

1.6

1.5

2.17

2.32

g/l

3.97

1565

9931

Triptan medication for migraine, min. 3 purchases

9435

53374

1.45

175.79

1.5

2.04

2.22

g/l

30.12

6406

34347

Other external causes of accidental injury

11960

46036

1.38

175.46

1.5

2.37

2.29

g/l

4.06

7342

30285

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2826

17030

1.97

174.97

1.8

1.5

2.45

2.34

g/l

2.90

2062

11070

Mucosal proctocolitis

2091

11600

2.22

174.06

1.9

1.5

2.52

2.33

g/l

4.71

1493

7571

Osteoporosis with pathological fracture (FG)

1087

4686

3.01

173.70

2.0

1.5

2.65

2.44

g/l

1.23

666

2409

Fall on same level

17195

74032

1.31

171.46

1.5

2.48

2.29

g/l

23.09

10272

47989

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2597

15406

2.02

171.25

1.8

1.5

2.46

2.32

g/l

3.23

1901

10031

Sulfasalazine

3939

25618

1.72

170.51

1.6

1.4

2.61

2.35

g/l

12.24

2657

15466

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8308

60714

1.45

169.98

1.6

1.5

2.48

2.40

g/l

2.21

5096

37634

Soft tissue disorders related to use, overuse and pressure

3674

23503

1.75

169.66

1.5

2.36

2.48

g/l

3.22

2208

14551

Fissure and fistula of anal and rectal regions

3175

19614

1.82

168.96

1.6

1.5

2.38

2.44

g/l

0.89

1985

12541

Infections of the skin and subcutaneous tissue

8623

63747

1.44

168.86

1.7

1.5

2.46

2.35

g/l

5.42

5506

40647

Ulcerative colitis (strict definition, require KELA)

2651

15868

1.99

168.74

1.8

1.5

2.46

2.33

g/l

3.25

1936

10336

Chronic diseases of tonsils and adenoids

11704

57335

1.38

168.47

1.5

2.06

2.35

g/l

69.11

7610

36422

Non-follicular lymphoma

1320

6256

2.66

168.40

2.7

1.5

1.99

2.67

g/l

19.64

1085

3661

Exposure to other specified factors

12098

81540

1.36

167.91

1.5

2.34

2.33

g/l

0.14

7428

52020

Faecal incontinence

1371

6600

2.59

167.41

1.6

1.4

2.25

2.41

g/l

2.39

735

3735

Subjective visual disturbances

3784

24676

1.75

166.67

1.6

1.5

2.17

2.37

g/l

9.93

2148

15247

Non-allergic asthma (mode), excluding more controls

2646

15508

1.93

166.36

1.6

1.4

2.33

2.29

g/l

0.49

1721

9158

Dental caries, including avohilmo

9626

36942

1.42

166.30

1.5

2.44

2.40

g/l

0.90

5803

23745

Ascites

1084

4739

2.91

166.22

1.8

1.5

4.36

2.53

g/l

52.70

880

2807

Diseases of the ear and mastoid process

17049

69071

1.30

166.14

1.6

1.5

2.27

2.36

g/l

7.28

10749

44197

Thrombocytopenia, unspecified

1164

5334

2.90

165.72

2.2

1.5

2.63

2.49

g/l

0.91

919

3245

Hyperlipidaemia, other/unspecified

4501

26971

1.64

165.67

1.6

1.5

2.58

2.60

g/l

0.25

2716

15931

Excessive, frequent and irregular menstruation

6099

22911

1.58

165.63

1.5

1.4

2.09

2.15

g/l

2.10

3894

14268

Gout, FINNGEN

3129

19103

1.80

165.01

1.9

1.5

3.00

2.71

g/l

5.11

2083

11153

Primary biliary cholangitis (PBC)

474

1390

6.34

163.64

2.0

1.4

2.56

2.36

g/l

1.40

398

797

KRA_PSY_EATING, excluding more controls

1744

9363

2.43

163.32

1.6

1.4

1.93

1.99

g/l

1.22

1038

6401

Chronic apical periodontitis

16288

73859

1.30

162.34

1.6

1.5

2.44

2.34

g/l

7.39

9804

47439

Concussion

7487

42617

1.47

161.86

1.6

1.4

2.40

2.30

g/l

4.31

4727

27292

Type1 diabetes, definitions combined, early onset

1415

7252

2.80

161.68

1.7

1.5

2.16

2.05

g/l

2.20

683

4717

Falls/tendency to fall

15996

64521

1.31

161.65

1.5

2.41

2.28

g/l

10.44

9814

42065

Bronchiectasis

1128

5110

2.83

161.04

2.0

1.5

2.60

2.51

g/l

0.78

820

2915

Hypertension

10897

47351

1.38

160.93

1.6

1.5

2.52

2.29

g/l

25.01

7043

30377

Other arrhythmias

9032

51000

1.42

160.71

1.5

2.33

2.32

g/l

0.13

5571

31911

Hypertensive diseases

10902

47412

1.38

160.22

1.6

1.5

2.52

2.29

g/l

25.12

7049

30409

Nonorganic sleeping disorders

3558

23209

1.78

159.87

1.6

1.5

2.21

2.26

g/l

0.85

2112

15205

Viral hepatitis, IBD co-morbidity

854

3383

3.20

159.33

1.5

1.3

2.58

2.28

g/l

4.59

572

2347

Benign neoplasm: Colon, unspecified

3051

18978

1.82

158.88

1.6

1.5

2.70

2.60

g/l

1.18

1702

11217

Accidents

11820

46036

1.36

158.59

1.5

2.36

2.29

g/l

3.78

7280

30285

Other heart diseases

7135

33857

1.49

158.38

1.7

1.4

2.42

2.17

g/l

20.98

4766

21804

Non-allergic asthma (mode)

2647

15730

1.90

158.31

1.6

1.4

2.33

2.31

g/l

0.19

1721

9329

Other retinal disorders

7980

45032

1.44

158.14

1.6

1.5

2.66

2.51

g/l

5.64

4617

27145

Missing teeth due to accident, extraction or parodontitis

7897

52618

1.44

158.01

1.6

1.5

2.59

2.49

g/l

3.13

4465

32235

Oxicams

2724

8987

1.89

157.71

1.5

2.51

2.56

g/l

0.47

1811

5629

Oxycodone

4680

27125

1.60

156.83

2.2

1.4

2.62

2.51

g/l

1.32

3144

16254

Ulcerative colitis, NAS

2166

12521

2.08

155.71

1.8

1.5

2.49

2.33

g/l

4.00

1575

8015

Polyuria

2813

17235

1.85

155.48

1.6

1.5

2.41

2.56

g/l

3.10

1613

10455

Heart failure and antihypertensive medication

2953

11621

1.84

155.00

1.8

1.5

2.93

2.41

g/l

21.13

1990

6993

Diseases of pulp and periapical tissues and dental caries

8595

32818

1.43

154.84

1.5

1.4

2.44

2.40

g/l

0.84

5146

21127

Urticaria

4754

33074

1.62

154.57

1.7

1.5

2.21

2.23

g/l

0.31

3014

20991

Bacterial intestinal infections, IBD co-morbidities

2486

14831

1.93

154.06

1.8

1.5

2.44

2.47

g/l

0.21

1644

8985

Disorders of skin appendages

7699

57552

1.45

153.91

1.6

1.5

2.31

2.28

g/l

0.57

4951

36679

Heartburn

1672

8923

2.24

151.72

1.5

1.4

2.21

2.36

g/l

2.96

996

5560

Care involving use of rehabilitation procedures

8844

60662

1.40

151.63

1.6

1.5

2.36

2.37

g/l

0.19

5454

37689

Atopic dermatitis, strict definition with reimbursement

5098

34609

1.59

151.22

1.6

1.5

2.27

2.16

g/l

4.11

3230

22554

Type 2 diabetes

13693

63347

1.32

151.08

1.6

1.5

2.65

2.29

g/l

66.31

8559

40441

Asthma and allergy, excluding more controls

2309

13510

2.00

150.84

1.6

1.4

2.21

2.14

g/l

1.61

1504

8683

2293

13592

2.01

150.65

1.7

1.4

2.24

g/l

0.03

1346

8868

Asthma and allergy

2309

13512

2.00

150.55

1.6

1.4

2.21

2.14

g/l

1.32

1504

8707

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7635

57163

1.44

149.73

1.6

1.5

2.50

2.41

g/l

2.61

4632

35408

Caries of dentine, including avohilmo

10543

41567

1.37

149.68

1.5

2.43

2.38

g/l

1.56

6344

26735

Other diseases of the digestive system

3768

24830

1.67

149.44

1.6

1.5

2.99

2.55

g/l

17.58

2425

14811

Other enthesopathies

4074

27448

1.64

148.68

1.5

2.27

2.39

g/l

3.34

2560

17480

Injuries to the ankle and foot

11070

74605

1.35

148.43

1.6

1.5

2.30

2.31

g/l

0.25

6892

48068

Migraine without aura and triptan purchases

3022

19470

1.85

147.38

1.6

1.5

2.03

2.15

g/l

5.15

1960

12755

Rheumatism, unspecified

1941

11002

2.11

147.33

1.6

1.5

2.28

2.36

g/l

1.27

1185

6618

Obesity due to excess calories

7149

53502

1.46

147.30

1.5

2.60

2.28

g/l

33.74

4570

34359

Cervicalgia

2861

17879

1.81

147.22

1.5

2.27

2.40

g/l

3.25

1728

11012

Diseases of pulp and periapical tissues, including avohilmo

15212

63732

1.30

146.55

1.5

2.41

2.31

g/l

6.51

9191

40838

Implicit fungal Sepsis, including avohilmo

1142

5471

2.71

144.84

2.0

1.5

2.56

2.41

g/l

0.91

769

3226

ILD, hospital admissions 3, with pneumonia sepsis

1117

5222

2.61

144.11

2.2

1.4

2.77

2.61

g/l

1.40

844

2942

Other viral diseases, including avohilmo

6116

44476

1.50

144.10

1.7

1.5

2.17

2.22

g/l

1.85

4179

28865

Papulosquamous disorders

5263

37594

1.54

142.51

1.6

1.5

2.68

2.42

g/l

9.91

3292

23289

Zoster [herpes zoster], including avohilmo

6816

48883

1.45

142.04

1.7

1.5

2.37

2.44

g/l

2.06

4272

29455

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

14225

72835

1.30

141.71

1.7

1.5

2.44

2.31

g/l

8.29

9213

45677

Irregular menses

8058

46262

1.43

141.67

1.5

1.4

2.09

2.15

g/l

3.03

5196

29478

Disorders of mineral metabolism

1287

6475

2.48

141.29

2.2

1.5

2.67

2.46

g/l

1.15

904

3930

Migraine with aura and triptan purchases

2895

18654

1.85

141.15

1.6

1.5

1.98

2.15

g/l

11.40

1869

12115

All influenza

3533

23376

1.68

140.90

2.2

1.4

2.35

2.40

g/l

0.57

2352

14139

Fenamates

1950

7380

2.05

140.36

1.5

2.30

2.43

g/l

1.43

1175

4611

Dermatophytosis, including avohilmo

9257

70541

1.37

140.14

1.5

2.35

2.39

g/l

1.03

5857

44813

Disorders of choroid and retina

10168

55529

1.36

140.11

1.6

1.5

2.59

2.47

g/l

4.94

5989

34238

Paracetamol or NSAID medication

2473

7258

1.89

139.21

1.5

2.27

2.23

g/l

0.37

1570

4451

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4169

25284

1.66

138.70

1.6

1.5

1.97

2.06

g/l

4.90

2527

16907

Disorders of lens

8005

37423

1.41

138.61

1.7

1.5

2.68

2.49

g/l

7.76

4825

23257

Excessive attrition of teeth

9112

70280

1.38

138.55

1.5

2.26

2.32

g/l

2.25

5550

45203

Endometriosis

4991

20377

1.58

138.51

1.5

1.4

2.15

2.20

g/l

1.17

3042

12760

Dialysis, with operation codes

1666

9159

2.17

138.45

2.2

1.5

2.63

2.49

g/l

1.57

1198

5570

Viral and other specified intestinal infections, including avohilmo

4702

31960

1.58

138.19

1.6

1.5

2.19

g/l

0.01

3160

20720

Viral infections characterized by skin and mucous membrane lesions

5937

43472

1.49

138.17

1.9

1.5

2.28

2.37

g/l

2.78

3983

27123

Mycoses

3888

26483

1.64

137.50

1.7

1.5

2.42

2.40

g/l

0.23

2599

16482

GI-bleeding

3698

24695

1.64

137.23

1.6

1.5

2.99

2.55

g/l

17.11

2403

14741

Menorrhagia

4852

18900

1.58

136.53

1.5

2.15

2.22

g/l

1.23

3039

11710

Polyarthrosis

2566

14214

1.83

136.27

1.5

2.46

2.47

g/l

0.08

1585

8188

Glomerular diseases

2355

14347

1.89

135.97

2.1

1.5

2.74

2.47

g/l

7.07

1671

8852

Oter anti-inflammatory and antirheumatic agents, non-steroids

2315

7328

1.89

135.62

1.5

2.52

2.67

g/l

2.26

1392

4560

Hypo-osmolality and hyponatraemia

2143

12539

1.92

135.26

1.7

1.5

3.00

2.54

g/l

9.62

1384

7232

Panic disorder

2570

16188

1.87

135.26

1.5

1.4

2.17

g/l

0.07

1472

10980

Herpesviral [herpes simplex] infections, including avohilmo

4053

28082

1.63

134.77

1.6

1.5

2.17

2.24

g/l

1.94

2670

17980

Abnormal results of function studies

1418

7552

2.35

134.59

1.9

1.5

2.53

2.37

g/l

2.16

1019

4681

Pain in thoracic spine

2258

13671

1.91

133.89

1.6

1.5

2.21

2.34

g/l

3.31

1443

8628

Dipeptidyl peptidase 4 (DPP-4) inhibitors

6388

36925

1.45

133.67

1.6

1.5

2.97

2.51

g/l

35.67

3972

21880

Personality disorders

4255

29811

1.61

133.62

1.5

2.23

g/l

0.11

2358

19903

Secondary and unspecified malignant neoplasm of lymph nodes

1176

5828

2.49

133.04

2.4

1.4

1.99

2.56

g/l

14.23

930

3427

Pruritus

1790

10248

2.10

132.76

1.7

1.5

2.31

g/l

0.07

1114

6326

Intracranial trauma

8373

43327

1.39

132.50

1.6

1.4

2.44

2.29

g/l

8.69

5275

27749

Ulcerative colitis (strict definition, all Crohn cases excluded)

2193

13302

1.95

132.46

1.8

1.5

2.40

2.33

g/l

1.17

1577

8623

Other necrotizing vasculopathies (FG)

861

3784

2.93

131.82

1.9

1.5

2.30

2.55

g/l

3.41

647

2184

Disorders of adult personality and behaviour

4515

32070

1.58

131.35

1.5

2.20

2.22

g/l

0.28

2515

21445

Other and unspecified immunodeficiencies with predominantly antibody defects

353

1055

10.67

131.16

6.2

1.5

1.20

2.27

g/l

26.27

288

657

Any operation in hilmo

647

1098

3.49

131.11

1.4

1.2

2.28

2.17

g/l

0.88

409

820

Cervical disc disorders

4339

30242

1.56

130.90

1.6

1.5

2.39

2.50

g/l

3.09

2723

18772

Infections with a predominantly sexual mode of transmission, including avohilmo

6613

45607

1.46

130.90

1.5

1.4

2.19

2.18

g/l

0.21

4069

30419

Disturbance of activity and attention

2681

16963

1.87

130.39

1.6

1.5

1.95

2.02

g/l

2.40

1659

11309

Colitis, primary sclerosing

374

1139

8.08

130.26

3.6

1.4

2.55

2.27

g/l

2.87

354

713

Gastroduodenal ulcer

2724

17074

1.74

130.18

1.6

1.5

3.02

2.60

g/l

9.56

1769

10078

Bleeding

10538

58455

1.33

130.04

1.6

1.5

2.71

2.41

g/l

28.43

6601

35808

Statin medication

9704

42653

1.36

129.96

1.5

2.36

2.34

g/l

0.52

6069

28514

Other symptoms and signs involving the nervous and musculoskeletal systems

5789

42680

1.48

129.65

1.6

1.5

2.25

2.37

g/l

5.41

4126

26492

Allergic rhinitis

5078

36444

1.53

129.10

1.6

1.5

2.20

2.19

g/l

0.14

3208

23689

Heart failure,strict

5739

29074

1.47

128.52

1.8

1.5

2.99

2.52

g/l

31.82

3750

16437

Benign neoplasm of other and ill-defined parts of digestive system

2315

14265

1.87

128.40

1.6

1.5

2.42

2.48

g/l

0.85

1442

8551

Diseases of arteries, arterioles and capillaries (FINNGEN)

2891

12642

1.74

128.40

1.7

1.4

2.75

2.37

g/l

14.33

1747

7586

Nonhereditary hypogammaglobulinemia

316

884

12.05

128.36

5.7

1.4

1.30

2.34

g/l

17.18

247

550

External causes of morbidity and mortality

9659

37699

1.36

127.99

1.5

1.4

2.34

2.26

g/l

3.30

5989

24730

Ulcer of lower limb, not elsewhere classified

1748

9916

2.03

127.69

1.7

1.5

3.06

2.60

g/l

10.03

1043

5864

Dental pulpitis, including avohilmo

13674

71597

1.29

127.56

1.5

2.33

g/l

0.06

8576

46391

Chronic pancreatitis

1563

8612

2.13

127.44

1.6

1.5

3.06

2.57

g/l

11.04

999

5259

Other CVD (FINNGEN)

1460

5878

2.20

126.97

1.8

1.4

2.72

2.41

g/l

3.50

839

3238

Paralytic ileus and intestinal obstruction

2836

18157

1.71

125.75

1.6

1.5

2.56

2.57

g/l

0.09

1817

10941

Noninflammatory disorders of female genital tract

6218

23054

1.48

124.63

1.5

1.4

2.07

2.15

g/l

3.40

3879

14342

Hyperkinetic disorders

2785

17936

1.82

124.62

1.6

1.5

1.95

2.02

g/l

2.70

1714

11844

Atrial fibrillation and flutter with reimbursement

2997

12102

1.71

124.58

1.6

1.4

2.71

2.39

g/l

12.91

1872

7108

Benign neoplasm: Ascending colon

1764

10177

2.03

124.33

1.5

2.54

2.61

g/l

0.56

1012

5972

Injuries to the abdomen, lower back, lumbar spine and pelvis

5436

39268

1.48

124.18

1.6

1.5

2.58

2.39

g/l

5.56

3176

24367

Ovarian cyst

5160

21248

1.53

124.13

1.6

1.4

2.15

2.19

g/l

0.76

3247

13302

Other necrotizing vasculopathies

1014

4907

2.62

123.89

1.8

1.5

2.28

2.55

g/l

4.50

757

2898

Atrial fibrillation and flutter

3838

16806

1.60

123.60

1.6

1.4

2.68

2.33

g/l

17.00

2502

10461

Intestinal malabsorption

813

3671

3.08

122.79

1.8

1.5

2.56

2.37

g/l

1.67

521

2306

Crohn's disease of small intestine

1164

6014

2.50

122.71

1.7

1.5

2.47

2.31

g/l

2.61

884

3876

Obesity, other/unspecified

5044

36818

1.51

122.63

1.5

2.54

2.25

g/l

17.75

3036

23982

Seropositive rheumatoid arthritis, wide

3335

22522

1.65

122.07

1.7

1.5

2.73

2.42

g/l

13.92

2293

13312

Other disorders of white blood cells

863

3983

2.91

121.89

1.9

1.5

2.17

2.47

g/l

5.56

638

2471

Chronic laryngitis and laryngotracheitis

1883

11159

1.96

120.52

1.6

1.5

2.43

2.48

g/l

0.45

1117

6893

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3259

21990

1.66

120.09

1.7

1.5

2.74

2.41

g/l

14.70

2242

13001

Injuries to the thorax

5697

42183

1.45

119.96

1.6

1.5

2.61

2.50

g/l

2.84

3434

26311

Senile cataract

7031

32259

1.41

119.85

1.7

1.5

2.74

2.53

g/l

7.55

4127

19681

Glomerular disorders in diseases classified elsewhere

1524

8545

2.12

119.01

2.2

1.5

2.85

2.52

g/l

6.46

1062

5335

Kela reimbursement Agammaglobulinemia (D80-84)

275

752

17.44

118.81

6.5

1.4

1.19

2.31

g/l

15.79

192

480

Disorders of sclera, cornea, iris and ciliary body

7475

57835

1.38

118.67

1.6

1.5

2.47

2.38

g/l

3.24

4887

36453

Other/unspecified seropositive rheumatoid arthritis

3289

22278

1.64

118.63

1.6

1.5

2.74

2.42

g/l

14.20

2261

13163

IBD (strict) with PSC

288

791

11.40

118.59

3.8

1.4

2.59

2.32

g/l

2.00

274

511

Early onset COPD, excluding more controls

2215

13567

1.80

118.51

1.7

1.4

2.73

2.54

g/l

2.26

1368

8151

Disorders of vitreous body and globe

6288

44847

1.42

118.01

1.6

1.5

2.35

2.51

g/l

8.19

3684

26932

6-mercaptopurine

709

3097

3.34

117.59

1.9

1.5

2.27

2.22

g/l

0.33

535

1955

Hepatic failure, not elsewhere classified

609

2439

3.52

117.56

1.9

1.5

4.04

2.41

g/l

26.77

517

1420

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4128

28895

1.56

117.40

1.5

1.4

2.25

2.22

g/l

0.42

2408

19811

Disorders of vitreous body

6137

43946

1.43

116.98

1.6

1.5

2.34

2.51

g/l

8.45

3590

26370

Diseases of salivary glands

4531

32764

1.52

115.79

1.6

1.5

2.32

2.36

g/l

0.72

2829

20423

Specific personality disorders

3679

25782

1.61

115.78

1.5

2.20

2.22

g/l

0.39

2056

17222

Other cataract

5113

27602

1.48

115.73

1.6

1.5

2.64

2.51

g/l

3.09

2962

16600

Other extrapyramidal and movement disorders in other diseases

3194

21636

1.65

115.48

1.5

2.29

2.46

g/l

5.75

1841

13179

Adalimumab

1643

9654

2.09

114.89

1.7

1.5

2.67

2.25

g/l

16.03

1195

6333

Hernia

12521

68021

1.28

114.56

1.5

2.48

2.38

g/l

4.89

7630

43173

Trochanteric bursitis

1992

12151

1.89

114.25

1.5

2.26

2.41

g/l

2.47

1137

7273

Presence of other functional implants

6884

35807

1.39

114.20

1.7

1.5

2.62

2.54

g/l

1.83

4260

20819

Methotrexate

1887

11355

1.92

114.12

1.8

1.4

2.69

2.33

g/l

9.39

1292

6650

Other and unspecified effects of external causes

4173

29932

1.55

113.82

1.6

1.5

2.27

2.25

g/l

0.44

2593

19365

Gout, idiopatic and unspecified

2590

16679

1.71

113.68

1.6

1.5

3.06

2.74

g/l

7.32

1666

9925

Nephropathy related operations

1573

9054

2.05

112.91

2.1

1.5

2.65

2.52

g/l

1.26

1126

5599

Lung transplantation

237

598

19.57

112.49

4.1

1.5

2.06

2.50

g/l

2.68

227

367

Substance abuse, excluding more controls

7145

45940

1.38

112.31

1.5

2.88

2.40

g/l

50.31

4286

30509

Lung transplant status

236

595

19.88

112.24

4.1

1.5

2.07

2.50

g/l

2.64

226

364

Autoimmune hepatitis

251

637

10.77

111.48

2.4

1.4

2.90

2.29

g/l

4.89

225

382

Injuries to the knee and lower leg

17123

77984

1.24

111.40

1.5

2.38

2.34

g/l

1.73

10589

49403

Polycystic ovarian syndrome, consortium definition

11202

52249

1.31

111.39

1.5

1.4

2.14

2.17

g/l

1.53

6918

32441

Erysipelas, including avohilmo

9124

53578

1.33

111.08

1.6

1.4

2.78

2.40

g/l

40.71

5785

32603

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4693

34387

1.50

111.04

1.6

1.5

2.25

2.33

g/l

2.39

2878

21214

Propionic acid derivatives

3740

12809

1.58

110.62

1.5

2.32

2.36

g/l

0.58

2363

7932

Arthrosis

8778

37704

1.34

110.32

1.5

2.48

2.41

g/l

2.18

5578

24034

Thyroiditis, ILD-related definition

1784

10790

1.98

110.23

1.7

1.4

2.13

2.22

g/l

1.51

1089

6619

Adjustment and management of implanted device

1974

12001

1.83

109.94

1.6

1.5

2.71

2.65

g/l

0.52

1077

6782

Unspecified kidney failure

1203

6356

2.19

108.97

2.0

1.5

2.96

2.60

g/l

4.28

797

3607

L04AC Interleukin inhibitors

1102

5836

2.44

108.97

1.7

1.5

2.76

2.31

g/l

9.20

799

3836

Lymphoid leukaemia

800

3723

2.79

108.78

2.3

1.5

1.65

2.57

g/l

22.46

663

2178

Persistent mood disorders

2652

17527

1.70

108.40

1.6

1.5

2.36

2.35

g/l

0.13

1424

11294

Injury, poisoning and certain other consequences of external causes

7889

30654

1.37

108.30

1.5

2.31

2.25

g/l

1.92

4959

19816

Erysipelas

6556

43184

1.39

107.89

1.6

1.4

2.85

2.47

g/l

25.33

4140

25835

Postmenopausal atrophic vaginitis

3218

11803

1.65

107.68

1.5

2.20

2.36

g/l

5.21

1881

6969

Carpal tunnel syndrome

7969

54331

1.35

107.51

1.5

2.34

2.42

g/l

3.15

4967

33900

Disorders of calcium metabolism

941

4669

2.52

107.37

2.4

1.5

2.69

2.48

g/l

0.77

651

2803

Disorders of tooth development and eruption

2375

12363

1.76

107.36

1.6

1.4

2.21

2.29

g/l

1.79

1541

8338

Injuries to the head

16018

79965

1.24

107.06

1.6

1.5

2.47

2.32

g/l

13.76

9793

50800

Deviated nasal septum

3847

27198

1.53

106.89

1.5

2.44

2.58

g/l

3.02

2418

17541

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6148

29310

1.42

106.59

1.6

1.4

2.60

2.21

g/l

32.81

4231

18974

Persons with potential health hazards related to communicable diseases

5974

45400

1.42

105.88

1.7

1.5

2.18

2.19

g/l

0.14

4244

29586

Enthesopathies of lower limb, excluding foot

3064

20944

1.62

104.97

1.5

2.29

2.37

g/l

1.60

1830

13257

Anti-inflammatory and antirheumatic products, non-steroids

3709

12815

1.56

104.89

1.5

2.34

2.36

g/l

0.25

2313

7934

Diabetic maculopathy, excluding more controls

1421

8084

2.05

104.68

1.7

1.5

2.70

2.41

g/l

6.62

833

5101

Persons encountering health services for specific procedures, not carried out

1387

7930

2.13

104.63

1.6

1.5

2.45

2.31

g/l

1.54

687

5152

Gout, strict definition

1892

11540

1.83

104.50

1.6

1.5

3.07

2.77

g/l

4.96

1232

6821

Pollen allergy

3263

22590

1.63

104.28

1.6

1.5

2.12

2.11

g/l

0.08

2011

14735

Chronic lymphocytic leukaemia

438

1551

3.90

104.21

2.0

1.3

1.67

2.83

g/l

11.95

371

870

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

438

1551

3.90

104.21

2.0

1.3

1.67

2.83

g/l

11.95

371

870

Chronic lymphocytic leukaemia, helper endpoint

438

1551

3.90

104.21

2.0

1.3

1.67

2.83

g/l

11.95

371

870

Colitis, primary sclerosing, strict definition

288

864

8.58

103.26

3.7

1.4

2.50

2.30

g/l

1.49

272

565

Gout, unspecified

2118

13332

1.76

102.79

1.6

1.5

3.07

2.75

g/l

6.20

1365

7868

Candidiasis

2096

13405

1.82

102.25

1.7

1.5

2.35

2.32

g/l

0.22

1381

8349

Benign neoplasm: Sigmoid colon

2211

14172

1.75

102.22

1.5

2.56

2.59

g/l

0.21

1279

8412

Iron deficiency anaemia secondary to blood loss (chronic)

1935

11996

1.82

101.96

1.7

1.5

2.92

2.44

g/l

12.85

1300

7127

Other specified/unspecified systemic involvement of connective tissue

906

4581

2.58

101.74

1.9

1.5

2.49

2.31

g/l

2.13

657

2834

Cervicobrachial syndrome

2915

19860

1.62

101.45

1.5

1.4

2.22

2.37

g/l

4.89

1889

12480

Childhood asthma (age<16), excluding more controls

2400

12283

1.75

101.02

1.5

1.4

2.05

2.10

g/l

1.06

1648

8120

Polymyalgia rheumatica

1497

8682

1.96

100.93

1.6

1.5

2.59

2.65

g/l

0.54

962

4790

Asthma and opportunity respiratory infection

683

3083

2.94

100.71

2.0

1.5

2.60

2.57

g/l

0.10

497

1772

Adverse effects, not elsewhere classified

2983

20651

1.64

100.43

1.6

1.5

2.22

2.24

g/l

0.26

1845

13177

Disorders of parathyroid gland

2466

16052

1.69

100.27

1.8

1.5

2.38

2.48

g/l

1.32

1483

9210

Other general symptoms and signs

929

4714

2.52

100.01

1.7

1.4

2.13

2.18

g/l

0.50

581

2877

Childhood asthma (age<16)

2401

12321

1.74

99.95

1.5

1.4

2.05

2.11

g/l

1.22

1649

8148

Ulcerative colitis (strict) with PSC

234

626

12.06

99.88

3.8

1.4

2.61

2.28

g/l

2.31

225

401

Extrapyramidal and movement disorders

4596

33941

1.46

99.87

1.5

2.30

2.51

g/l

10.68

2616

20383

Percutaneous Coronary Intervention

9557

46779

1.31

99.61

1.6

1.5

2.55

2.46

g/l

3.77

6251

28339

Bipolar affective disorders

2785

19014

1.65

98.94

1.5

1.4

2.27

2.25

g/l

0.20

1559

12935

Other symptoms and signs involving cognitive functions and awareness

5479

36701

1.41

98.58

1.5

2.55

2.54

g/l

0.21

2982

22314

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

661

3011

3.07

98.44

1.8

1.5

2.42

2.32

g/l

0.79

364

2130

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3075

21569

1.63

98.42

1.6

1.4

2.09

2.12

g/l

0.46

1972

13867

Eating disorder

1754

11059

1.99

98.14

1.6

1.4

1.94

2.00

g/l

1.22

1040

7273

Phobic anxiety disorders

2263

14868

1.76

97.95

1.6

1.4

2.21

2.15

g/l

0.97

1290

10146

Other viral diseases, not elsewhere classified, including avohilmo

4102

29909

1.51

97.61

1.7

1.5

2.17

2.23

g/l

1.20

2779

19294

Fracture of rib(s), sternum and thoracic spine

3544

25134

1.53

97.37

1.6

1.5

2.72

2.57

g/l

2.86

2126

15488

Atopic dermatitis, strict definition

4854

35839

1.46

97.23

1.6

1.5

2.23

2.14

g/l

3.10

3051

23387

Gastric ulcer

1841

11325

1.79

97.05

1.6

1.5

3.03

2.57

g/l

7.12

1190

6673

SLE (Finngen)

579

2486

3.22

96.97

1.9

1.4

2.38

2.24

g/l

1.19

404

1502

Diffuse large B-cell lymphoma, helper endpoint

666

2998

2.85

96.83

2.9

1.3

1.96

2.72

g/l

22.78

551

1709

Diffuse large B-cell lymphoma

666

2998

2.85

96.83

2.9

1.3

1.96

2.72

g/l

22.78

551

1709

Diffuse large B-cell lymphoma, including Hilmo

666

2998

2.85

96.83

2.9

1.3

1.96

2.72

g/l

22.78

551

1709

Deforming dorsopathies

3688

26460

1.52

96.66

1.6

1.5

2.23

2.34

g/l

3.24

2299

16272

Fracture of lumbar spine and pelvis

2629

17614

1.64

96.47

1.7

1.5

2.86

2.49

g/l

5.85

1450

10440

Viral pneumonia

1721

10551

1.87

96.41

2.3

1.4

2.36

2.38

g/l

0.09

1168

6413

Other and unspecified urticaria

2912

20215

1.63

96.26

1.6

1.5

2.21

2.25

g/l

0.73

1821

12785

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

9475

70368

1.30

96.17

1.5

2.20

2.29

g/l

6.58

6127

45279

Restless leg syndrome

1976

12629

1.81

95.93

1.6

1.5

2.22

2.39

g/l

4.35

1178

7806

Iron deficiency

705

3414

3.12

95.91

1.7

1.5

2.04

2.05

g/l

0.14

512

2248

Vascular disorders of the intestines

755

3514

2.52

95.74

1.6

1.5

2.92

2.77

g/l

0.89

480

2039

Acne, including avohilmo

4057

24169

1.52

95.35

1.5

2.03

2.07

g/l

1.16

2645

15855

Other Crohn's disease

1104

6085

2.26

95.18

1.8

1.5

2.61

2.29

g/l

7.83

830

3952

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1123

6249

2.27

95.10

1.7

1.5

2.45

2.29

g/l

2.74

834

4083

Psoriasis

3638

26161

1.52

95.04

1.6

1.5

2.77

2.42

g/l

11.98

2281

16497

Crohn disease (strict definition, require KELA, min 2 HDR)

1056

5772

2.34

95.00

1.7

1.5

2.46

2.28

g/l

3.00

793

3755

Spondyloarthritis

2265

14844

1.70

94.33

1.6

1.4

2.70

2.40

g/l

8.27

1587

9348

Crohn disease (strict definition, require KELA)

1066

5856

2.32

94.31

1.7

1.5

2.45

2.28

g/l

2.98

799

3814

Exclusions for E4_PCOS_BROAD

2515

17024

1.68

94.09

1.8

1.5

2.35

2.29

g/l

0.59

1663

10681

Internal derangement of knee

4684

34622

1.43

93.67

1.6

1.5

2.38

g/l

0.03

2983

22065

Stomatitis and related lesions

2843

19727

1.62

93.30

1.7

1.5

2.28

2.31

g/l

0.36

1755

12356

Heart failure, strict

6113

32649

1.37

93.30

1.8

1.5

2.99

2.58

g/l

27.58

3965

18602

Benign neoplasm: Rectum

2073

13385

1.74

92.99

1.6

1.5

2.51

2.58

g/l

0.63

1206

7949

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

12395

65235

1.25

92.93

1.6

1.5

2.63

2.38

g/l

22.10

7902

41104

Coronary revascularization (ANGIO or CABG)

9507

46807

1.29

92.86

1.6

1.5

2.55

2.46

g/l

3.72

6218

28355

Enterocolitis due to Clostridium difficile

1317

7566

2.01

92.80

1.9

1.5

2.48

2.54

g/l

0.38

915

4505

Eating disorders

1929

12524

1.86

92.74

1.6

1.5

1.97

2.05

g/l

2.03

1152

8194

Thyrotoxicosis, other and/or unspecified

2749

18930

1.62

92.49

1.5

2.24

2.33

g/l

1.69

1658

11670

Ischemic heart diseases

10110

49113

1.28

92.49

1.6

1.5

2.55

2.44

g/l

5.44

6580

29955

Emergency coronary revascularization (for ACS)

10112

49786

1.28

92.40

1.6

1.5

2.56

2.48

g/l

3.08

6571

29988

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

184

412

10.72

92.37

4.7

1.3

1.58

2.95

g/l

5.97

167

238

Alcohol use disorder, Swedish definition

6603

46985

1.35

92.13

1.5

3.36

2.40

g/l

126.74

4121

30450

Adrenocortical insufficiency

622

2842

3.05

92.03

2.1

1.5

2.32

2.36

g/l

0.21

458

1760

Conjunctivitis (acute, non atopic)

4069

29929

1.48

91.65

1.7

1.5

2.24

2.28

g/l

0.74

2526

19011

Convulsions, not elsewhere classified

3107

21520

1.55

91.52

1.6

1.4

2.43

2.31

g/l

2.37

1868

13398

Other eating disorders

1054

5919

2.39

91.48

1.7

1.5

1.95

1.97

g/l

0.26

625

3845

Benign neoplasm: Caecum

1313

7614

2.02

91.44

1.6

1.5

2.58

2.59

g/l

0.04

792

4487

Benign neoplasm: Rectum, anus and anal canal

2276

15070

1.68

90.47

1.6

1.5

2.49

2.57

g/l

0.82

1331

8952

Other disorders of veins

5263

39698

1.40

89.60

1.5

2.48

2.37

g/l

2.33

2919

24294

Endometriosis of pelvic peritoneum

2336

14239

1.69

89.59

1.4

2.05

2.20

g/l

4.57

1488

9108

Hard cardiovascular diseases

10357

50249

1.28

89.28

1.6

1.5

2.52

2.41

g/l

5.84

6750

30890

Non-Hodgkin lymphoma, all

553

2350

2.92

89.12

2.4

1.3

2.16

2.81

g/l

5.63

464

1324

Gonarthrosis

7363

32772

1.33

88.96

1.5

2.52

2.46

g/l

1.52

4567

20654

Implicit fungal Sepsis

606

2744

2.93

88.81

2.2

1.4

2.62

2.45

g/l

0.60

458

1634

Diseases of middle ear and mastoid

8510

56429

1.31

88.75

1.6

1.5

2.18

2.28

g/l

6.01

5509

36335

Hypokalaemia

1519

9208

1.88

88.32

1.7

1.4

2.90

2.48

g/l

7.02

978

5478

Other (seronegative) rheumatoid arthritis, wide

2322

15590

1.67

87.95

1.6

1.5

2.56

2.43

g/l

1.71

1533

9327

Acute tubulo-interstitial nephritis

8203

55905

1.30

87.94

1.6

1.5

2.52

2.30

g/l

14.17

5147

33780

Disorders of vestibular function (Vertigo)

5705

43111

1.37

87.70

1.5

2.28

2.46

g/l

10.54

3342

25986

Recurrent aphthous stomatitis , including avohilmo

2079

13753

1.74

87.33

1.8

1.5

2.24

2.30

g/l

0.81

1289

8487

Coxarthrosis

5484

26959

1.38

87.23

1.5

2.58

2.52

g/l

1.02

3257

16528

Diseases of external ear

4553

34350

1.43

87.23

1.6

1.5

2.38

2.41

g/l

0.47

2631

21319

Spondylopathies (FG)

1881

12111

1.77

87.06

1.6

1.5

2.63

2.33

g/l

7.87

1319

7823

All-cause Heart Failure

5976

32148

1.36

86.95

1.8

1.5

3.00

2.58

g/l

27.10

3874

18289

Other disorders of eyelid

5008

36003

1.40

86.12

1.5

2.39

2.53

g/l

4.28

2887

21267

Transport accidents

6516

42756

1.34

85.79

1.5

2.34

2.29

g/l

1.34

4136

28323

Other diseases of biliary tract

1085

6046

2.10

85.44

2.0

1.5

2.68

2.50

g/l

1.74

814

3499

Acute pancreatitis

2224

14803

1.65

85.34

1.7

1.5

2.86

2.51

g/l

9.96

1476

9125

Hypotension

1834

11655

1.73

85.29

1.7

1.5

2.76

2.68

g/l

0.56

1033

6679

Special screening examination for other diseases and disorders

1564

9606

1.83

85.03

1.5

1.4

2.43

2.35

g/l

0.87

1111

6069

Fungal Sepsis

635

2980

2.76

84.85

2.2

1.4

2.62

2.47

g/l

0.50

480

1777

Other diseases of pancreas

1052

5838

2.13

84.81

1.7

1.5

2.72

2.53

g/l

1.86

695

3442

Other CVD

2125

13982

1.66

84.81

1.7

1.5

2.75

2.62

g/l

1.16

1210

8095

Cerebrovascular diseases (FINNGEN)

3789

19333

1.48

84.65

1.6

1.4

2.46

2.28

g/l

7.12

2424

12137

Cervicocranial syndrome

1463

8914

1.89

84.65

1.5

2.15

2.36

g/l

6.50

937

5539

Infections with a predominantly sexual mode of transmission

4662

35569

1.43

84.63

1.6

1.4

2.25

2.20

g/l

1.18

2826

23631

Adenomyosis (Endometriosis of uterus)

1743

11084

1.79

84.37

1.4

1.5

2.15

2.29

g/l

2.61

932

6711

Other metabolic disorders

1904

12421

1.75

84.29

1.7

1.4

2.26

2.29

g/l

0.24

1242

7805

Psoriatic and enteropathic arthropathies

1539

9517

1.85

83.99

1.6

1.5

2.61

2.38

g/l

4.90

1037

6025

Injuries to the wrist and hand

14339

81072

1.22

83.92

1.5

2.31

2.35

g/l

1.23

8800

51454

Other disorders of adrenal gland

758

3877

2.59

83.75

2.1

1.5

2.37

2.29

g/l

0.38

543

2388

Postmenopausal osteoporosis with pathological fracture

842

4387

2.35

83.54

1.8

1.5

2.65

2.48

g/l

0.92

480

2316

Gonarthrosis [arthrosis of knee](FG)

8664

40343

1.29

83.41

1.5

2.53

2.44

g/l

2.95

5327

24940

Crohn disease (strict definition, all UC cases excluded)

841

4453

2.44

83.35

1.7

1.5

2.41

2.30

g/l

1.25

634

2869

Other diseases of pleura

4713

30983

1.40

83.31

1.8

1.5

2.88

2.58

g/l

10.26

3146

18140

Cutaneous abscess, furuncle and carbuncle

3528

25834

1.49

83.08

1.7

1.5

2.54

2.35

g/l

6.10

2230

16645

Lichen simplex chronicus and prurigo

876

4642

2.31

82.98

1.7

1.5

2.72

2.45

g/l

2.49

526

2878

7077

50527

1.32

82.82

1.5

3.28

2.38

g/l

123.24

4440

32705

Artrosis, including avohilmo

10520

47607

1.26

82.80

1.5

2.43

2.42

g/l

0.17

6725

30813

Tonsillectomy and adenotomy

8820

50365

1.29

82.73

1.5

1.95

2.24

g/l

82.85

5925

33262

Diseases of inner ear

6523

49539

1.33

82.65

1.5

2.31

2.47

g/l

9.20

3839

30168

Other noninflammatory disorders of vulva and perineum

1436

8812

1.91

82.54

1.5

1.4

2.09

2.22

g/l

2.39

856

5553

Coxarthrosis [arthrosis of hip](FG)

5985

32041

1.35

82.43

1.5

2.57

2.51

g/l

1.16

3530

19063

Other menopausal disorders

3453

13844

1.52

82.35

1.4

1.5

2.13

2.29

g/l

6.49

2100

8466

Unspecified fall

6694

52395

1.33

82.29

1.6

1.5

2.54

2.37

g/l

6.53

3790

32504

Diseases of tongue

815

4200

2.33

81.89

1.7

1.4

2.31

2.43

g/l

0.75

502

2654

Other diseases of stomach and duodenum

817

4212

2.32

81.87

1.7

1.5

2.76

2.48

g/l

2.27

517

2531

Agranulocytosis

1488

9250

1.88

81.50

2.5

1.5

2.18

2.41

g/l

3.89

1144

5568

Care involving dialysis

1005

5572

2.14

81.49

2.1

1.5

2.57

2.50

g/l

0.50

713

3413

Seronegative rheumatoid arthritis

1432

8749

1.87

81.17

1.7

1.5

2.52

2.42

g/l

0.70

928

5132

Need for other prophylactic measures

861

4612

2.35

81.09

1.9

1.5

2.33

2.39

g/l

0.32

491

2851

Diseases of male genital organs

5384

20700

1.38

80.37

1.5

1.6

2.54

2.69

g/l

5.43

3576

13827

Meniscus derangement

6371

33283

1.33

80.34

1.5

2.50

2.45

g/l

0.80

3960

21014

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3820

28432

1.45

80.25

1.5

2.75

2.40

g/l

23.20

2486

18077

Glucagon-like peptide-1 (GLP-1) analogues

3820

28432

1.45

80.25

1.5

2.75

2.40

g/l

23.20

2486

18077

Radiculopathy

1809

11656

1.71

80.13

1.5

2.34

2.48

g/l

2.65

1079

7046

Other or unspecified ileus, impaction or obstruction

1875

12111

1.68

80.09

1.6

1.5

2.66

2.57

g/l

0.61

1224

7300

Unspecified/other endometriosis

1497

9187

1.88

80.06

1.5

1.4

2.04

2.12

g/l

1.25

971

6064

COPD (mode)

3022

16633

1.51

79.77

1.5

1.4

2.98

2.59

g/l

8.96

1766

9309

Non-rheumatic valve diseases

5187

28458

1.37

79.72

1.7

1.5

2.63

2.47

g/l

5.04

3315

16643

Emotionally unstable personality disorder

2038

13784

1.72

79.53

1.5

2.14

g/l

0.06

1075

9351

Other viral diseases

4282

32488

1.43

79.36

1.8

1.5

2.17

2.23

g/l

1.77

2950

20980

Seropositive rheumatoid arthritis, strict definition

1912

12648

1.71

79.02

1.6

1.5

2.80

2.40

g/l

13.78

1358

7655

Unspecified haematuria

4515

27818

1.40

78.94

1.6

1.5

2.75

2.59

g/l

3.91

2766

16967

Benign neoplasm: Transverse colon

1274

7634

1.93

78.41

1.6

1.5

2.66

2.63

g/l

0.15

761

4540

Paroxysmal tachycardia

2897

17083

1.53

78.27

1.6

1.4

2.33

2.23

g/l

2.25

1830

10383

7443

52370

1.30

78.18

1.5

3.24

2.37

g/l

124.24

4652

33951

Valvular heart disease excluding rheumatic fever

5225

28797

1.37

78.13

1.7

1.5

2.62

2.46

g/l

5.16

3345

16820

Obsessive-compulsive disorder

1226

7406

2.02

78.01

1.5

1.4

2.03

2.11

g/l

1.36

728

5021

Tinnitus

2908

20829

1.53

77.82

1.6

1.5

2.24

2.47

g/l

8.65

1664

12820

Zoster [herpes zoster]

2218

15089

1.62

77.77

2.0

1.5

2.34

2.49

g/l

2.17

1431

8926

Colonic or urogenital fistula

3312

24239

1.49

77.71

1.6

1.5

2.39

2.43

g/l

0.54

2083

15292

Major coronary heart disease event

9954

49353

1.26

77.70

1.6

1.5

2.55

2.46

g/l

3.95

6490

29843

Uterine polyps

3555

15174

1.49

77.51

1.5

2.25

2.28

g/l

0.50

2075

9245

Other obstetric conditions, not elsewhere classified

5500

27328

1.39

77.23

1.5

1.4

2.03

2.05

g/l

0.74

3618

18571

Covid-19 suspected case

3149

23008

1.51

77.11

1.6

1.5

2.21

2.26

g/l

0.74

2046

14994

Other and unspecified disorders of vitreous body

4895

37058

1.38

76.83

1.5

2.30

2.51

g/l

10.52

2818

21955

Other inflammation of eyelid

1888

12520

1.70

76.73

1.7

1.5

2.35

2.39

g/l

0.50

1038

7705

Sequelae of external causes of morbidity and mortality

3118

22636

1.50

76.57

1.7

1.5

2.51

2.44

g/l

1.13

2007

13876

Cellulitis

2855

20458

1.53

76.28

1.8

1.5

2.56

2.39

g/l

3.72

1789

12869

Other and unspecified disorders of white blood cells

599

2882

2.72

76.18

1.9

1.5

2.14

2.47

g/l

4.48

443

1761

Secondary uncertain malignant neoplasm

1482

9228

1.79

76.16

2.2

1.4

2.11

2.60

g/l

13.33

1137

5293

STROKE

6550

35127

1.32

75.86

1.6

1.5

2.49

2.41

g/l

2.36

4000

21507

Thyrotoxicosis

3317

24441

1.48

75.80

1.5

2.25

2.33

g/l

1.92

1986

14999

Abnormal findings on diagnostic imaging of other body structures

1832

12095

1.71

75.73

1.8

1.5

2.55

2.42

g/l

1.79

1264

7289

Acute myeloid leukaemia and myelodysplastic syndromes

345

1276

3.65

75.67

1.6

1.3

2.61

2.74

g/l

0.54

288

733

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

5395

26765

1.39

75.66

1.5

1.4

2.02

2.05

g/l

0.69

3550

18193

Diabetic retinopathy, strict definition

2071

12475

1.67

75.63

1.7

1.6

2.69

2.70

g/l

0.11

1209

7753

Abnormalities of gait and mobility

1442

8996

1.82

75.53

1.5

1.6

2.53

2.54

g/l

0.08

761

5215

Other enthesopathy of foot (+metatarsalgia)

1430

8938

1.84

75.30

1.6

1.5

2.23

2.34

g/l

1.65

891

5598

Adhesive capsulitis of shoulder

1933

12846

1.66

75.25

1.5

2.42

2.47

g/l

0.53

1118

7915

Monoamine oxidase A inhibitors

1419

8818

1.83

75.22

1.5

2.41

2.44

g/l

0.17

814

5576

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4321

32890

1.42

75.00

1.6

1.5

2.12

2.15

g/l

0.66

2535

21584

Erosion of teeth , including avohilmo

3944

29967

1.44

74.58

1.6

1.5

2.20

2.26

g/l

1.38

2355

19616

Other symptoms and signs involving the urinary system

1254

7565

1.89

74.54

1.6

1.5

2.42

2.52

g/l

0.95

894

4656

Intracranial injury

7724

58847

1.28

74.51

1.6

1.5

2.47

2.36

g/l

4.46

4751

36972

Polyp of the female genital tract

3788

15909

1.46

74.48

1.5

2.19

2.27

g/l

1.97

2220

9746

Benign neoplasm: Stomach

1182

7062

1.95

74.35

1.6

1.5

2.43

2.51

g/l

0.56

689

4184

Impingement syndrome of shoulder

2627

18587

1.53

73.59

1.5

2.42

2.53

g/l

2.08

1558

11526

Heart failure and bmi 25plus

3327

16109

1.47

73.56

1.8

1.5

3.07

2.65

g/l

14.67

2132

9407

Diabetic retinopathy, excluding more controls

3230

13142

1.51

73.56

1.7

1.5

2.75

2.60

g/l

3.16

1908

7812

Post-traumatic stress disorder

1506

9708

1.84

73.41

1.5

1.4

2.03

2.10

g/l

1.05

868

6671

Myelodysplastic syndrome, including Hilmo

391

1555

3.22

73.28

1.8

1.3

2.75

2.83

g/l

0.26

296

864

Congenital malformations, deformations and chromosomal abnormalities

8468

66564

1.27

73.12

1.5

2.20

2.28

g/l

3.67

5499

42966

Crohn's disease NAS

958

5469

2.14

73.09

1.8

1.5

2.61

2.30

g/l

6.17

718

3484

Other (not insulin) diabetes medications

12605

62952

1.22

73.08

1.5

2.68

2.32

g/l

59.60

7814

40008

Postmenopausal bleeding

3014

11252

1.52

73.02

1.5

2.39

2.38

g/l

0.13

1656

6559

Metatarsalgia

1320

8166

1.86

72.55

1.6

1.5

2.24

2.35

g/l

1.61

814

5131

Keratitis

4629

35920

1.38

72.33

1.6

1.5

2.44

2.38

g/l

1.45

2982

22679

Psoriatic arthropathies

1276

7809

1.87

72.19

1.5

2.59

2.41

g/l

2.47

841

4970

Malignant immunoproliferative diseases

209

620

6.47

71.95

4.0

1.4

1.31

2.74

g/l

15.68

186

364

Systemic lupus erythematosus

579

2838

2.74

71.68

1.9

1.5

2.38

2.30

g/l

0.55

404

1748

Type 2 diabetes, definitions combined

12151

60084

1.22

71.39

1.5

2.67

2.30

g/l

60.69

7719

38194

Other protozoal intestinal diseases, including avohilmo

430

1893

3.35

70.99

1.6

1.5

2.07

2.24

g/l

1.47

233

1215

Other disorders of glucose regulation and pancreatic internal secretion

1134

6798

1.95

70.85

1.6

1.5

2.63

2.39

g/l

2.32

671

4274

Type 2 diabetes, strict (exclude DM1)

12185

60339

1.22

70.40

1.5

2.67

2.30

g/l

60.56

7739

38358

Small fibre neuropathy

458

2046

3.05

70.37

2.1

1.5

2.40

2.57

g/l

0.83

302

1237

Inflammatory disease of uterus

2145

14988

1.63

70.09

1.5

1.4

2.10

2.14

g/l

0.70

1301

9688

Idiopathic thrombocytopenic purpura

489

2259

2.96

70.08

2.5

1.4

2.42

2.37

g/l

0.16

392

1387

Localized swelling, mass and lump of skin and subcutaneous tissue

3997

30533

1.40

70.07

1.6

1.5

2.27

2.41

g/l

2.83

2507

18847

Nonsuppurative otitis media, including avohilmo

4936

33598

1.37

69.87

1.7

1.5

2.10

2.21

g/l

5.11

3162

21686

Explicit bacterial Sepsis, including avohilmo

1309

8107

1.82

69.60

2.1

1.5

2.71

2.41

g/l

4.30

950

4812

Abnormal involuntary movements

1732

11517

1.70

69.48

1.6

1.5

2.29

2.43

g/l

2.30

1016

7098

Fibroblastic disorders

2442

17189

1.53

69.06

1.5

2.54

2.56

g/l

0.18

1427

10562

Secondary hypertension

970

5470

2.00

68.83

1.8

1.5

2.46

2.29

g/l

1.38

652

3233

Other disorders of eye and adnexa

2010

13864

1.64

68.66

1.7

1.5

2.20

2.29

g/l

1.78

1198

8748

Diagnoses used for exclusion with ILD

2759

19911

1.49

68.57

1.7

1.5

2.60

2.54

g/l

0.75

1851

12177

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1716

11450

1.70

68.43

1.6

1.4

2.23

2.28

g/l

0.58

1097

7222

Exclusions for E4_PCOS_CONSORTIUM

10650

56353

1.24

68.41

1.5

2.17

2.23

g/l

2.74

6542

35555

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1724

11462

1.68

68.07

1.7

1.5

2.63

2.45

g/l

2.50

1107

6982

Other sleep disorders

1455

9332

1.76

67.91

1.6

1.5

2.39

2.43

g/l

0.27

951

5902

Prurigo nodularis

386

1621

3.30

67.88

1.6

1.5

2.71

2.52

g/l

0.83

196

996

Other shoulder lesions

1285

8027

1.83

67.67

1.6

1.5

2.25

2.36

g/l

1.36

781

5177

Hernia of abdominal wall

5253

41663

1.33

67.55

1.5

2.62

2.50

g/l

3.34

3262

25991

Sequelae with surgical and medical care as external cause

2409

17116

1.54

67.55

1.7

1.5

2.52

2.48

g/l

0.47

1567

10377

Mouth breathing

4709

36874

1.36

67.54

1.5

2.40

2.46

g/l

1.04

3031

23315

Elevated blood glucose level

1101

6632

1.93

67.41

1.9

1.5

2.73

2.40

g/l

5.14

684

4086

Hyperparathyroidism

2028

13758

1.60

67.35

1.6

1.5

2.41

2.49

g/l

0.72

1194

7851

Other symptoms and signs involving the circulatory and respiratory systems

881

4963

2.08

67.34

1.8

1.5

2.54

2.40

g/l

1.07

609

3055

Diseases of arteries, arterioles and capillaries

7183

42977

1.28

67.13

1.6

1.5

2.68

2.56

g/l

4.83

4376

25767

SLE, ICD10

553

2745

2.73

66.90

1.9

1.5

2.37

2.29

g/l

0.59

387

1692

SLE, strict definition

553

2745

2.73

66.90

1.9

1.5

2.37

2.29

g/l

0.59

387

1692

Acute pancreatitis (for exclusion)

2224

15561

1.56

66.70

1.7

1.5

2.86

2.52

g/l

9.59

1476

9667

Bacterial pneumonia (organism specified)

5045

35982

1.34

66.59

1.9

1.5

2.53

2.47

g/l

0.74

3338

21762

Anogenital herpesviral [herpes simplex] infection, including avohilmo

1838

12622

1.68

66.53

1.5

2.13

2.14

g/l

0.11

1137

8457

Female infertility, cervical, vaginal, other or unspecified origin

3761

18249

1.43

66.52

1.4

2.12

2.18

g/l

1.62

2421

11643

Explicit bacterial Sepsis

1268

7887

1.81

66.23

2.1

1.5

2.73

2.42

g/l

4.32

923

4676

Demyelinating diseases of the central nervous system

1264

7996

1.87

66.13

2.4

1.5

2.04

2.26

g/l

7.42

967

5254

Myeloid leukaemia

397

1701

3.14

66.12

1.6

1.5

2.26

2.56

g/l

2.61

343

1036

Streptococcal septicaemia, including avohilmo

1090

6543

1.90

65.83

2.1

1.5

2.71

2.45

g/l

2.85

800

3824

Eosinophilic disease (BM)

270

966

4.21

65.61

1.8

1.4

2.21

2.34

g/l

0.75

201

612

Psoriasis vulgaris

2267

16031

1.56

65.56

1.6

1.5

2.89

2.44

g/l

10.48

1429

10180

Etanercept

1008

6055

2.03

65.41

1.7

1.5

2.73

2.24

g/l

11.09

704

3887

Periodontitis

12900

70831

1.20

65.39

1.5

2.55

2.38

g/l

12.52

7497

45441

Trigger finger

1778

11994

1.64

65.11

1.5

2.33

2.41

g/l

1.05

1028

7526

Superficial injury of lower leg

3619

27628

1.42

64.87

1.5

2.27

2.29

g/l

0.42

2195

17516

Chronic periodontitis, including avohilmo

12871

70786

1.20

64.86

1.5

2.55

2.39

g/l

12.43

7476

45401

Other disorders of ear

11770

65096

1.21

64.75

1.6

1.5

2.38

2.41

g/l

0.57

7194

40815

4128

28594

1.37

64.73

1.6

1.5

2.56

2.63

g/l

0.91

2373

16070

Selective deficiency of immunoglobulin G [IgG] subclasses

186

578

8.95

64.71

4.4

1.4

1.73

2.28

g/l

4.74

157

356

Herpesviral [herpes simplex] infections

1595

10617

1.71

64.64

1.9

1.5

2.24

2.32

g/l

0.93

1098

6691

Other and unspecified tonsillitis

4975

32811

1.35

64.24

1.6

1.4

2.33

2.25

g/l

2.10

3312

21729

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

121

259

11.72

64.22

5.2

1.3

1.57

2.97

g/l

3.60

109

142

Type 2 diabetes, definitions combined, including avohilmo

12180

60377

1.21

64.18

1.5

2.66

2.30

g/l

60.89

7758

38422

Bacterial pneumoniae

4684

32243

1.34

64.13

1.9

1.4

2.55

2.43

g/l

1.99

3054

19283

Other and unspecified mood [affective] disorders

1167

7296

1.90

64.03

1.5

1.4

2.15

2.16

g/l

0.08

628

4980

Substance abuse

7145

54677

1.27

63.83

1.5

2.88

2.40

g/l

50.78

4286

35534

Other disorders of bladder

1276

8004

1.78

63.82

1.7

1.5

2.43

2.62

g/l

2.68

733

4888

Acquired haemolytic anaemia

381

1646

3.21

63.38

2.2

1.4

2.06

2.48

g/l

4.31

299

977

Mental and behavioural disorders due to psychoactive substance use

7394

56014

1.26

63.25

1.5

2.87

2.39

g/l

51.52

4463

36356

Female infertility

4061

18774

1.40

63.07

1.4

2.13

2.17

g/l

1.05

2612

11990

Suppurative and unspecified otitis media

5489

39204

1.32

63.02

1.7

1.5

2.14

2.21

g/l

2.99

3574

25622

Streptococcal septicaemia

1055

6356

1.89

62.82

2.2

1.5

2.72

2.45

g/l

2.81

776

3715

Hypermobility syndrome

915

5464

2.11

62.62

1.7

1.5

1.94

2.12

g/l

4.38

627

3594

Rare circulating lymphoid malignancy, including Hilmo

433

1980

2.88

62.08

2.9

1.4

1.70

2.45

g/l

10.65

354

1137

Acute pharyngitis

2310

16454

1.54

62.02

1.6

1.4

2.21

g/l

0.04

1498

10705

Non-ischemic cardiomyopathy

3208

18995

1.43

61.89

1.8

1.5

3.02

2.56

g/l

15.44

2067

10591

Emotional disorders starting during childhood or adolecense, excluding more controls

885

5103

2.13

61.39

1.8

1.5

1.88

g/l

0.03

462

3373

Raynaud syndrome

1273

8200

1.82

61.38

1.6

1.5

2.15

2.30

g/l

3.11

873

5250

Other and unspecified types of non-Hodgkin lymphoma, hilmo

518

2534

2.53

61.10

2.6

1.5

1.92

2.65

g/l

14.70

421

1489

Disorder of lipoprotein metabolism, unspecified

1332

8514

1.72

60.93

1.6

1.5

2.60

2.64

g/l

0.28

776

4979

Skin changes due to chronic exposure to nonionizing radiation

3828

26641

1.37

60.79

1.6

1.5

2.57

2.65

g/l

1.02

2187

14801

Poisoning by drugs, medicaments and biological substances

3320

25330

1.43

60.75

1.5

2.36

2.26

g/l

2.34

1887

16743

Hallux valgus (acquired)

3868

21264

1.38

60.51

1.5

2.30

2.36

g/l

0.71

2197

12965

Social phobias

1405

9283

1.76

60.41

1.6

1.4

2.20

2.13

g/l

0.84

785

6342

Otitis externa

2980

22365

1.45

60.37

1.6

1.5

2.35

g/l

0.00

1763

14126

Intestinal adhesions without obstruction

913

5324

1.93

60.17

1.6

1.5

2.52

2.54

g/l

0.05

547

3237

Actinic keratosis

3695

25752

1.38

60.16

1.6

1.5

2.59

2.66

g/l

0.97

2108

14263

Unspecified jaundice

572

2884

2.33

59.98

1.8

1.5

3.31

2.58

g/l

9.50

436

1701

Viral and other specified intestinal infections

3212

23820

1.43

59.95

1.7

1.5

2.18

2.17

g/l

0.21

2149

15320

Systemic lupus erythematosus, unspecified

484

2386

2.77

59.94

1.9

1.5

2.38

2.29

g/l

0.63

341

1459

Injuries to the shoulder and upper arm

11135

73829

1.21

59.83

1.5

2.50

2.38

g/l

6.36

6757

46480

Other diseases of oesophagus

1022

6158

1.86

59.81

1.6

1.5

2.67

2.50

g/l

1.20

620

3688

Other ulcerative colitis

821

4747

2.09

59.74

2.0

1.5

2.52

2.35

g/l

2.25

644

3089

Dysplasia of cervi uteri

3273

17418

1.43

59.58

1.5

1.4

2.16

2.19

g/l

0.44

2083

11145

Other disorders of bone

2552

18750

1.49

59.50

1.8

1.5

2.35

2.31

g/l

0.25

1655

12028

Venous thromboembolism

5943

46575

1.29

59.43

1.8

1.5

2.55

2.52

g/l

0.51

3797

27945

Disorders of muscles

1276

8183

1.75

59.34

1.5

2.44

2.41

g/l

0.13

821

5208

Reactive arthropathies

1090

6744

1.84

59.29

1.6

1.5

2.58

2.39

g/l

2.61

719

4297

Cytomegalovirus infection, IBD co-morbidity

380

1704

3.16

59.25

2.5

1.5

2.08

2.41

g/l

2.70

304

1075

Benign paroxysmal vertigo

3416

26159

1.40

58.88

1.6

1.5

2.29

2.46

g/l

5.29

2003

15639

Idiopathic pulmonary fibrosis

781

4384

2.03

58.82

2.1

1.5

2.98

2.74

g/l

1.87

571

2481

MS-disease / Multiple Sclerosis

1080

6781

1.89

58.61

2.5

1.5

2.00

2.24

g/l

7.95

827

4476

Haemolytic anaemias

518

2615

2.56

58.33

2.1

1.5

2.13

2.39

g/l

2.52

378

1596

Marginal zone B-cell lymphoma, including Hilmo

256

947

3.94

58.18

2.4

1.3

1.85

2.80

g/l

8.29

210

550

Bacterial pneumonia, not elsewhere classified

4378

30253

1.34

58.17

1.8

1.4

2.55

2.44

g/l

1.97

2847

18045

Heart failure and coronary heart disease

4051

21986

1.36

57.97

1.7

1.5

2.95

2.69

g/l

8.09

2655

12299

Cytomegaloviral disease, including avohilmo

397

1830

3.03

57.94

2.5

1.5

2.08

2.42

g/l

2.89

319

1154

Lichen ruber planus, wide definition including periferal and oral lichen planus

2676

19864

1.46

57.93

1.5

2.46

g/l

0.01

1612

11996

Drug-induced osteoporosis with pathological fracture

288

1158

3.80

57.58

2.5

1.6

2.62

2.50

g/l

0.20

216

663

Ankylosing spondylitis

1079

6706

1.83

57.53

1.5

2.81

2.44

g/l

6.32

736

4383

Extracorporeal dialysis

734

4127

2.12

57.48

2.2

1.6

2.54

2.59

g/l

0.28

535

2567

Ocular pain

1243

8083

1.79

57.46

1.8

1.5

2.16

2.28

g/l

2.09

774

5106

Poisoning by medicine

3018

22923

1.44

57.25

1.5

2.36

2.25

g/l

2.34

1720

15138

Speech and linguistic disorders, excluding more controls

1310

8065

1.76

57.23

1.7

1.5

2.03

2.04

g/l

0.05

754

5361

Suggestive for eosinophilic asthma

1093

6832

1.82

57.21

1.7

1.5

2.54

2.48

g/l

0.22

713

4217

Ischaemic heart disease, wide definition

8483

43897

1.24

56.98

1.6

1.5

2.66

2.52

g/l

6.09

5201

26647

Spondylolisthesis/Spondylolysis

2092

14907

1.53

56.95

1.6

1.5

2.32

2.43

g/l

1.87

1312

9075

Nonalcoholic steatohepatitis

208

726

5.52

56.92

1.9

1.4

3.19

2.33

g/l

4.28

170

451

Allergic contact dermatitis

1817

12721

1.59

56.84

1.5

2.37

2.26

g/l

1.60

1114

8093

Cytomegaloviral disease

390

1801

3.02

56.68

2.5

1.5

2.09

2.41

g/l

2.65

312

1133

Anorexia (incl.atypical)

992

6170

1.94

56.64

1.6

1.5

1.92

2.09

g/l

4.15

600

4018

Bullous disorders

706

3944

2.12

56.24

1.8

1.5

2.52

2.54

g/l

0.07

446

2369

Sarcoidosis

1554

10554

1.64

56.11

1.7

1.5

2.46

2.48

g/l

0.16

1077

6620

Other neurological diseases

8338

54519

1.23

56.08

1.6

1.5

2.43

2.48

g/l

1.20

5098

33198

Hyperkalaemia

635

3390

2.15

55.98

2.0

1.5

3.05

2.72

g/l

1.92

448

2013

Intestinal stricture

3297

25227

1.39

55.86

1.6

1.5

2.59

2.54

g/l

0.43

2093

15058

Abrasion of teeth

4607

36945

1.33

55.72

1.5

2.27

2.37

g/l

2.70

2681

23244

Other/unspecified cytomegaloviral diseases

337

1481

3.32

55.65

2.6

1.4

2.06

2.41

g/l

2.75

273

935

Other disorders involving the immune mechanism, not elsewhere classified

483

2426

2.61

55.64

2.8

1.5

2.91

2.41

g/l

3.77

369

1557

Other abnormal uterine and vaginal bleeding

2823

15137

1.44

55.62

1.5

2.28

2.25

g/l

0.34

1623

9182

Coronary atherosclerosis

6783

35299

1.26

55.58

1.6

1.5

2.70

2.57

g/l

4.55

4112

20751

Vitamin B12 deficiency anaemia

1056

6524

1.79

55.58

1.6

1.5

2.75

2.51

g/l

1.57

602

3827

Other/unspecified synovitis and tenosynovitis

1401

9307

1.68

55.53

1.5

2.36

2.40

g/l

0.24

865

5867

Retention of urine

3333

20525

1.38

55.19

1.7

1.5

2.72

2.65

g/l

0.73

2037

12444

Degeneration of macula and posterior pole

4795

29523

1.31

55.10

1.6

1.5

2.72

2.61

g/l

1.74

2702

16622

Viral warts, including avohilmo

3068

23478

1.42

55.05

1.6

1.5

2.23

2.27

g/l

0.56

2049

14978

Pneumonia due to other infectious organisms, not elsewhere classified

468

2307

2.56

55.04

2.6

1.4

2.29

2.46

g/l

0.87

368

1381

Dermatographic urticaria

1015

6381

1.89

54.83

1.8

1.4

2.19

2.22

g/l

0.26

684

4135

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1652

11349

1.59

54.69

2.2

1.4

2.09

2.58

g/l

15.95

1267

6575

Autoimmune hyperthyroidism

831

4919

1.98

54.48

1.6

1.4

2.17

2.26

g/l

0.93

510

3052

Other disorders of patella

2182

15836

1.50

54.26

1.5

2.25

2.31

g/l

1.01

1324

10333

Hypoglycaemia, other or unspecified

898

5440

1.93

54.23

1.6

1.5

2.56

2.38

g/l

1.64

530

3413

Pain associated with micturition

1526

10409

1.64

54.16

1.6

1.5

2.33

2.37

g/l

0.22

939

6338

Open wound of head

6581

51318

1.26

53.94

1.6

1.5

2.64

2.44

g/l

8.99

3935

32272

Lactose intolerance

501

2583

2.51

53.63

1.8

1.5

2.12

2.28

g/l

1.29

273

1607

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

5714

46510

1.29

53.60

1.5

2.22

g/l

0.02

3634

30531

Fall on same level involving ice and snow

7453

62775

1.24

53.54

1.5

2.42

2.37

g/l

1.17

4434

39280

Pneumocystosis

301

1270

3.40

53.51

3.2

1.5

2.30

2.62

g/l

1.14

240

752

Pneumocystosis, including avohilmo

301

1270

3.40

53.51

3.2

1.5

2.30

2.62

g/l

1.14

240

752

Rash and other nonspecific skin eruption

1240

8140

1.73

53.50

1.7

1.5

2.39

2.38

g/l

0.02

762

5001

Ethmoidectomy

1623

11247

1.61

53.44

1.8

1.5

2.32

2.40

g/l

1.14

1172

7221

Otalgia

1197

7851

1.77

53.18

1.6

1.5

2.02

2.24

g/l

5.32

706

4778

Hyperplasia of prostate

3045

12826

1.40

52.82

1.5

1.6

2.67

2.95

g/l

6.87

1912

8399

Endometriosis of ovary

2134

14586

1.51

52.81

1.5

2.19

2.25

g/l

0.69

1338

9111

Other specified/unspecified bacterial intestinal infections

835

4994

1.96

52.81

1.7

1.5

2.38

2.46

g/l

0.45

496

3025

Hypercalcemia

572

3072

2.29

52.74

2.7

1.5

2.84

2.53

g/l

0.73

415

1796

Viral hepatitis, including avohilmo

1049

6678

1.83

52.70

1.5

2.55

2.35

g/l

2.69

698

4483

Other noninflammatory disorders of vagina

1045

6612

1.81

52.66

1.5

1.4

2.21

2.25

g/l

0.47

643

4073

Use of pramipexole

2407

17803

1.46

52.58

1.6

1.5

2.34

2.49

g/l

2.57

1429

10613

Toxic liver disease

272

1109

3.66

52.56

1.7

1.4

2.44

2.26

g/l

0.80

219

671

Substance use, excluding alcohol

2579

19341

1.45

52.50

1.6

1.5

2.39

2.30

g/l

1.45

1497

12749

Inflammatory diseases of prostate (prostatitis)

1184

7606

1.70

52.38

1.5

1.6

2.59

2.92

g/l

5.47

757

4950

Thyrotoxicosis with diffuse goitre

1841

13110

1.56

52.26

1.6

1.5

2.22

2.28

g/l

1.02

1118

8249

Diplopia

1562

10766

1.61

52.13

1.7

1.5

2.37

2.45

g/l

0.78

974

6666

Female genital prolapse

3362

14331

1.39

52.12

1.5

2.21

2.30

g/l

1.85

2010

8678

Ganglion

2669

20092

1.43

52.08

1.5

2.20

2.32

g/l

3.08

1709

12966

FESS (DNB20)

1572

10889

1.61

51.97

1.8

1.5

2.32

2.40

g/l

1.03

1137

7006

Other hearing loss

2857

20895

1.40

51.97

1.6

1.5

2.44

2.60

g/l

3.23

1588

12004

Amenorrhoea

1104

7165

1.80

51.89

1.7

1.4

1.99

2.06

g/l

0.87

693

4708

Disorders of ocular muscles, binocular movement, accommodation and refraction

6679

55519

1.25

51.71

1.6

1.5

2.21

2.27

g/l

2.08

4307

35254

Other complications of surgical and medical care, not elsewhere classified

1277

8500

1.70

51.57

1.8

1.5

2.32

2.35

g/l

0.24

845

5315

Other autoimmune haemolytic anaemias

222

827

4.25

51.53

2.2

1.6

1.87

2.61

g/l

6.49

181

477

Barrett oesophagus

566

3016

2.21

51.47

1.4

1.5

2.84

2.61

g/l

1.22

307

1846

Chronic periodontitis, complicated

6460

52496

1.25

51.44

1.5

2.68

2.49

g/l

7.71

3596

32715

Drug-induced adrenocortical insufficiency

326

1468

3.25

51.41

2.3

1.5

2.39

2.35

g/l

0.13

269

900

Iridocyclitis

2693

20352

1.43

51.36

1.7

1.5

2.53

2.40

g/l

2.10

1799

12718

DVT of lower extremities and pulmonary embolism

4378

34899

1.31

51.16

1.9

1.5

2.57

2.54

g/l

0.32

2834

20785

Maternal care for other conditions predominantly related to pregnancy

3216

24511

1.40

50.61

1.5

1.4

2.11

2.09

g/l

0.39

2046

16483

Mixed and other personality disorders

1122

7334

1.77

50.54

1.6

1.5

2.24

2.29

g/l

0.41

577

4975

Volume depletion

999

6233

1.77

50.46

1.8

1.5

3.02

2.57

g/l

4.71

680

3625

Diabetic retinopathy

3814

18650

1.36

50.24

1.6

1.5

2.79

2.73

g/l

0.77

2244

11387

Carbimazole or st.post thyroidectomy, condition for graves disease

2685

20423

1.43

50.18

1.5

2.21

2.31

g/l

2.29

1603

12785

Arthropathic psoriasis

1379

9372

1.65

50.11

1.5

2.61

2.43

g/l

2.73

897

5960

Ulcerative proctitis

858

5267

1.92

50.00

1.6

1.4

2.36

2.32

g/l

0.21

577

3419

Injuries to the hip and thigh

5518

40652

1.27

49.87

1.6

1.5

2.62

2.47

g/l

4.10

3246

24653

Other viral hepatitis, including avohilmo

929

5833

1.87

49.74

1.6

1.5

2.56

2.34

g/l

2.82

630

3973

Giant cell arteritis

496

2571

2.33

49.72

1.6

1.5

2.41

2.59

g/l

1.25

339

1449

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

4128

33198

1.33

49.66

1.5

2.25

2.22

g/l

0.35

2408

22003

Umbilical hernia

3013

23179

1.38

49.63

1.5

2.64

2.51

g/l

2.34

1909

14975

Crohn's disease of large intestine

715

4198

2.04

49.47

1.8

1.5

2.64

2.32

g/l

5.30

537

2697

Systemic sclerosis (FG)

359

1682

2.84

49.29

1.7

1.5

2.23

2.32

g/l

0.43

248

1007

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

8052

53398

1.22

48.93

1.5

2.25

2.26

g/l

0.24

5257

33808

Injuries to the elbow and forearm

9678

71794

1.20

48.87

1.5

2.36

2.32

g/l

1.38

5723

45203

Other medical care

5478

37814

1.27

48.71

1.9

1.5

2.65

2.46

g/l

5.10

3730

22399

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

446

2286

2.53

48.69

2.7

1.4

2.91

2.42

g/l

3.54

337

1465

Other/unspecified enthesopathies of lower limb, excluding foot

961

6074

1.81

48.68

1.5

2.20

2.32

g/l

1.67

567

3889

Unspecified urinary incontinence

1097

7149

1.74

48.65

1.6

1.5

2.48

2.38

g/l

0.79

579

4163

Unspecified privation

1310

8861

1.66

48.57

1.7

1.5

2.40

g/l

0.03

714

5620

Arthropathies in other diseases classified elsewhere

462

2360

2.39

48.51

1.7

1.5

2.73

2.49

g/l

1.22

287

1494

Superficial injury of head

2975

22924

1.38

48.42

1.5

2.52

2.35

g/l

3.51

1727

14283

Excessive earwax

7561

58191

1.22

48.35

1.5

2.37

2.46

g/l

3.52

4697

35532

Reactive arthropathies, FINNGEN

900

5610

1.84

48.25

1.6

1.5

2.57

2.34

g/l

2.93

592

3542

Complications of internal orthopaedic prosthetic devices, implants and grafts

2313

17183

1.44

48.19

1.6

1.5

2.68

2.54

g/l

1.63

1360

9867

Injuries to the neck

3038

23615

1.38

47.89

1.6

1.5

2.29

2.32

g/l

0.49

1928

15353

Nasal polyp

2015

14669

1.48

47.88

1.6

1.5

2.53

2.59

g/l

0.42

1272

9280

Vitamin deficiency

647

3721

2.07

47.44

1.8

1.5

2.63

2.36

g/l

2.43

395

2302

Vitamin deficiency, wide

647

3721

2.07

47.44

1.8

1.5

2.63

2.36

g/l

2.43

395

2302

Psychotic depression

751

4461

1.92

47.42

1.5

1.4

2.32

2.31

g/l

0.03

428

2935

Disorders of breast

6845

51015

1.24

47.41

1.5

2.14

2.20

g/l

2.46

4085

31669

Follicular lymphoma, hilmo

514

2756

2.27

47.33

2.4

1.5

1.69

2.63

g/l

30.63

406

1595

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

3096

24273

1.39

47.20

1.6

1.4

2.19

2.15

g/l

0.70

1974

16297

Lichen planus, including avohilmo

2204

16396

1.46

47.14

1.5

2.46

g/l

0.01

1326

9893

Viral hepatitis

973

6251

1.80

46.98

1.5

2.57

2.36

g/l

2.64

649

4201

Acute suppurative otitis media

4072

30674

1.33

46.98

1.7

1.5

2.10

2.17

g/l

2.30

2685

20216

Other disorders of kidney and ureter

1420

9790

1.60

46.92

1.7

1.5

2.56

2.53

g/l

0.22

889

5885

Other respiratory disorders and diseases

1990

14471

1.47

46.88

1.8

1.5

2.74

2.58

g/l

2.08

1340

8526

Other diseases of the respiratory system

1990

14471

1.47

46.88

1.8

1.5

2.74

2.58

g/l

2.08

1340

8526

Blepharochalasis

3086

24007

1.37

46.75

1.5

2.36

2.53

g/l

3.71

1766

13961

Acute myeloid leukaemia, helper endpoint

203

742

3.89

46.73

1.5

1.3

2.42

2.72

g/l

1.59

180

435

Acute myeloid leukaemia

203

742

3.89

46.73

1.5

1.3

2.42

2.72

g/l

1.59

180

435

Acute myeloid leukaemia, including Hilmo

203

742

3.89

46.73

1.5

1.3

2.42

2.72

g/l

1.59

180

435

Brachial plexus disorders

1266

8611

1.67

46.64

1.5

1.4

2.25

2.29

g/l

0.35

869

5674

Other hammer toe(s) (acquired)

1763

11432

1.51

46.58

1.4

1.5

2.40

2.48

g/l

0.84

919

6425

Ulcerative rectosigmoiditis

1050

6855

1.74

46.46

1.7

1.5

2.63

2.37

g/l

3.25

743

4494

Glomerulonephritis

1142

7574

1.69

46.44

1.9

1.5

2.67

2.44

g/l

3.17

836

4728

Lateral epicondylitis

1565

11007

1.56

46.36

1.5

2.28

2.39

g/l

1.64

989

7150

Hepatocellular carcinoma, including Hilmo

321

1431

2.70

46.24

1.8

1.3

4.43

2.95

g/l

15.56

272

813

All influenza (not pneumonia)

1787

12872

1.51

46.17

1.9

1.4

2.43

2.36

g/l

0.50

1201

8000

Cardiomyopathy

1674

11841

1.51

46.08

1.6

1.5

2.61

2.54

g/l

0.62

1089

6998

Failure and rejection of transplanted organs and tissues

248

1040

3.62

45.91

2.8

1.4

1.97

2.42

g/l

3.27

208

646

Other and unspecified visual disturbances

1332

9156

1.63

45.86

1.5

2.19

2.39

g/l

4.07

776

5685

Other/unspecified rheumatoid arthritis

1333

9118

1.61

45.83

1.6

1.5

2.68

2.48

g/l

2.34

894

5292

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4916

40002

1.27

45.75

1.5

3.14

2.47

g/l

56.62

2991

26078

Unknown and unspecified causes of morbidity

824

5055

1.84

45.71

1.7

1.4

2.24

2.41

g/l

2.88

698

3121

Superficial injury of wrist and hand

2932

22871

1.38

45.52

1.6

1.5

2.20

2.26

g/l

1.10

1768

14852

Speech therapy

2908

22576

1.37

45.37

1.6

1.5

2.38

2.45

g/l

1.11

1630

13807

Other skin changes

2237

16747

1.44

45.19

1.8

1.5

2.35

2.48

g/l

2.38

1490

10069

Other specified/unspecified inflammatory spondylopathies

669

3947

2.01

45.16

1.6

1.5

2.42

2.29

g/l

1.22

483

2636

Respiratory disorders in diseases classified elsewhere

237

975

3.63

45.14

2.3

1.6

2.34

2.45

g/l

0.40

195

580

Other viral hepatitis

860

5426

1.85

45.11

1.5

2.59

2.34

g/l

3.03

586

3685

Striking against or struck by other objects

4414

35989

1.29

45.00

1.5

2.29

2.34

g/l

0.74

2634

23545

Ventral hernia

2578

19673

1.40

44.98

1.5

2.58

2.48

g/l

1.32

1567

12042

Other protozoal intestinal diseases

271

1196

3.37

44.93

1.7

1.5

2.07

2.24

g/l

0.99

139

756

COPD

4275

28001

1.29

44.91

1.6

1.5

2.93

2.62

g/l

8.73

2559

16246

Pulmonary heart disease, diseases of pulmonary circulation

3236

25401

1.34

44.78

1.9

1.5

2.61

2.55

g/l

0.64

2156

14982

Rosacea

1676

12083

1.54

44.71

1.6

1.5

2.44

2.31

g/l

1.91

1105

7647

Vitreous haemorrhage

1114

7392

1.68

44.50

1.6

2.47

2.56

g/l

0.71

665

4567

Necrosis of pulp, including avohilmo

7739

65673

1.21

44.50

1.6

1.5

2.40

2.34

g/l

1.46

4790

42724

Polyarthritis, unspecified

470

2492

2.28

44.41

1.7

1.5

2.61

2.42

g/l

1.13

331

1550

Eosinophilia

271

1197

3.26

44.20

1.9

1.4

2.20

2.49

g/l

2.00

202

733

Atrophic disorders of skin

2007

14905

1.47

44.18

1.5

2.32

2.30

g/l

0.12

1217

9025

Benign thyroid growths and nodules

3729

27763

1.32

44.07

1.5

2.26

2.39

g/l

2.43

2239

16394

Fracture of shoulder and upper arm

4283

34818

1.29

44.03

1.6

1.5

2.58

2.40

g/l

5.53

2494

21137

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1145

7703

1.68

44.00

2.0

1.5

2.28

2.34

g/l

0.50

756

4831

ILD-related respiratory insufficiency

389

1930

2.45

43.99

2.2

1.6

2.80

2.72

g/l

0.31

303

1093

Disorders of continuity of bone

1305

9018

1.62

43.96

1.7

1.5

2.34

2.32

g/l

0.14

792

5689

Primary hyperparathyroidism

1259

8630

1.63

43.75

1.7

1.5

2.29

2.47

g/l

2.48

746

4999

Disorders of oesophagus in diseases classified elsewhere

286

1266

2.91

43.71

2.0

1.5

2.64

2.61

g/l

0.09

210

754

Anogenital herpesviral [herpes simplex] infection

993

6568

1.77

43.50

1.6

1.4

2.18

2.17

g/l

0.10

601

4417

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

494

2642

2.13

43.29

1.7

1.3

3.93

2.79

g/l

14.69

387

1502

Biguanides

11968

63688

1.17

43.23

1.5

2.69

2.34

g/l

55.70

7358

40199

Fracture of foot, except ankle

3272

26006

1.34

43.12

1.6

1.5

2.41

2.30

g/l

1.36

1959

16823

Neuromuscular dysfunction of bladder

1015

6647

1.70

43.05

1.7

1.5

2.49

2.50

g/l

0.04

613

4131

Diseases of the myoneural junction and muscle

1328

9183

1.59

43.03

1.6

1.5

2.45

2.52

g/l

0.62

843

5561

Dermatitis due to substances taken internally

719

4374

1.92

42.96

2.1

1.5

2.33

g/l

0.00

511

2727

Common variable immunodeficiency

147

502

6.30

42.87

5.7

1.4

1.23

2.30

g/l

11.19

313

Mental and behavioural disorders due to alcohol

5874

46991

1.24

42.71

1.5

3.02

2.42

g/l

56.79

3586

30670

Colectomy operation

1719

12444

1.49

42.69

1.7

1.5

2.66

2.55

g/l

1.18

1033

7414

Unspecified acute lower respiratory infection

1782

12999

1.48

42.57

1.8

1.5

2.43

g/l

0.01

1273

8293

Other specified and unspecified personality disorders

1208

8299

1.65

42.56

1.5

2.33

2.28

g/l

0.34

653

5501

Other diseases of pericardium

526

2919

2.11

42.33

2.0

1.5

2.62

2.49

g/l

0.72

381

1722

Conduction disorders

3012

18844

1.34

41.84

1.6

1.5

2.62

2.47

g/l

2.69

1851

10791

Lactose intolerance, other/unspecified

422

2233

2.39

41.73

1.7

1.5

2.18

2.29

g/l

0.66

220

1387

Presence of cardiac and vascular implants and grafts

4064

24115

1.29

41.70

1.5

2.78

2.69

g/l

1.38

2478

13840

Other problems related to primary support group, including family circumstances

1763

12701

1.52

41.65

1.8

1.5

1.96

2.08

g/l

2.95

1073

8116

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2241

17100

1.43

41.61

1.6

1.5

2.37

2.25

g/l

2.07

1246

11377

Other peripheral vascular diseases

1014

6730

1.70

41.55

1.6

1.5

2.28

2.39

g/l

1.23

675

4170

Cardiodefibrillation

3203

25268

1.33

41.36

1.7

1.5

2.86

2.70

g/l

3.64

1909

14816

Viral pneumonia (unknown virus, not influenza)

856

5479

1.79

41.32

2.5

1.5

2.34

2.39

g/l

0.23

598

3476

Disorders of psychological development

1947

13581

1.48

40.98

1.7

1.5

1.97

2.04

g/l

1.32

1124

8707

Agoraphobia

537

3097

2.16

40.87

1.7

1.4

2.38

2.17

g/l

1.28

269

2121

Hypertensive heart and/or renal disease

2385

13179

1.39

40.68

1.6

1.5

2.84

2.60

g/l

4.53

1422

7389

Early onset COPD

2215

16787

1.41

40.62

1.7

1.5

2.73

2.56

g/l

1.83

1368

10401

Other diseases of blood and blood-forming organs

787

4946

1.81

40.56

1.8

1.5

2.54

2.51

g/l

0.14

534

3035

Other follicular disorders

1022

6857

1.70

40.52

1.6

1.5

2.53

2.30

g/l

2.98

691

4551

Mixed connective tissue disease

285

1329

2.95

40.49

1.9

1.5

2.44

2.38

g/l

0.25

226

799

Other abnormal immunological findings in serum

355

1817

2.67

40.39

1.9

1.5

2.35

2.15

g/l

1.14

244

1091

Osteonecrosis

733

4539

1.86

40.39

2.8

1.5

2.40

2.51

g/l

0.55

471

2717

Other abnormal findings of blood chemistry

607

3590

1.99

40.35

1.9

1.5

2.64

2.41

g/l

1.64

458

2207

Other chronic obstructive pulmonary disease

4049

26892

1.28

40.24

1.6

1.5

2.94

2.62

g/l

8.27

2415

15552

Psoriatic arthropathies, ICD10

1252

8726

1.60

40.20

1.5

2.56

2.43

g/l

1.59

826

5575

Chronic ulcer of skin, not elsewhere classified

741

4577

1.82

40.17

1.7

1.5

2.91

2.60

g/l

2.96

513

2762

Protozoal diseases, including avohilmo

416

2213

2.35

40.13

2.8

1.5

2.32

2.47

g/l

0.52

310

1354

Other and unspecified rosacea

1156

7952

1.63

40.11

1.6

1.5

2.52

2.36

g/l

1.77

766

5048

Vulvovaginal ulceration/inflammation in other diseases

1065

7274

1.70

40.08

1.6

1.4

2.08

2.10

g/l

0.17

689

4667

Golimumab

536

3103

2.13

40.03

1.7

1.5

2.80

2.25

g/l

7.36

390

2060

Systemic sclerosis

359

1831

2.56

39.94

1.7

1.5

2.23

2.36

g/l

0.67

248

1103

Nonsuppurative otitis media

3507

24610

1.32

39.80

1.7

1.5

2.04

2.16

g/l

4.70

2259

15748

Nummular dermatitis

928

6069

1.71

39.76

1.7

1.5

2.59

2.52

g/l

0.53

584

3760

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

623

3663

1.89

39.68

1.7

1.3

3.65

2.76

g/l

12.47

470

2052

Alcohol abuse, main dg, excluding more controls

1683

12296

1.48

39.61

1.5

2.93

2.38

g/l

16.69

1014

8389

Other viral diseases, not elsewhere classified

2421

18698

1.39

39.60

1.8

1.5

2.19

2.25

g/l

0.83

1626

11825

Lichen planus

1453

10401

1.53

39.55

1.5

2.51

2.45

g/l

0.34

895

6180

Contact with and exposure to communicable diseases

4582

38006

1.27

39.55

1.7

1.5

2.13

2.15

g/l

0.53

3450

24924

Childhood allergy (age < 16)

2621

17019

1.40

39.50

1.6

1.5

1.96

1.95

g/l

0.23

1675

11004

Alcohol use disorder, ICD-based

4525

37413

1.26

39.48

1.5

3.12

2.47

g/l

49.87

2753

24419

Other psoriatic arthropathies

1219

8494

1.60

39.21

1.5

2.55

2.43

g/l

1.54

802

5428

Protozoal diseases

398

2103

2.37

39.19

2.9

1.5

2.30

2.48

g/l

0.67

297

1285

Problems related to lifestyle

1321

9315

1.56

39.12

1.6

1.4

2.60

2.31

g/l

2.51

832

6210

Emotional disorders and disorders of social functioning with onset specific to childhood

978

6541

1.78

39.11

1.8

1.5

1.88

1.87

g/l

0.08

507

4182

Acute and subacute iridocyclitis

2184

16672

1.41

38.96

1.7

1.5

2.57

2.41

g/l

2.63

1490

10465

Fracture of lower leg, including ankle

6789

57185

1.21

38.91

1.5

2.57

2.38

g/l

9.18

4030

35949

Neuralgia and neuritis, unspecified

646

3910

1.91

38.90

1.7

1.5

2.29

2.41

g/l

0.85

397

2496

Other immunodeficiencies

226

1001

3.67

38.86

3.8

1.5

1.84

2.23

g/l

3.00

192

601

Other disorders of conjunctiva

1498

10783

1.51

38.79

1.5

2.42

2.52

g/l

0.69

894

6503

Benign neoplasm: Descending colon

758

4766

1.80

38.79

1.5

2.60

2.62

g/l

0.07

444

2870

Biological medicines for asthma

363

1893

2.55

38.69

1.8

1.5

2.24

2.29

g/l

0.28

275

1229

Other and unspecified coagulation defects

710

4461

1.88

38.51

1.9

1.5

2.28

g/l

0.01

452

2901

Other coagulation defects

965

6459

1.70

38.50

1.8

1.5

2.28

2.31

g/l

0.27

627

4103

Other degenerative diseases of the nervous system

2894

16533

1.34

38.40

1.9

1.5

2.40

2.51

g/l

1.84

1768

9896

Later onset COPD, excluding more controls

1739

9646

1.45

38.38

1.5

1.4

3.21

2.65

g/l

9.29

995

4875

Amyloidosis

286

1332

2.68

38.36

3.3

1.4

2.37

2.59

g/l

0.74

230

794

Other and unspecified diseases of blood and blood-forming organs

358

1836

2.46

38.31

2.2

1.5

2.52

2.50

g/l

0.06

248

1122

Marginal zone B-cell lymphoma

161

585

4.11

38.28

2.2

1.3

2.09

2.84

g/l

2.96

133

345

Other demyelinating diseases of the central nervous system

557

3307

2.07

38.24

2.3

1.4

2.12

2.29

g/l

2.32

433

2203

Other superficial mycoses, including avohilmo

1505

10962

1.52

38.23

1.5

2.18

2.25

g/l

1.03

923

7180

Abscess of anal and rectal regions

948

6279

1.67

37.87

1.5

2.56

2.45

g/l

0.85

616

4143

Fitting and adjustment of other devices

3678

26236

1.29

37.81

1.5

2.51

2.55

g/l

0.65

2466

15007

Respiratory insufficiency

736

4545

1.76

37.75

1.8

1.4

2.90

2.56

g/l

2.32

488

2524

Seborrhoeic dermatitis

1118

7687

1.60

37.58

1.7

1.5

2.55

2.48

g/l

0.55

733

4794

Temporal arteritis

416

2236

2.22

37.55

1.6

1.5

2.36

2.59

g/l

1.87

282

1261

In situ neoplasms

4566

38042

1.26

37.37

1.6

1.5

2.39

2.41

g/l

0.29

2654

22861

Anterior Iridocyclitis

2307

17855

1.38

37.25

1.7

1.5

2.55

2.41

g/l

2.37

1568

11178

Anosmia

274

1193

2.61

37.18

1.4

1.3

2.58

2.34

g/l

0.82

151

745

Bulimia nervosa (incl. atypical)

604

3727

2.03

37.16

1.6

1.4

2.06

2.03

g/l

0.26

335

2488

Dislocation, sprain and strain of joints and ligaments at neck level

2098

16119

1.42

37.08

1.6

1.5

2.20

2.25

g/l

0.91

1339

10597

Other bursopathies

1357

9658

1.52

37.01

1.7

1.5

2.52

2.51

g/l

0.04

830

5928

Acne

1769

13280

1.48

36.94

1.5

2.08

2.05

g/l

0.42

1180

8754

Anaemia in chronic diseases classified elsewhere

301

1454

2.56

36.93

1.9

1.4

2.90

2.57

g/l

1.75

227

861

Systemic sclerosis, icd10

357

1874

2.48

36.86

1.7

1.5

2.23

2.33

g/l

0.50

247

1125

Atypical facial pain

670

4176

1.87

36.82

1.8

1.4

2.13

2.33

g/l

1.43

384

2589

Hyperhidrosis

477

2717

2.12

36.75

1.6

1.4

2.12

2.20

g/l

0.54

315

1701

Other predominantly sexually transmitted diseases, not elsewhere classified

2405

18859

1.38

36.68

1.6

1.4

2.24

2.19

g/l

0.91

1512

12656

Lesion of ulnar nerve

1539

11241

1.48

36.62

1.5

2.51

2.48

g/l

0.19

976

7187

Other infectious diseases, including avohilmo

1003

6789

1.63

36.55

1.8

1.5

2.45

2.49

g/l

0.27

715

4221

Plantar fascial fibromatosis

1165

8126

1.58

36.52

1.5

2.24

2.38

g/l

1.96

678

5135

Other disorders of penis

977

6536

1.63

36.51

1.6

2.67

2.69

g/l

0.07

575

4257

Acute gastritis

768

4890

1.74

36.42

1.6

1.5

2.71

2.48

g/l

1.94

504

2963

Ankylosing spondylitis, ICD10

1049

7208

1.63

36.37

1.5

2.76

2.43

g/l

5.42

714

4716

Pleural effusion

1417

10167

1.49

36.26

1.8

1.5

3.09

2.62

g/l

9.28

998

5904

Other disorders starting during childhood or adolecense, excluding more controls

822

5190

1.79

36.23

1.8

1.5

1.85

1.88

g/l

0.21

472

3431

Hypopituitarism

941

6349

1.68

36.22

1.7

1.6

2.30

2.34

g/l

0.32

637

4038

Tongue abnormality

728

4639

1.81

36.19

1.7

1.5

2.34

2.43

g/l

0.51

445

2765

Superficial injury of abdomen, lower back and pelvis

1980

15095

1.41

36.07

1.5

2.39

2.31

g/l

0.92

1193

9660

Preparatory care for dialysis

503

2914

2.04

35.92

1.7

1.5

2.54

2.63

g/l

0.43

327

1799

Gluteal tendinitis

574

3458

1.95

35.79

1.5

1.4

2.35

2.32

g/l

0.13

319

2119

Diseases of spleen

269

1283

2.78

35.62

2.1

1.4

2.48

2.46

g/l

0.03

195

819

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3887

32131

1.28

35.51

1.5

2.26

2.30

g/l

0.58

2432

21104

Chronic hepatitis NAS

218

968

3.27

35.47

2.1

1.4

2.96

2.39

g/l

3.27

180

583

Pacemaker

3262

24417

1.29

35.42

1.6

1.5

2.76

2.66

g/l

1.52

2090

13910

Redundant prepuce, phimosis and paraphimosis

2060

15458

1.38

35.33

1.6

1.5

2.74

2.67

g/l

0.79

1385

10513

Other or unspecified common variable immunodeficiency

263

10.24

35.29

5.5

1.4

1.20

2.18

g/l

6.27

159

Calcific aortic valvular stenosis

2502

18801

1.34

35.23

1.6

1.5

3.01

2.73

g/l

5.03

1563

10519

Calcific aortic valvular stenosis, operated

2502

18801

1.34

35.23

1.6

1.5

3.01

2.73

g/l

5.03

1563

10519

Myelodysplastic syndrome

164

612

3.49

35.21

1.6

1.2

2.84

g/l

0.01

128

347

Hepatomegaly and splenomegaly, not elsewhere classified

174

697

3.77

35.12

2.1

1.5

2.10

2.32

g/l

0.75

134

414

Cluster headache, wide

521

3075

2.00

35.04

1.6

1.5

2.20

2.36

g/l

1.30

321

2039

Wegener granulomatosis

229

1031

3.03

35.00

2.2

1.5

2.06

2.52

g/l

3.89

190

620

Operations 2 for CAVS

2491

18726

1.34

34.94

1.6

1.5

3.02

2.73

g/l

5.10

1556

10480

Calcific aortic valvular stenosis, diagnosis (helper)

2491

18726

1.34

34.94

1.6

1.5

3.02

2.73

g/l

5.10

1556

10480

Cluster headache, strict

497

2903

2.04

34.90

1.6

1.5

2.16

2.35

g/l

1.52

309

1936

Vasculitis limited to skin, not elsewhere classified

349

1831

2.37

34.86

2.0

1.5

3.23

2.46

g/l

5.67

274

1097

AV-block

1604

10031

1.44

34.77

1.6

1.5

2.73

2.59

g/l

1.68

1000

5556

Infective dermatitis

1252

8917

1.53

34.76

1.5

2.75

2.46

g/l

4.43

832

5558

Hypoparathyroidism

470

2715

2.09

34.72

2.3

1.5

2.33

2.39

g/l

0.24

307

1563

Osteomyelitis

692

4365

1.78

34.71

2.0

1.5

2.97

2.53

g/l

3.02

454

2680

Oesophagitis

580

3495

1.88

34.71

1.6

1.5

2.74

2.52

g/l

1.34

364

2150

Idiopathic gout

854

5617

1.66

34.67

1.6

1.5

3.03

2.74

g/l

2.82

563

3372

Presbycusis

1181

8126

1.52

34.65

1.7

1.5

2.61

2.82

g/l

1.83

599

4289

Calcific aortic valvular stenosis, including rheumatic fever

2498

18788

1.33

34.59

1.6

1.5

3.02

2.73

g/l

5.22

1560

10508

Malignant neoplasm, including Hilmo

10909

56490

1.16

34.43

1.8

1.4

2.38

g/l

0.09

7238

35720

Acute generalized exanthematous pustulosis

582

3567

1.92

34.38

2.2

1.5

2.34

2.33

g/l

0.03

415

2209

Amyloidosis, other/unspecified

243

1113

2.78

34.36

3.5

1.4

2.24

2.62

g/l

1.55

195

660

Diabetic neuropathy

1177

8294

1.56

34.31

1.8

1.5

3.02

2.80

g/l

2.20

722

5133

Benign neoplasm of other and unspecified endocrine glands

1490

10980

1.48

34.24

1.5

2.41

2.43

g/l

0.12

924

6794

Ulcerative ileocolitis

524

3128

1.99

34.16

2.1

1.4

2.71

2.35

g/l

5.36

379

2054

Duodenal ulcer

910

6051

1.61

34.14

1.5

3.21

2.67

g/l

4.89

580

3572

Conductive and sensorineural hearing loss

8905

51947

1.17

34.08

1.6

1.5

2.46

2.49

g/l

0.65

5441

31887

Other and unspecified drugs and medicaments

1033

7173

1.61

34.03

2.0

1.5

2.30

2.38

g/l

0.68

690

4459

Haemorrhage, not elsewhere classified

410

2242

2.09

33.95

1.6

1.4

2.75

2.61

g/l

0.42

261

1311

Appendectomy

8414

70496

1.17

33.94

1.5

2.27

2.34

g/l

2.71

5400

45272

Sequelae of injuries, of poisoning and of other consequences of external causes

2719

21714

1.33

33.93

1.6

1.5

2.53

2.42

g/l

1.41

1649

14052

Open wound of lower leg

1808

13714

1.42

33.91

1.6

1.5

2.52

2.38

g/l

1.73

1069

8584

Misadventures to patients during surgical and medical care

1618

12074

1.45

33.86

1.7

1.5

2.50

2.42

g/l

0.85

1039

7486

Giant cell arteritis with polymyalgia rheumatica

416

2320

2.12

33.60

1.6

1.5

2.36

2.60

g/l

2.04

282

1310

Phlebitis and thrombophlebitis (not including DVT)

2449

19314

1.34

33.60

1.7

1.5

2.48

2.41

g/l

0.83

1552

11850

1464

10925

1.51

33.48

1.5

1.4

2.09

2.05

g/l

0.55

768

7501

Pediculosis, acariasis and other infestations, including avohilmo

2397

18982

1.36

33.46

1.5

2.25

2.22

g/l

0.36

1515

12369

Sensorineural hearing loss

8257

48176

1.17

33.45

1.6

1.5

2.48

2.52

g/l

0.73

5034

29338

Guillain-Barre syndrome

240

1123

2.86

33.38

1.7

1.4

2.37

2.50

g/l

0.54

188

719

Gonarthrosis,primary

9776

52132

1.16

33.29

1.5

2.55

2.51

g/l

0.68

5871

32274

Other local infections of skin and subcutaneous tissue

1219

8731

1.53

33.29

1.7

1.5

2.50

2.40

g/l

1.00

753

5480

Cholecystitis

1348

9736

1.48

33.27

1.6

1.5

2.67

2.52

g/l

1.79

878

5757

Acute laryngitis and tracheitis

1761

13202

1.43

33.05

1.6

1.4

2.08

2.16

g/l

1.36

1154

8533

Pericarditis

409

2270

2.10

32.96

2.1

1.5

2.61

2.53

g/l

0.26

293

1386

Dermatopolymyositis (FG)

209

926

3.04

32.84

2.0

1.4

2.32

2.45

g/l

0.37

164

537

Pulmonary embolism

2903

23355

1.30

32.77

1.9

1.5

2.58

2.55

g/l

0.29

1920

13856

Malignant neoplasm, wide definition

10887

56510

1.15

32.71

1.8

1.4

2.38

g/l

0.09

7235

35721

Other bullous disorders

365

1991

2.26

32.68

1.9

1.5

2.42

2.43

g/l

0.06

230

1212

Diabetic maculopathy

1371

9510

1.50

32.60

1.6

2.71

2.67

g/l

0.37

803

5921

Other abnormalities of plasma proteins

227

1044

2.87

32.58

2.7

1.4

2.56

2.55

g/l

0.03

186

601

Diabetic nephropathy, excluding more controls

1620

9880

1.44

32.49

1.7

1.5

2.88

2.67

g/l

3.45

1041

5877

Scabies, including avohilmo

2103

16465

1.38

32.48

1.5

2.22

2.20

g/l

0.31

1353

10800

Hypertensive Heart Disease

2102

12250

1.36

32.33

1.5

2.84

2.61

g/l

3.80

1216

6827

Ptosis of eyelid

1154

8204

1.53

32.31

1.5

2.32

2.55

g/l

2.83

617

4837

Retinal detachments and breaks

3503

28800

1.27

32.25

1.6

1.5

2.52

2.57

g/l

0.55

2070

17216

Hallux rigidus

1366

9965

1.47

32.21

1.4

1.5

2.38

2.49

g/l

1.28

716

5801

Other maternal disorders predominantly related to pregnancy

7980

43926

1.18

32.19

1.5

2.15

g/l

0.07

5120

27781

Pulmonary heart disease

2903

23412

1.30

32.08

1.9

1.5

2.58

2.55

g/l

0.24

1920

13891

Sleep disorders, other/unspecified

547

3379

1.94

32.05

1.7

1.5

2.13

2.22

g/l

0.55

298

2202

Chondrocostal junction syndrome [Tietze]

509

3078

1.97

32.03

1.7

1.5

2.25

2.32

g/l

0.38

287

1916

Endometriosis ASRM stages 1,2

2394

19100

1.36

32.03

1.5

2.06

2.15

g/l

2.36

1518

12357

Sacroiliitis, not elsewhere classified

663

4266

1.79

31.95

1.5

2.39

2.22

g/l

1.49

475

2866

Corneal ulcer

2189

17175

1.36

31.91

1.6

1.5

2.39

2.37

g/l

0.23

1424

10977

Primary adrenocortical insufficiency

198

889

3.31

31.89

2.2

1.5

2.07

2.27

g/l

1.06

130

549

Superficial injury of hip and thigh

1631

12250

1.42

31.86

1.5

2.50

2.44

g/l

0.57

935

7488

Otitis externa, unspecified

1449

10785

1.47

31.84

1.6

1.5

2.29

2.30

g/l

0.10

907

6862

Transient ischemic attack

5146

34822

1.22

31.74

1.5

2.51

2.59

g/l

1.80

2971

20472

conjunctival haemorrhage

812

5427

1.66

31.65

1.5

2.35

2.55

g/l

2.46

469

3242

Other and unspecified local infections of skin and subcutaneous tissue

1154

8265

1.53

31.64

1.7

1.5

2.49

2.39

g/l

0.94

720

5197

Psoriasis (vulgaris), strict definition

447

2608

2.04

31.61

1.6

1.5

3.24

2.47

g/l

7.86

310

1715

Mantle cell lymphoma, including Hilmo

179

742

3.13

31.57

2.5

1.3

1.89

2.90

g/l

7.58

145

432

Epilepsy

3401

27861

1.27

31.56

1.6

1.5

2.36

2.41

g/l

0.75

2049

17283

Myositis

316

1649

2.32

31.41

1.6

1.5

2.62

2.49

g/l

0.45

227

1031

Suicide or other Intentional self-harm

3068

25092

1.30

31.38

1.5

2.37

2.29

g/l

1.57

1711

16513

Graves disease, strict definition

1330

9817

1.50

31.36

1.5

2.17

2.24

g/l

0.84

807

6277

Disorders of refraction and accommodation

3839

31991

1.26

31.33

1.6

1.5

2.14

2.24

g/l

3.86

2472

20485

Other and unspecified nerve root and plexus disorders, also in other diseases

2357

18681

1.34

31.32

1.5

2.33

2.43

g/l

1.96

1480

11925

Other noninflammatory disorders of uterus, except cervix

2235

11642

1.36

31.30

1.4

1.5

2.38

2.35

g/l

0.28

1276

6831

Other and unspecified vasculitis limited to skin

314

1652

2.36

31.21

2.0

1.5

3.27

2.49

g/l

5.11

251

990

Familial hypercholesterolemia

1338

9750

1.46

31.20

1.6

1.5

2.62

2.66

g/l

0.28

825

5620

Dissociative [conversion] disorders

577

3642

1.88

31.01

1.6

1.5

2.28

2.16

g/l

0.51

343

2424

Fall on and from stairs and steps

3049

24906

1.29

30.97

1.5

2.49

2.38

g/l

2.08

1706

15527

Superficial injury of thorax

1700

12948

1.41

30.71

1.5

2.46

2.43

g/l

0.25

1033

8183

Other spirochaetal diseases

3932

32968

1.25

30.65

1.5

2.31

2.41

g/l

2.34

2136

20497

Other spirochaetal diseases, including avohilmo

3984

33445

1.25

30.63

1.5

2.31

2.40

g/l

2.06

2164

20802

Scoliosis

1142

8244

1.53

30.57

1.6

1.5

2.05

2.16

g/l

1.49

679

5059

Fracture of femur

2520

18057

1.31

30.50

1.6

1.5

2.89

2.58

g/l

5.26

1398

10322

Diseases of appendix

9404

74938

1.15

30.43

1.5

2.29

2.37

g/l

4.77

5997

48083

Generalized skin eruption due to drugs and medicaments

513

3147

1.93

30.43

2.3

1.5

2.34

2.32

g/l

0.07

375

1938

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

198

13.13

30.43

6.8

1.4

0.88

2.24

g/l

9.82

133

Lyme disease

3891

32626

1.25

30.32

1.5

2.30

2.41

g/l

2.51

2110

20291

Lyme disease, including avohilmo

3891

32626

1.25

30.32

1.5

2.30

2.41

g/l

2.51

2110

20291

Other female pelvic inflammatory diseases

1926

15025

1.38

30.30

1.6

1.5

2.20

2.25

g/l

0.62

1188

9134

Hypocalcemia

328

1781

2.32

30.30

2.1

1.5

2.64

2.44

g/l

0.74

220

1084

Other and unspecified disorders of skin and subcutaneous tissue

719

4744

1.71

30.25

1.7

1.5

2.36

2.43

g/l

0.38

428

2890

2602

17840

1.30

30.25

1.5

2.81

2.71

g/l

1.05

1461

9637

Other disorders of the musculoskeletal system and connective tissue

1571

11869

1.42

30.22

1.5

2.41

2.50

g/l

0.92

948

7335

Spirochaetal infections, other/unspecified, including avohilmo

3919

32900

1.25

30.14

1.5

2.30

2.41

g/l

2.60

2122

20451

Nail disorders

1037

7371

1.56

30.11

1.6

1.5

2.24

2.35

g/l

1.14

642

4633

Abnormal findings in secretions and smears from cervix uteri vagina vulva

7012

45283

1.19

30.06

1.5

1.4

2.17

2.16

g/l

0.22

4493

28869

Total colectomy

514

3156

1.90

30.02

1.9

1.5

2.67

2.41

g/l

2.76

377

2023

Total colectomy operation

514

3156

1.90

30.02

1.9

1.5

2.67

2.41

g/l

2.76

377

2023

Hereditary hypogammaglobulinemia

299

7.74

29.88

5.1

1.4

1.61

2.35

g/l

3.17

182

Angina pectoris

5490

31196

1.20

29.85

1.6

1.5

2.69

2.60

g/l

1.82

3348

18017

Other/unspecified enthesopathies, not elsewhere classified

884

6062

1.59

29.83

1.5

2.36

2.47

g/l

0.57

552

3785

Other pleural conditions

923

6359

1.56

29.75

1.8

1.5

3.02

2.67

g/l

4.12

639

3685

Infliximab

345

1927

2.28

29.71

1.6

1.5

2.54

2.23

g/l

3.86

267

1285

Hodgkin lymphoma, hilmo

387

2221

2.13

29.66

1.9

1.5

2.10

2.40

g/l

1.47

306

1403

Appendicitis, broad definition

9319

74630

1.15

29.48

1.5

2.30

2.37

g/l

4.35

5945

47925

Allergic urticaria

1094

7906

1.54

29.45

1.8

1.5

2.17

2.21

g/l

0.42

688

5000

Disorders resulting from impaired renal tubular function

438

2591

2.00

29.41

1.7

1.5

2.50

2.49

g/l

0.03

296

1579

Other chronic obstructive pulmonary disease, including avohilmo

5199

36540

1.20

29.39

1.6

1.5

2.88

2.60

g/l

8.98

3061

21710

Other/unspecified soft tissue disorders related to use, overuse and pressure

395

2271

2.08

29.39

1.4

1.5

2.34

2.35

g/l

0.02

229

1471

Excessive vomiting in pregnancy

1159

8501

1.53

29.21

1.6

1.5

2.07

2.10

g/l

0.29

749

5600

Infection due to other mycobacteria

209

964

2.75

29.15

1.8

1.4

2.61

2.49

g/l

0.36

152

523

Testicular dysfunction

459

2739

1.93

29.06

1.6

1.5

2.38

2.67

g/l

3.73

334

1903

Chronic viral hepatitis

674

4449

1.73

29.06

1.5

2.55

2.34

g/l

2.09

428

3050

D07AA Corticosteroids, weak (group I)

2067

16337

1.36

29.01

1.5

2.34

2.18

g/l

3.99

1296

10430

Other specified/unspecified necrotizing vasculopathies

195

891

2.90

28.54

2.1

1.4

2.53

2.52

g/l

0.03

158

543

Other disorders of breast

1779

13875

1.39

28.45

1.5

2.11

2.21

g/l

1.36

1048

8646

Dermatophytosis

1466

11063

1.42

28.39

1.7

1.5

2.58

2.51

g/l

0.37

990

6842

Amputation

880

6056

1.56

28.31

1.7

1.5

3.07

2.69

g/l

3.55

539

3582

Dermatopolymyositis

215

1029

2.76

28.31

2.1

1.5

2.31

2.48

g/l

0.55

167

611

Emotional disorders starting during childhood or adolescence

898

6376

1.66

28.19

1.8

1.5

1.88

1.87

g/l

0.04

468

3999

Special screening examination for neoplasms

628

4034

1.70

28.16

1.5

2.60

2.58

g/l

0.05

381

2576

Carcinoma in situ of skin of other and unspecified parts of face

758

5083

1.62

28.13

1.9

1.5

2.59

2.80

g/l

1.04

395

2793

COPD, hospital admission 2, with asthma infections

2827

19773

1.28

28.12

1.6

1.5

2.94

2.67

g/l

4.17

1735

11587

Any event in hilmo or specialist outpatient

5.66

28.08

1.4

1.1

2.51

2.18

g/l

0.66

Peripheral artery disease

3829

25283

1.24

28.08

1.6

1.5

2.88

2.68

g/l

5.39

2295

14539

Urolithiasis

3140

25905

1.26

28.05

1.6

1.5

2.56

2.57

g/l

0.18

1946

16221

Fibrosis of liver

140

572

3.92

28.04

1.8

1.4

3.27

2.35

g/l

4.99

117

333

Inflammatory diseases of the central nervous system

957

6783

1.56

28.04

1.9

1.5

2.33

2.38

g/l

0.36

669

4307

Peripheral artery operations in Hilmo

1065

7595

1.49

27.83

1.7

1.5

3.05

2.72

g/l

3.47

644

4477

Myeloproliferative diseases

832

5732

1.59

27.82

1.6

1.5

2.36

2.56

g/l

1.91

556

3407

Other peripheral vertigo

988

7041

1.54

27.77

1.5

2.26

2.48

g/l

2.96

563

4278

Acute appendicitis, no complications

6990

61285

1.17

27.62

1.5

2.27

2.36

g/l

4.54

4503

39971

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

966

6869

1.54

27.58

1.5

2.52

2.48

g/l

0.23

555

4174

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3762

31718

1.24

27.50

1.6

1.5

2.49

2.35

g/l

3.91

2603

20057

Lichen sclerosus et atrophicus

1335

10024

1.45

27.48

1.4

1.5

2.34

2.36

g/l

0.12

810

5920

Postviral fatigue syndrome

182

858

3.35

27.37

2.2

1.4

1.87

2.10

g/l

2.04

136

575

Kidney transplant status

632

4172

1.73

27.30

2.0

1.6

2.42

2.39

g/l

0.14

439

2602

Speech and linguistic disorders

1378

10057

1.46

27.22

1.7

1.5

2.01

2.03

g/l

0.17

790

6324

Thyroiditis

890

6291

1.58

27.19

1.6

1.5

2.13

2.27

g/l

2.16

533

3931

Acne vulgaris

1342

10169

1.46

27.16

1.5

2.06

2.05

g/l

0.13

893

6736

Open wound of wrist and hand

5517

46302

1.19

27.12

1.5

2.35

2.39

g/l

0.72

3429

30446

Other and unspecified psoriasis

745

5067

1.63

27.00

1.6

1.5

3.03

2.47

g/l

6.74

445

3174

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

685

4606

1.69

26.99

1.5

2.40

2.38

g/l

0.09

406

2692

Selective deficiency of immunoglobulin A [IgA]y

110

423

5.64

26.96

2.9

1.5

1.04

2.28

g/l

6.84

258

Diabetic nephropathy

1637

12501

1.39

26.93

1.7

1.6

2.88

2.79

g/l

0.95

1051

7591

Amputation of toe

647

4241

1.67

26.92

1.7

1.6

3.07

2.73

g/l

2.12

388

2551

Peripheral arterial reconstruction

1361

10166

1.41

26.83

1.6

1.5

3.00

2.77

g/l

2.58

819

5843

Endocarditis

376

2160

1.99

26.82

1.9

1.5

3.17

2.59

g/l

3.25

266

1287

Other diseases of arteries and capillaries

937

6637

1.53

26.81

1.6

1.5

2.64

2.50

g/l

0.83

585

4045

Hypertrophy of breast in women and men

2450

19934

1.31

26.80

1.5

2.28

2.25

g/l

0.31

1563

12759

Any death

5135

41522

0.84

26.79

1.8

1.5

3.14

2.50

g/l

29.79

3433

24187

Malignant neoplasm

10409

54856

1.14

26.71

1.8

1.4

2.36

2.39

g/l

0.73

6900

34621

Other/unspecified reactive arthropathies

779

5381

1.62

26.68

1.7

1.5

2.55

2.37

g/l

1.84

502

3449

Testicular hypofunction

408

2416

1.95

26.68

1.7

1.5

2.37

2.68

g/l

3.60

300

1679

Sacrococcygeal disorders, not elsewhere classified

410

2452

1.97

26.56

1.6

1.5

2.22

2.27

g/l

0.17

233

1589

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3402

28495

1.25

26.48

1.5

2.40

2.42

g/l

0.21

2144

18365

Cardiomyopathy in other diseases

309

4.59

26.48

3.3

1.4

2.28

2.62

g/l

0.59

176

Postprocedural disorders of nervous system

975

7052

1.55

26.48

1.7

1.5

2.06

2.20

g/l

2.27

705

4662

Macular pucker

1463

11129

1.40

26.41

1.6

1.5

2.65

2.61

g/l

0.19

809

6299

Myocarditis

518

3247

1.77

26.40

1.9

1.4

2.40

2.35

g/l

0.28

361

2019

Pyogenic arthritis

655

4325

1.66

26.39

1.7

1.5

2.98

2.53

g/l

3.86

432

2674

Malignant neoplasm

10407

54912

1.14

26.14

1.8

1.4

2.36

2.39

g/l

0.67

6907

34650

Secondary right heart disease

423

2533

1.89

26.14

2.0

1.5

2.77

2.59

g/l

0.88

300

1461

Presence of other devices

2313

18293

1.30

26.09

1.5

2.46

2.55

g/l

1.39

1529

10409

Acute appendicitis

8716

72459

1.15

26.08

1.5

2.30

2.37

g/l

3.87

5576

46674

Other specified/unspecified soft tissue disorders

520

3282

1.77

26.02

1.8

1.5

2.30

2.41

g/l

0.69

336

1994

Calculus of kidney and ureter

2923

24136

1.26

26.02

1.6

1.5

2.54

2.56

g/l

0.15

1820

15119

Emphysema

645

4243

1.65

26.02

1.7

1.6

3.04

2.64

g/l

1.61

418

2478

Otitis media, unspecified

1686

12181

1.39

25.98

1.7

1.5

2.01

2.07

g/l

0.99

1065

7721

Coxarthrosis, primary

5958

43184

1.18

25.97

1.5

2.54

2.60

g/l

1.06

3446

25420

Other disorders of nervous system

708

4801

1.63

25.91

1.7

1.5

2.45

2.55

g/l

0.61

432

2954

Biomechanical lesions, not elsewhere classified

567

3680

1.74

25.84

1.5

2.41

2.49

g/l

0.33

313

2254

Infection due to other mycobacteria, including avohilmo

220

1087

2.51

25.81

1.7

1.4

2.57

2.45

g/l

0.42

161

609

Hepatocellular carcinoma

217

1045

2.41

25.78

1.8

1.2

4.43

2.95

g/l

10.44

185

578

Type of accident

3467

29193

1.24

25.77

1.6

1.5

2.48

2.36

g/l

3.19

2402

18406

Other infectious diseases

784

5419

1.59

25.74

1.9

1.5

2.47

2.53

g/l

0.28

552

3344

Other keratitis

1365

10383

1.42

25.64

1.6

1.5

2.49

2.34

g/l

2.41

887

6662

Nephrotic syndrome

397

2387

1.98

25.62

2.0

1.5

2.45

2.36

g/l

0.37

281

1441

Chondropathies

1814

14342

1.35

25.42

1.6

1.5

2.27

2.32

g/l

0.42

1170

9209

Cardiomyopathy, other and unspecified

741

5064

1.59

25.38

1.7

1.5

2.62

2.54

g/l

0.46

461

2986

Flat foot [pes planus] (acquired)

1072

7855

1.48

25.36

1.5

2.29

2.34

g/l

0.40

685

4790

Chronic conjunctivitis

398

2403

1.97

25.31

1.6

1.5

2.22

2.31

g/l

0.46

234

1486

Charcot foot

228

1152

2.45

25.27

1.8

1.4

3.02

2.47

g/l

2.63

135

691

COPD related to multimorbidity

3466

24540

1.23

25.27

1.6

1.5

2.95

2.67

g/l

7.01

2068

14264

DVT of lower extremities

1839

14489

1.34

25.20

1.8

1.5

2.55

2.49

g/l

0.49

1160

8702

Disorders of optic nerve and visual pathways

1155

8622

1.47

25.16

1.9

1.5

2.09

2.28

g/l

4.26

769

5456

Spontaneous rupture of synovium and tendon

835

5858

1.55

25.08

1.7

1.5

2.41

2.49

g/l

0.67

510

3549

Procreative management

4500

31947

1.21

24.96

1.6

1.5

2.13

2.26

g/l

7.01

2846

20941

Overexertion and strenuous or repetitive movements

1133

8423

1.46

24.93

1.6

1.5

2.35

2.41

g/l

0.41

608

5482

Mantle cell lymphoma

123

480

3.42

24.83

2.3

1.3

1.91

3.00

g/l

7.28

101

279

Fracture of skull and facial bones

2430

19833

1.29

24.79

1.6

1.5

2.56

2.39

g/l

2.78

1438

12810

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

450

2753

1.79

24.77

1.7

1.3

3.72

2.80

g/l

9.91

347

1554

Palmar fascial fibromatosis [Dupuytren]

1217

9044

1.41

24.73

1.6

1.5

2.85

2.73

g/l

0.73

685

5401

Other endocrine disorders

785

5343

1.63

24.70

1.9

1.6

1.98

2.00

g/l

0.12

430

3127

Other or unspecified immunodeficiency

348

5.84

24.50

4.9

1.5

1.81

2.27

g/l

2.35

225

Spirochaetal infections, other/unspecified

982

7162

1.50

24.45

1.6

1.5

2.23

2.44

g/l

3.06

534

4415

Viral pneumonia (known virus, not influenza)

355

2092

2.01

24.38

2.7

1.5

2.51

2.41

g/l

0.19

243

1229

Cluster headache, strict, including avohilmo

653

4456

1.67

24.32

1.6

1.5

2.15

2.30

g/l

1.63

424

2972

Malignant neoplasm of liver and intrahepatic bile ducts

290

1578

2.08

24.28

1.8

1.3

4.08

2.88

g/l

9.43

231

902

Other otitis externa (chronic)

789

5555

1.58

24.28

1.6

1.5

2.39

g/l

0.03

443

3483

Enteropathic arthropathies

306

1733

2.13

24.18

1.8

1.5

2.74

2.30

g/l

3.43

227

1135

Fracture of forearm

7015

56026

1.16

24.14

1.5

2.36

2.32

g/l

0.92

4084

34634

Cerebral cysts

705

4870

1.62

24.12

1.7

1.5

2.46

2.33

g/l

0.76

491

3114

Cluster headache, wide,, including avohilmo

677

4658

1.65

24.08

1.6

1.5

2.17

2.31

g/l

1.42

436

3096

Cramp and spasm

579

3855

1.71

24.02

1.8

1.5

2.27

2.37

g/l

0.62

347

2463

Oral lichen planus, including avohilmo , including avohilmo

809

5740

1.56

23.97

1.5

2.36

2.37

g/l

0.07

490

3481

Postprocedural disorders of digestive system, not elsewhere classified

383

2305

1.93

23.93

1.7

1.5

2.61

2.42

g/l

0.91

267

1394

Ulcerative enterocolitis

387

2345

1.93

23.91

2.1

1.4

2.53

2.37

g/l

1.02

299

1526

Oligomenorrhoea

496

3210

1.79

23.76

1.6

1.4

2.14

2.13

g/l

0.02

319

2064

Cerebral palsy and other paralytic syndromes

1223

9246

1.42

23.66

1.7

1.5

2.36

2.38

g/l

0.11

751

5770

Personal history of other diseases and conditions

1659

13107

1.37

23.65

1.6

1.5

2.09

2.05

g/l

0.43

987

8257

CR(E)ST syndrome

229

1209

2.47

23.60

1.6

1.5

2.09

2.30

g/l

1.04

154

716

Alzheimer disease

1794

16236

0.77

23.59

1.5

2.77

2.74

g/l

0.12

851

8841

Alcohol-induced chronic pancreatitis

627

4224

1.64

23.58

1.5

3.76

2.65

g/l

15.23

388

2720

COPD-related respiratory insufficiency

985

7155

1.46

23.56

1.8

1.5

3.08

2.71

g/l

2.30

614

4142

Drug-induced neutropenia

777

5486

1.57

23.51

2.4

1.5

2.10

2.46

g/l

6.08

604

3327

Carcinoma in situ of skin

806

5692

1.54

23.49

1.9

1.5

2.59

2.67

g/l

0.34

457

3268

Benign neoplasm: Small intestine

422

2615

1.85

23.46

1.6

1.5

2.60

2.58

g/l

0.05

257

1556

Other benign neoplasms of skin

4013

34428

1.21

23.44

1.6

1.5

2.37

2.44

g/l

0.94

2406

20876

Anomalies of dental arch relationship, including avohilmo

2774

20956

1.27

23.38

1.5

2.03

2.16

g/l

6.03

1785

13439

Other and unspecified follicular disorders

511

3336

1.75

23.17

1.6

1.5

2.48

2.40

g/l

0.38

346

2179

Other pulmonary heart/vessel disease

455

2865

1.78

23.08

2.0

1.5

2.73

2.60

g/l

0.57

318

1657

Wide developmental disorders, excluding more controls

538

3506

1.76

23.01

1.6

1.5

1.83

1.92

g/l

0.93

300

2311

Endometriosis of rectovaginal septum and vagina

857

6167

1.52

22.98

1.5

2.15

2.27

g/l

1.24

563

3769

Dementia in Alzheimer disease

787

9325

0.68

22.85

1.6

1.5

2.94

2.78

g/l

0.62

447

5050

Speech disturbances, not elsewhere classified

890

6423

1.50

22.84

1.5

2.63

2.55

g/l

0.29

511

3883

Assault

1676

13304

1.35

22.82

1.5

2.52

2.31

g/l

3.64

983

9024

Benign neoplasm: Liver/bile ducts

361

2192

1.98

22.76

1.7

1.5

2.16

2.30

g/l

1.01

244

1399

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

978

7035

1.45

22.76

1.6

1.3

2.85

2.82

g/l

0.09

563

3746

Memory loss

837

5979

1.51

22.76

1.5

2.46

2.58

g/l

0.63

365

3514

Glucosamine medication

4419

30442

1.19

22.75

1.5

2.43

2.58

g/l

3.55

2357

17066

Impacted cerumen

1166

8793

1.42

22.75

1.5

2.39

2.51

g/l

1.32

600

5193

Fracture at wrist and hand level

4181

35981

1.20

22.73

1.5

2.41

2.38

g/l

0.39

2507

23377

Drug-induced cataract

306

1776

2.09

22.68

2.5

1.5

2.35

2.40

g/l

0.15

227

1063

Vitamin D deficiency

289

1661

2.17

22.65

1.9

1.4

2.45

2.26

g/l

1.07

192

1051

Vasomotor rhinitis (mode)

818

5869

1.54

22.62

1.6

1.5

2.17

2.41

g/l

3.50

521

3667

Myasthenia gravis

226

1194

2.37

22.60

1.7

1.5

2.08

2.52

g/l

3.30

167

737

Cyst of kidney

690

4776

1.58

22.54

1.6

1.5

2.63

2.62

g/l

0.03

401

2860

Algoneurodystrophy

440

2812

1.84

22.50

1.7

1.4

2.26

2.27

g/l

0.03

281

1799

Orchitis and epididymitis

793

5592

1.51

22.46

1.6

2.58

2.79

g/l

2.03

520

3676

Need for immunization against other single viral diseases

254

1398

2.25

22.46

2.2

1.4

2.17

2.55

g/l

2.42

133

872

Myocardial infarction, without ST-elevation

3399

25923

1.22

22.45

1.6

1.5

2.85

2.72

g/l

2.07

2014

15077

Mental and behavioural disorders due to tobacco

975

7208

1.47

22.30

1.6

1.5

2.49

2.44

g/l

0.38

573

4616

Ankylosing spondylitis, strict definition

534

3557

1.71

22.19

1.5

2.83

2.36

g/l

5.15

364

2415

Other acute viral hepatitis

201

1040

2.56

22.14

1.7

1.4

2.62

2.39

g/l

0.87

148

681

Other infective otitis externa

700

4909

1.58

22.02

1.6

1.5

2.43

2.42

g/l

0.04

385

3114

Synovial cyst of popliteal space [Baker]

739

5200

1.54

21.96

1.6

1.5

2.55

2.49

g/l

0.31

428

3132

Other diseases of gallbladder

463

2966

1.74

21.95

1.5

2.42

2.46

g/l

0.16

275

1734

Smoking dependency

975

7232

1.47

21.85

1.6

1.5

2.49

2.43

g/l

0.40

573

4619

Female infertility, associated with anovulation

1114

8468

1.44

21.63

1.5

1.4

2.13

2.08

g/l

0.70

775

5758

Disorders of orbit

508

3361

1.71

21.54

1.8

1.5

2.31

2.38

g/l

0.36

324

2123

Benign neoplasm: Liver

330

1990

2.01

21.53

1.7

1.5

2.15

2.29

g/l

0.91

219

1277

Other juvenile arthritis

602

4171

1.67

21.51

1.9

1.5

2.43

2.01

g/l

4.77

394

2658

Open wound of ankle and foot

1188

9081

1.41

21.49

1.7

1.5

2.50

2.38

g/l

1.45

727

5844

Trigeminal neuralgia

662

4609

1.59

21.44

1.6

1.4

2.03

2.38

g/l

5.61

398

2824

Folate deficiency anaemia

140

625

2.90

21.39

2.0

1.4

3.44

2.56

g/l

2.95

103

362

Seborrhoeic keratosis

2488

20643

1.26

21.35

1.7

1.5

2.41

2.51

g/l

1.26

1553

12084

Habitual aborter

318

1901

2.02

21.35

1.5

1.4

2.01

2.08

g/l

0.39

163

1310

Other specified/unspecified hearing loss

875

6372

1.48

21.22

1.6

1.5

2.33

2.54

g/l

2.23

498

3785

Scleritis and episcleritis

739

5287

1.55

21.06

1.6

1.5

2.44

2.32

g/l

0.76

490

3403

Olecranon bursitis

556

3723

1.62

20.98

1.6

2.60

2.69

g/l

0.47

368

2393

Diabetes mellitus in pregnancy

4843

27023

1.19

20.85

1.4

2.16

2.06

g/l

5.75

3143

18424

Drug-induced osteoporosis

190

980

2.52

20.83

2.6

1.5

2.19

2.47

g/l

1.00

146

559

Artificial opening status

561

3797

1.63

20.80

1.7

1.5

2.83

2.46

g/l

1.05

335

2227

Benign neoplasm: Adrenal gland

799

5781

1.51

20.80

1.5

2.54

2.51

g/l

0.14

486

3525

Specific development disorders of scholastic skills

733

5217

1.59

20.75

1.9

1.6

1.90

1.96

g/l

0.59

428

3228

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1559

12403

1.35

20.74

1.6

1.5

2.02

2.08

g/l

0.99

980

7835

1813

13564

1.30

20.71

1.5

2.77

2.70

g/l

0.45

1011

7287

Oral lichen planus

330

2000

1.95

20.70

1.6

1.5

2.37

2.43

g/l

0.28

203

1198

Melanocytic naevi

3785

32719

1.20

20.69

1.7

1.5

2.19

2.31

g/l

3.80

2481

20820

Pneumonia derived septicemia

407

2588

1.80

20.62

2.3

1.5

2.49

2.38

g/l

0.39

292

1556

Atherosclerosis, excluding cerebral and coronary sclerosis

3435

22960

1.21

20.60

1.5

2.92

2.71

g/l

4.93

2057

13079

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

1105

8360

1.44

20.56

1.8

1.5

1.97

2.03

g/l

0.68

720

5205

COPD, hospital admissions

4020

29240

1.19

20.45

1.6

1.5

2.93

2.64

g/l

7.12

2401

17129

Hypertrophy of breast

2177

18028

1.28

20.41

1.5

2.22

2.19

g/l

0.36

1367

11504

Medical abortion

8619

42273

1.14

20.37

1.5

2.21

2.18

g/l

0.79

4976

26541

Other surgical follow-up care

442

2880

1.76

20.37

1.5

2.59

2.25

g/l

2.70

268

1791

Chronic iridocyclitis

565

3866

1.64

20.35

1.7

1.5

2.45

2.37

g/l

0.41

383

2400

ILD and respiratory illness in diseases classified elsewhere

374

3.97

20.31

2.5

1.4

2.38

2.51

g/l

0.25

215

L01XX Other antineoplastic agents

546

3687

1.63

20.30

2.2

1.5

2.20

2.68

g/l

4.57

368

2126

Dystonia

635

4451

1.59

20.27

1.5

2.14

2.35

g/l

3.03

383

2805

Lichen simplex chronicus

380

2382

1.82

20.24

1.7

1.5

2.79

2.49

g/l

1.42

245

1495

242

1333

2.10

20.14

2.1

1.5

2.86

2.69

g/l

0.68

179

749

Hordeolum and other deep inflammation of eyelid

739

5329

1.53

20.13

1.7

1.5

2.25

2.32

g/l

0.49

435

3351

Myeloproliferative diseases (CML excluded)

723

5158

1.52

20.12

1.6

1.5

2.42

2.57

g/l

0.98

468

3070

Defects in the complement system

139

670

3.27

20.07

3.1

1.5

1.79

2.08

g/l

1.57

118

393

Juvenile arthritis (FINNGEN)

665

4748

1.59

20.03

1.9

1.5

2.44

2.04

g/l

4.88

442

3019

Squamous cell neoplasms and carcinomas of the skin

777

5557

1.48

20.01

1.6

1.3

2.89

2.82

g/l

0.22

450

2967

Abnormal findings in nipple discharge synovial fluid wound secretions

218

1196

2.32

19.99

1.7

1.5

2.81

2.32

g/l

1.82

150

748

Other dialysis

354

2201

1.88

19.98

2.1

1.5

2.70

2.52

g/l

0.65

244

1348

Progressive vascular leukoencephalopathy

348

2116

1.82

19.94

1.4

1.6

2.89

2.77

g/l

0.30

125

1173

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1036

7852

1.42

19.92

1.8

1.5

2.37

2.44

g/l

0.50

694

4848

COPD, hospital admissions 3, with asthma pneumonia sepsis

2235

15744

1.26

19.91

1.7

1.5

2.96

2.71

g/l

2.63

1371

9130

COPD, early/later onset

4060

29504

1.19

19.90

1.6

1.5

2.94

2.64

g/l

7.52

2422

17290

Flatulence and related conditions

152

727

2.69

19.90

1.5

1.4

2.19

2.38

g/l

0.66

429

Nontoxic goitre/thyroid nodule

3099

26436

1.22

19.87

1.5

2.27

2.40

g/l

2.11

1869

15492

Carcinoma in situ of other and unspecified digestive organs

443

2885

1.72

19.84

1.6

1.5

2.57

2.70

g/l

0.56

233

1745

Hypertension, portal

228

5.48

19.84

2.4

1.4

4.37

2.35

g/l

4.80

128

Abnormal blood-pressure reading, without diagnosis

530

3590

1.64

19.71

1.7

1.5

2.23

2.32

g/l

0.55

313

2179

Unspecified lump in breast

1818

14820

1.30

19.69

1.5

2.11

2.26

g/l

3.68

1011

9011

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

839

6211

1.49

19.53

1.7

1.5

2.42

2.23

g/l

2.07

500

4038

Deficiency of other B group vitamins

243

1361

2.09

19.48

1.9

1.5

2.73

2.45

g/l

1.02

129

821

Autoimmune thyroiditis

274

1619

2.07

19.44

1.6

1.5

2.02

2.24

g/l

1.95

170

1011

Viral warts

1214

9465

1.38

19.44

1.7

1.5

2.26

2.28

g/l

0.12

866

5994

Thoracic aortic aneurysm

1239

9603

1.36

19.40

1.7

1.5

2.65

2.73

g/l

0.68

685

5864

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

4691

27692

1.17

19.40

1.6

1.4

2.54

2.59

g/l

0.63

2661

16087

Thiazolidinediones

993

7474

1.41

19.40

1.5

2.97

2.56

g/l

5.86

610

4391

Schizophrenia or delusion, excluding more controls

3351

28403

1.21

19.38

1.5

2.21

2.33

g/l

3.23

1839

19117

Paralytic ileus

325

1952

1.83

19.35

1.6

1.5

2.56

2.70

g/l

0.59

218

1193

Dislocation, sprain and strain of joints and ligaments of knee

7936

65029

1.13

19.33

1.5

2.29

2.32

g/l

0.68

5175

42211

Diseases of peritoneum

995

7514

1.42

19.30

1.7

1.5

2.82

2.46

g/l

4.39

660

4599

Major coronary heart disease event excluding revascularizations

5684

33217

1.16

19.28

1.6

1.5

2.74

2.61

g/l

3.47

3394

19279

Malnutrition

286

1707

2.02

19.27

2.0

1.6

2.36

2.30

g/l

0.22

195

948

Benign neoplasm of mouth and pharynx

1106

8494

1.39

19.25

1.7

1.5

2.39

2.48

g/l

0.70

663

5217

Visual impairment including blindness (binocular or monocular)

695

4957

1.52

19.23

1.6

1.5

2.50

2.47

g/l

0.14

379

2918

Varicose veins of other sites

661

4683

1.54

19.21

1.5

2.53

2.47

g/l

0.28

418

2963

Strabismus

3194

27357

1.22

19.14

1.6

1.5

2.26

2.28

g/l

0.21

2054

17202

Effects of foreign body entering through natural orifice

2683

22686

1.23

19.13

1.5

2.39

2.41

g/l

0.11

1693

14709

Suppurative and necrotic conditions of lower respiratory tract

529

3591

1.61

19.08

1.8

1.5

2.95

2.63

g/l

1.87

343

2231

Hidradenitis suppurativa

509

3480

1.67

19.08

1.6

1.5

2.65

2.22

g/l

4.12

347

2336

Portal vein thrombosis

197

1045

2.29

19.07

1.8

1.5

3.32

2.48

g/l

5.16

165

631

Cardiomyopathies, Primary/intrinsic

1017

7676

1.40

19.06

1.5

2.71

2.60

g/l

0.88

674

4553

Impotence

484

3213

1.64

19.04

1.6

2.67

2.93

g/l

1.82

307

2090

Ulcer of oesophagus

568

3896

1.57

18.96

1.4

1.5

2.89

2.64

g/l

1.70

380

2353

Injury of muscle and tendon at shoulder and upper arm level

3451

29739

1.20

18.92

1.5

2.53

2.59

g/l

0.88

2163

18570

Short stature, not elsewhere classified

445

2853

1.88

18.70

2.2

1.7

1.54

1.66

g/l

1.19

209

1588

Injuries to unspecified part of trunk, limb or body region

1138

8819

1.38

18.69

1.7

1.5

2.43

2.39

g/l

0.29

626

5490

Ingrowing nail

634

4508

1.56

18.69

1.5

2.29

2.34

g/l

0.28

386

2863

Bicipital tendinitis

493

3322

1.64

18.65

1.5

1.6

2.32

2.53

g/l

1.78

284

2138

Valvular operations

1173

9052

1.36

18.61

1.5

2.74

2.61

g/l

1.34

739

5205

Degenerative macular diseases

1045

7963

1.39

18.58

1.6

1.5

2.63

2.58

g/l

0.24

576

4538

Abnormal findings on examination of urine, without diagnosis

487

3295

1.66

18.55

2.2

1.5

2.69

2.47

g/l

1.45

371

2021

Glaucoma

5606

42342

1.15

18.55

1.5

2.52

2.55

g/l

0.38

3310

24876

Ehlers-Danlos syndrome, including avohilmo

227

1316

2.31

18.53

1.9

1.4

2.08

2.03

g/l

0.23

149

868

Bronchitis, not specified as acute or chronic

845

6259

1.44

18.43

1.6

1.5

2.44

2.46

g/l

0.08

565

3958

Delirium, not induced by alcohol and other psychoactive substances

1050

7983

1.38

18.34

1.6

1.5

2.90

2.66

g/l

1.93

622

4659

Persons encountering health services in circumstances related to reproduction

7399

44858

1.14

18.34

1.5

2.21

2.33

g/l

5.90

4770

29078

Benign neoplasm: Duodenum

276

1638

1.96

18.34

1.7

1.5

2.64

2.58

g/l

0.15

171

981

Other and unspecified aplastic anaemias

156

780

2.56

18.33

2.3

1.4

2.29

2.45

g/l

0.51

123

463

Pneumococcal septicemia

386

2495

1.77

18.33

2.3

1.5

2.49

2.40

g/l

0.32

277

1527

Dermatitis herpetiformis

224

1263

2.16

18.29

2.0

1.5

2.54

2.44

g/l

0.35

138

770

Radial styloid tenosynovitis [de Quervain]

680

4906

1.52

18.26

1.4

1.5

2.20

2.27

g/l

0.41

412

3179

Degenerative diseases of the nervous system

2167

18794

0.81

18.18

1.5

2.85

2.72

g/l

1.07

1061

10456

Optic neuritis

533

3712

1.63

18.15

2.2

1.5

2.06

2.25

g/l

2.35

381

2435

Primary coxarthrosis, bilateral

2612

22080

1.23

18.12

1.4

1.5

2.54

2.62

g/l

0.94

1516

12605

335

3.91

18.09

2.5

1.4

2.40

2.51

g/l

0.17

190

Superficial injury of shoulder and upper arm

1366

10871

1.33

18.03

1.5

2.44

2.36

g/l

0.74

807

6960

Hypersplenism

301

4.17

18.03

2.7

1.4

2.52

2.55

g/l

0.03

180

Superficial injury of ankle and foot

1647

13433

1.31

17.98

1.6

1.5

2.17

2.21

g/l

0.53

1018

8708

Cerebrovascular diseases

7525

47180

1.13

17.97

1.5

2.61

2.53

g/l

2.17

4452

28503

Autism spe, excluding more controls

386

2525

1.79

17.96

1.6

1.5

1.87

1.98

g/l

1.06

232

1708

Any dementia

2459

20243

0.82

17.96

1.5

2.86

2.70

g/l

1.52

1247

11155

Other embolism and thrombosis

1253

9848

1.34

17.92

1.8

1.5

2.53

2.44

g/l

0.79

838

6000

Alopecia areata

378

2470

1.80

17.90

1.9

1.5

2.17

2.24

g/l

0.44

256

1555

Haemorrhage in early pregnancy

3611

30603

1.20

17.87

1.4

2.08

2.15

g/l

2.22

2289

19644

Decubitus ulcer and pressure area

546

3764

1.56

17.84

1.6

1.5

2.98

2.66

g/l

2.17

335

2221

Mixed hyperlipidaemia

384

2470

1.72

17.81

1.5

2.74

2.67

g/l

0.27

249

1523

Combinations of oral blood glucose lowering drugs

2551

21555

1.23

17.80

1.5

2.96

2.56

g/l

12.27

1645

13115

Volvulus

262

1526

1.92

17.76

1.6

1.4

2.44

2.60

g/l

0.41

160

932

Mental and behavioural disorders due to sedatives or hypnotics

785

5828

1.47

17.74

1.5

2.41

2.35

g/l

0.33

438

3854

Invasive ventilation

745

5468

1.48

17.73

1.9

1.5

2.75

2.46

g/l

2.09

477

3342

Idiopathic urticaria

323

2046

1.89

17.69

1.6

1.4

2.19

g/l

0.01

189

1316

Nontoxic multinodular goitre

1934

15979

1.27

17.68

1.5

2.31

2.43

g/l

0.99

1151

9247

Other sexually transmitted chlamydial diseases, including avohilmo

1534

12482

1.32

17.67

1.5

1.4

2.14

2.06

g/l

1.66

887

8521

Viral infections of the central nervous system, including avohilmo

874

6596

1.44

17.65

1.7

1.5

2.27

2.34

g/l

0.50

569

4222

Allergic purpura

380

2481

1.77

17.64

1.6

1.5

3.06

2.31

g/l

9.71

257

1590

Dialysis

428

2850

1.69

17.61

2.1

1.5

2.54

2.46

g/l

0.29

301

1741

Achilles tendinitis

1049

8081

1.38

17.58

1.5

2.32

2.44

g/l

1.27

637

5136

Salpingitis and oophoritis

1958

16266

1.27

17.55

1.5

2.33

2.28

g/l

0.52

1167

9840

Any event in cancer register

11570

62361

1.10

17.54

1.7

1.4

2.33

2.36

g/l

0.71

7586

39699

Other inflammation of vagina/vulva

531

3732

1.62

17.52

1.5

2.11

2.13

g/l

0.18

301

2443

Recurrent dislocation and subluxation of joint

797

5931

1.46

17.48

1.4

1.5

2.22

2.26

g/l

0.29

510

3965

Disorder of the sleep-wake schedule

275

1682

2.00

17.47

1.7

1.5

2.21

2.22

g/l

0.03

166

1046

Vascular diseases of the intestine

359

2281

1.73

17.38

1.6

1.5

2.98

2.72

g/l

1.35

227

1313

Corns and callosities

685

4979

1.49

17.33

1.6

1.5

2.46

g/l

0.02

447

3055

Atypical mycobacterium lung infection

150

751

2.49

17.32

1.8

1.6

2.63

2.58

g/l

0.11

106

410

Other malignant neoplasms of skin (=non-melanoma skin cancer)

4431

26419

1.17

17.30

1.6

1.4

2.57

2.60

g/l

0.25

2497

15213

Nonischemic cardiomyopathy

891

6707

1.41

17.25

1.7

1.5

2.81

2.56

g/l

1.86

586

3979

Mental disorders, not otherwise specified

1041

8100

1.39

17.22

1.6

1.5

2.17

2.23

g/l

0.58

563

5399

Episcleritis

624

4498

1.54

17.15

1.6

1.5

2.43

2.30

g/l

0.79

413

2945

Unspecific neurodegenerative disorder

2654

21406

0.83

17.11

1.4

1.5

2.73

2.70

g/l

0.16

1293

11751

Disorders of porphyrin and bilirubin metabolism

157

807

2.45

17.07

1.7

1.4

1.99

2.38

g/l

2.11

111

498

Lesion of lateral popliteal nerve

504

3478

1.59

17.05

1.7

1.5

2.70

2.56

g/l

0.70

318

2206

Leisure time condition

2039

17022

1.26

17.01

1.6

1.5

2.52

2.35

g/l

2.87

1389

10666

Meralgia paraesthetica

379

2477

1.73

16.99

1.4

2.21

2.44

g/l

1.56

221

1543

Certolizumab pegol

288

1801

1.96

16.97

1.6

1.4

2.72

2.18

g/l

3.27

192

1174

Osteonecrosis due to drugs

183

992

2.27

16.95

5.3

1.4

2.12

2.63

g/l

1.73

136

579

Endometriosis ASRM stages 3,4

2744

23563

1.22

16.94

1.5

2.17

2.20

g/l

0.35

1744

14672

Acute lymphadenitis

708

5222

1.49

16.93

1.9

1.5

2.20

2.25

g/l

0.33

492

3392

Panniculitis affecting regions of neck and back

384

2509

1.70

16.89

1.6

1.5

2.24

2.39

g/l

0.88

240

1607

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

889

6711

1.45

16.81

1.8

1.5

1.88

1.91

g/l

0.31

516

4295

Cardiac murmurs and other cardiac sounds

1199

9383

1.35

16.81

1.6

1.5

2.12

2.14

g/l

0.16

755

5695

Aortic aneurysm

1804

14505

1.26

16.77

1.7

1.5

2.72

2.79

g/l

0.81

1026

8657

Complications predominantly related to the puerperium

3417

29871

1.20

16.76

1.5

1.4

2.10

2.15

g/l

1.57

2129

19228

Superficial injury of forearm

1248

9940

1.34

16.74

1.5

2.33

2.24

g/l

0.91

779

6418

Other encephalitis

337

2164

1.80

16.74

2.1

1.5

2.13

2.39

g/l

2.41

236

1362

Other puerperal infections

1133

8988

1.38

16.73

1.6

1.4

2.06

g/l

0.02

720

6031

Traumatic subdural haemorrhage

1035

7427

1.36

16.72

1.5

3.02

2.73

g/l

2.72

596

4349

Sequelae of other external causes

612

4396

1.52

16.69

1.7

1.5

2.51

2.41

g/l

0.56

392

2752

Other crystal arthropathies

189

1020

2.13

16.69

1.6

1.5

2.64

2.74

g/l

0.24

128

596

Isolated proteinuria

334

2142

1.80

16.67

2.4

1.4

2.78

2.39

g/l

2.78

261

1340

Chronic nephritic syndrome

398

2637

1.69

16.65

2.0

1.5

2.83

2.51

g/l

2.20

299

1649

Any prescribed medicine buy

4.38

16.64

1.4

1.3

2.51

1.71

g/l

1.22

Encephalitis

357

2326

1.76

16.63

2.0

1.5

2.14

2.37

g/l

2.15

248

1473

Personal history of malignant neoplasm

996

7727

1.39

16.62

1.7

1.5

2.07

2.25

g/l

1.60

468

4595

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

889

6770

1.41

16.59

1.4

1.5

2.21

2.28

g/l

0.48

566

4501

Disturbances of smell and taste

461

3156

1.63

16.59

1.6

1.5

2.48

2.41

g/l

0.16

275

1956

Other localized connective tissue disorders

251

1508

1.99

16.52

1.9

1.5

2.52

2.34

g/l

0.29

152

885

Other specified and unspecified disorders of eye and adnexa

416

2794

1.67

16.47

1.7

1.5

2.54

2.41

g/l

0.57

190

1739

IgA nephropathy (IgA glomerulonephritis)

283

1750

1.89

16.45

1.7

1.4

3.58

2.50

g/l

10.68

199

1143

Drug-induced hypoglycaemia without coma

196

1091

2.14

16.38

1.6

1.4

2.66

2.49

g/l

0.45

109

668

Alcohol abuse, main dg

1683

13841

1.28

16.38

1.5

2.93

2.39

g/l

16.29

1014

9078

Disorders of iron metabolism

205

1163

2.12

16.30

1.6

1.5

2.54

2.49

g/l

0.13

158

757

Primary gonarthrosis, bilateral

5094

38020

1.15

16.30

1.5

2.58

2.57

g/l

0.17

2939

22512

Asthma mixed form (mode), excluding more controls

527

3683

1.55

16.25

1.5

1.4

2.28

2.27

g/l

0.05

396

2231

Polyarteritis nodosa and related conditions

183

1008

2.23

16.22

2.1

1.5

2.36

2.31

g/l

0.13

138

612

Disorders of plasma-protein metabolism, not elsewhere classified

111

517

2.97

16.22

2.5

1.4

2.62

2.39

g/l

0.58

319

Other and unspecified myopathies

803

6024

1.42

16.20

1.6

1.5

2.62

2.64

g/l

0.06

491

3639

Wet age-related macular degeneration

1371

10569

1.30

16.19

1.5

2.81

2.73

g/l

0.41

768

5609

Other specified/unspecified dorsopathies

362

2359

1.71

16.14

1.6

1.5

2.42

g/l

0.00

200

1473

Other and unspecified acquired haemolytic anaemias

133

660

2.61

16.13

2.2

1.4

2.28

2.64

g/l

1.18

100

391

Carrier of infectious disease

319

2047

1.82

16.12

1.8

1.4

2.54

2.32

g/l

1.26

230

1308

Malignant neoplasm of digestive organs, including Hilmo

4017

25922

1.17

16.07

1.5

1.4

2.84

2.62

g/l

5.93

2430

15075

Convalescence

595

4292

1.52

16.04

1.7

1.4

2.19

2.33

g/l

1.09

348

2659

Laparoscopic right hemicolectomy

536

3787

1.55

16.00

1.3

1.5

2.51

2.65

g/l

0.80

291

2189

Cardiomyopathy (excluding other)

1043

8102

1.35

15.96

1.5

2.72

2.60

g/l

0.98

688

4789

Varicose veins

6320

43077

1.13

15.95

1.5

2.53

2.43

g/l

2.14

3869

26048

Viral infections of the central nervous system

794

6001

1.43

15.91

1.8

1.5

2.28

2.35

g/l

0.42

522

3837

Other disorders of the genitourinary system

1268

10158

1.32

15.88

1.5

2.22

2.42

g/l

2.87

704

5837

Cutaneous lupus erythematosus

287

1798

1.86

15.88

1.7

1.5

2.60

2.42

g/l

0.76

191

1081

Deep bite

1573

11384

1.30

15.85

1.6

1.94

2.07

g/l

3.52

965

7044

Other strabismus

2691

23087

1.21

15.81

1.6

1.5

2.20

2.25

g/l

0.74

1725

14628

Pemphigoid

268

1635

1.85

15.72

1.6

1.5

2.89

2.65

g/l

0.97

173

936

Alcohol-induced acute pancreatitis

355

2319

1.71

15.72

1.6

1.5

3.60

2.64

g/l

7.14

202

1518

Collapsed vertebra, not elsewhere classified

407

2.93

15.69

2.8

1.8

3.08

2.57

g/l

0.35

228

Examination and encounter for administrative purposes

701

5160

1.44

15.67

1.6

1.5

2.63

2.60

g/l

0.08

459

3087

Other and unspecified mononeuropathies of lower limb

304

1928

1.80

15.62

1.6

1.4

2.31

2.49

g/l

0.99

164

1178

therapeutic use

322

2068

1.76

15.56

1.8

1.5

2.82

2.53

g/l

0.63

178

1216

Ménière disease

902

6939

1.39

15.54

1.5

2.31

2.49

g/l

2.04

536

4169

Assault by bodily force

961

7493

1.38

15.50

1.5

2.54

2.28

g/l

4.03

557

5127

Spondylopathies in diseases classified elsewhere

139

699

2.39

15.49

4.0

1.4

1.84

2.56

g/l

2.75

407

Other blood glucose lowering drugs, excl. Insulins

1368

11040

1.29

15.41

1.5

2.98

2.52

g/l

7.91

845

6403

Postzoster neuralgia

177

970

2.14

15.32

1.9

1.4

2.13

2.67

g/l

2.94

117

544

Desensitization to allergens

756

5751

1.45

15.30

1.6

1.5

2.06

2.12

g/l

0.56

481

3870

Familial hypercholesterolemia, with ischemic heart disease

721

5355

1.42

15.24

1.4

1.5

2.78

2.75

g/l

0.13

444

3013

Acute bronchiolitis

958

6810

1.41

15.24

1.8

1.6

1.88

1.86

g/l

0.14

596

4080

Alzheimer disease, including avohilmo

2247

18400

0.82

15.24

1.4

1.5

2.75

2.73

g/l

0.11

1041

10051

Other deformities of toe(s)

375

2499

1.67

15.23

1.5

1.4

2.15

2.37

g/l

1.26

180

1486

Fentanyl

831

6271

1.38

15.23

1.8

1.4

2.55

2.57

g/l

0.08

537

3664

Crohn's disease (strict) with PSC

155

7.81

15.20

4.1

1.5

2.53

2.30

g/l

0.47

Chalazion

1248

10035

1.32

15.19

1.6

1.5

2.32

2.38

g/l

0.49

806

6364

Ovarian dysfunction

1144

9195

1.35

15.16

1.6

1.4

1.99

2.04

g/l

0.71

726

6135

Allergic bronchopulmonary aspergillosis (ABPA)

148

4.37

15.11

2.1

1.3

2.53

2.33

g/l

0.34

Mixed conductive and sensorineural hearing loss

1123

8896

1.33

15.10

1.5

2.51

2.54

g/l

0.15

630

5230

N06DA Anticholinesterases

2076

19028

0.82

15.06

1.4

1.5

2.73

2.75

g/l

0.11

967

10346

Use of anticholinesterases

2076

19028

0.82

15.06

1.4

1.5

2.73

2.75

g/l

0.11

967

10346

Asthma mixed form (mode)

527

3738

1.52

15.06

1.5

1.4

2.28

2.30

g/l

0.07

396

2287

Simple and mucopurulent chronic bronchitis

368

2429

1.65

14.99

1.8

1.5

2.34

2.47

g/l

0.66

272

1400

321

2104

1.78

14.94

1.6

1.4

2.05

2.10

g/l

0.29

242

1413

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

390

2637

1.65

14.92

2.1

1.5

2.40

2.47

g/l

0.30

261

1604

Malignant neoplasm of skin, including Hilmo

5302

31836

1.14

14.91

1.6

1.4

2.47

2.55

g/l

1.85

3047

18908

Early lumbar disc prolapse, operated

1153

9207

1.33

14.91

1.4

2.25

2.30

g/l

0.46

834

6430

Other specified/unspecified spondylopathies

235

1400

1.88

14.90

1.6

1.5

2.53

2.58

g/l

0.15

151

825

Carcinoma in situ of skin of trunk

291

1834

1.76

14.80

2.0

1.5

2.46

2.81

g/l

1.02

152

1042

Other and unspecified injuries of head

790

6015

1.41

14.78

1.5

1.6

2.64

2.41

g/l

1.67

430

3720

Anankastic personality disorder

504

3611

1.57

14.77

1.5

2.20

2.26

g/l

0.31

322

2405

Malignant neoplasm of colon, including Hilmo

1539

12558

1.27

14.74

1.5

1.3

2.64

2.67

g/l

0.19

847

6983

Personal history of allergy to drugs, medicaments and biological substances

175

989

2.22

14.70

1.8

1.4

2.23

2.27

g/l

0.12

116

639

Dermatopolymyositis, unspecified

383

3.29

14.70

2.3

1.4

2.27

2.44

g/l

0.43

222

Left bundle-branch block

652

4803

1.44

14.68

1.5

2.52

2.57

g/l

0.17

380

2739

Dermatitis due to ingested food

606

4336

1.54

14.67

1.7

1.6

1.74

1.77

g/l

0.26

370

2572

Ehlers-Danlos syndrome

180

1047

2.30

14.66

1.9

1.4

2.01

2.05

g/l

0.16

115

689

Embedded and impacted teeth

4032

29115

1.17

14.65

1.5

2.04

2.11

g/l

3.16

2832

19108

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

431

3001

1.61

14.60

1.5

2.20

2.32

g/l

0.84

265

1956

Cervical polyps

996

7829

1.35

14.56

1.5

2.20

2.33

g/l

1.90

590

4772

Infectious mononucleosis

1184

9574

1.33

14.53

1.5

1.4

2.12

2.09

g/l

0.36

837

6380

Infectious mononucleosis, including avohilmo

1184

9574

1.33

14.53

1.5

1.4

2.12

2.09

g/l

0.36

837

6380

Colorectal cancer, including Hilmo

2316

18374

1.21

14.53

1.5

1.4

2.64

2.66

g/l

0.18

1296

10440

Subacute thyroiditis

421

2916

1.61

14.51

1.5

2.13

2.33

g/l

2.03

259

1817

Other epidermal thickening

484

3427

1.55

14.50

1.7

1.5

2.55

2.44

g/l

0.53

337

2093

Other and unspecified injuries of lower leg

947

7436

1.37

14.47

1.6

1.5

2.25

2.23

g/l

0.08

578

4802

Benign neoplasm: Skin of eyelid, including canthus

1503

12370

1.27

14.46

1.6

1.5

2.47

g/l

0.00

858

7386

Hydrocele

865

6628

1.36

14.39

1.6

2.70

2.89

g/l

1.57

558

4219

Open wound of forearm

1045

8281

1.34

14.39

1.5

2.49

2.41

g/l

0.62

623

5326

Crystal arthropathies, rheuma endpoint

189

1072

2.01

14.36

1.6

1.5

2.64

2.62

g/l

0.05

128

596

Congenital iodine-deficiency syndrome/hypothyroidism

315

2055

1.73

14.35

1.5

2.23

2.34

g/l

0.55

178

1228

Panniculitis, unspecified

136

705

2.38

14.34

1.9

1.4

2.59

2.46

g/l

0.16

444

Pneumonia due to Streptococcus pneumoniae

423

2917

1.59

14.33

2.1

1.4

2.33

2.42

g/l

0.38

296

1775

Basal cell carcinoma, including Hilmo

4436

26715

1.15

14.33

1.6

1.4

2.50

2.59

g/l

1.82

2489

15426

Abnormal findings on diagnostic imaging of central nervous system

572

4188

1.50

14.30

1.8

1.5

2.37

2.33

g/l

0.16

398

2603

Herpesviral keratitis and keratoconjunctivitis

445

3111

1.57

14.27

1.7

1.5

2.69

2.48

g/l

0.84

299

1928

Atopic conjunctivitis

564

4136

1.51

14.21

1.5

2.18

2.21

g/l

0.17

372

2636

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2068

17097

1.23

14.16

1.6

2.11

2.24

g/l

3.11

1359

10645

Artificial joint operation, meniscal resection

10003

59222

1.10

14.14

1.5

2.53

2.48

g/l

1.20

6167

36793

Other and unspecified injuries of ankle and foot

555

4067

1.51

14.12

1.7

1.5

2.30

2.23

g/l

0.41

337

2630

Medial epicondylitis

413

2854

1.60

14.11

1.6

1.5

2.17

2.37

g/l

1.63

257

1842

Other salmonella infections, including avohilmo

462

3259

1.55

14.09

1.8

1.5

2.32

2.37

g/l

0.22

284

2080

Gonarthrosis, primary, with knee surgery

5610

39435

1.13

14.08

1.5

2.62

2.58

g/l

0.45

3243

23324

Other and unspecified mononeuropathies, also in other diseases

294

1889

1.74

14.06

1.6

1.5

2.36

2.57

g/l

1.26

187

1156

Other prurigo

148

798

2.29

14.04

1.8

1.4

2.61

2.39

g/l

0.57

101

475

Ulcer of vagina/vulva

376

2586

1.67

14.00

1.6

1.5

2.22

2.16

g/l

0.29

226

1560

Exposure to other and unspecified inanimate mechanical forces

878

6855

1.38

13.97

1.6

1.5

2.39

2.35

g/l

0.21

511

4435

Other and unspecified iridocyclitis

526

3811

1.51

13.96

1.6

1.5

2.34

2.38

g/l

0.15

325

2391

Other and/or unspecified nontoxic goitre

825

6375

1.38

13.96

1.6

1.5

2.17

2.39

g/l

3.61

453

3773

Carcinoma in situ of colon

292

1884

1.75

13.92

1.6

2.66

2.67

g/l

0.01

143

1129

Monoarthritis, not elsewhere classified

431

3003

1.57

13.90

1.5

2.53

2.37

g/l

0.99

287

1912

Microscopic polyangiitis

425

3.03

13.85

2.0

1.5

2.15

2.50

g/l

0.91

227

Other erythematous conditions

394

2717

1.62

13.84

1.6

1.5

2.22

2.40

g/l

1.26

252

1689

Bacterial, viral and other infectious agents, including avohilmo

985

7799

1.35

13.84

1.7

1.5

2.43

2.39

g/l

0.20

650

5142

Crushed, pushed or stepped on by crowd or human stampede

942

7451

1.36

13.69

1.5

2.31

2.20

g/l

0.91

517

4931

Unspecified mental disorder

4730

42557

1.14

13.69

1.5

2.24

2.34

g/l

3.54

2621

27874

Disorders of lacrimal system and orbit in diseases classified elsewhere

295

1930

1.76

13.65

1.6

1.5

2.20

2.37

g/l

0.87

176

1194

Discitis, unspecified

171

958

2.05

13.65

2.0

1.5

3.30

2.61

g/l

2.50

127

584

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

446

3173

1.58

13.61

1.5

2.34

2.28

g/l

0.16

236

2029

Disorders of magnesium metabolism

108

529

2.63

13.58

1.9

1.5

3.01

2.71

g/l

0.64

328

Unspecified chronic bronchitis

309

2006

1.67

13.55

1.6

1.5

2.54

2.53

g/l

0.04

209

1177

Hypertensive Renal Disease

298

1915

1.68

13.53

1.7

1.5

2.71

2.67

g/l

0.12

217

1061

Abnormality of white blood cells, not elsewhere classified

132

703

2.44

13.52

2.3

1.4

2.09

2.34

g/l

1.07

103

419

Alzheimer’s disease, strict definition

1386

13663

0.80

13.50

1.4

1.5

2.77

2.76

g/l

0.03

604

7485

Encephalopathy

126

651

2.40

13.49

1.8

1.5

4.38

2.69

g/l

5.39

379

Traumatic subarachnoid haemorrhage

318

2080

1.65

13.48

1.5

1.6

2.88

2.70

g/l

0.67

182

1290

Mature T/NK-cell lymphomas, hilmo

152

832

2.18

13.47

1.6

1.4

2.51

2.73

g/l

0.46

120

482

Aspergillosis, including avohilmo

119

606

2.49

13.45

2.3

1.4

2.25

2.52

g/l

0.96

369

Injury of unspecified body region

819

6361

1.38

13.44

1.6

1.5

2.34

2.37

g/l

0.16

438

3920

Haemangioma, any site

924

7296

1.35

13.41

1.6

1.5

2.27

2.35

g/l

0.60

568

4537

Alcohol dependence

2487

21473

1.19

13.41

1.5

3.19

2.51

g/l

28.12

1485

13932

Malignant neoplasm of bronchus and lung

976

10329

0.77

13.35

1.5

1.3

2.71

2.74

g/l

0.13

557

5685

Malignant neoplasm of skin

4941

30055

1.14

13.35

1.6

1.4

2.48

2.56

g/l

1.60

2815

17713

Other contact dermatitis

862

6736

1.36

13.34

1.5

2.55

2.33

g/l

1.60

545

4302

Benign lipomatous neoplasm

2945

25784

1.18

13.34

1.5

2.30

2.47

g/l

5.77

1806

15903

Use of glatiramer acetate

233

1466

1.92

13.33

2.8

1.4

1.90

2.20

g/l

3.62

182

991

Amiodarone users

811

6263

1.37

13.32

1.5

2.78

2.73

g/l

0.22

475

3692

Inguinal or femoral hernia, bilateral

843

6529

1.35

13.30

1.5

1.6

2.59

2.75

g/l

1.27

487

4095

Female infertility, tubal origin

559

4122

1.48

13.27

1.4

2.21

g/l

0.01

353

2735

Other disorders starting during childhood or adolescence

835

6541

1.41

13.26

1.8

1.6

1.85

1.87

g/l

0.21

475

4034

Right bundle-branch block

339

2263

1.63

13.26

1.9

1.5

2.68

2.57

g/l

0.32

219

1332

Premenstrual syndrome

221

1368

1.93

13.25

1.5

1.4

1.92

2.11

g/l

2.04

139

923

Use of memantine

1524

14806

0.81

13.20

1.5

2.86

2.75

g/l

0.54

734

7975

Use of other anti-dementia drugs

1524

14806

0.81

13.20

1.5

2.86

2.75

g/l

0.54

734

7975

Acute posthaemorrhagic anaemia

315

2075

1.66

13.15

1.8

1.5

2.80

2.57

g/l

0.75

200

1203

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

280

1857

1.82

13.15

1.8

1.5

2.05

2.04

g/l

0.06

186

1182

Other sexually transmitted chlamydial diseases

892

7072

1.37

13.07

1.5

1.4

2.19

2.11

g/l

1.10

490

4853

Basal cell carcinoma

4213

25619

1.15

13.04

1.6

1.4

2.51

2.60

g/l

1.38

2349

14684

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1541

17909

0.81

13.02

1.5

1.4

2.50

2.64

g/l

1.25

987

10287

Car occupant injured in other and unspecified transport accidents

2236

19275

1.21

13.01

1.5

2.33

2.30

g/l

0.30

1460

12595

Other noninfective disorders of lymphatic vessels and lymph nodes

396

2763

1.59

13.01

1.7

1.4

2.57

2.39

g/l

0.91

250

1708

Event of undetermined intent

743

5735

1.40

13.01

1.7

1.5

2.30

2.33

g/l

0.15

441

3743

Haemangioma and lymphangioma, any site

991

7923

1.33

12.97

1.6

1.5

2.26

2.34

g/l

0.67

608

4918

Acute alcohol intoxication, ICD10

2112

18098

1.21

12.95

1.5

2.94

2.39

g/l

20.65

1303

11883

Stenosis and insufficiency of lacrimal passages

940

7451

1.34

12.93

1.6

1.5

2.32

2.40

g/l

0.79

599

4446

Other forms of systemic lupus erythematosus

128

689

2.44

12.87

1.9

1.4

2.35

2.19

g/l

0.55

424

Benign neoplasm of breast

1301

10727

1.29

12.87

1.5

2.12

2.26

g/l

2.63

729

6455

Retinal breaks without detachment

1548

12926

1.25

12.85

1.5

2.42

2.50

g/l

0.49

909

7865

Other/unspecified disorders of vestibular function

416

2931

1.56

12.82

1.6

1.5

2.27

2.45

g/l

1.22

221

1775

Polypectomy (DHB20)

612

4583

1.43

12.81

1.5

2.57

2.60

g/l

0.15

405

2917

Aspergillosis

115

589

2.47

12.81

2.3

1.4

2.24

2.53

g/l

1.01

360

Erythema intertrigo

265

1706

1.75

12.75

1.7

1.5

2.76

2.51

g/l

1.01

176

1031

Lesion of radial nerve

370

2549

1.59

12.73

1.5

2.40

2.52

g/l

0.75

240

1598

Localized scleroderma [morphea]

189

1134

2.00

12.71

1.7

1.6

2.47

2.30

g/l

0.19

111

666

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1068

8668

1.32

12.71

1.5

1.4

2.10

2.14

g/l

0.43

696

5647

Bruxism

256

1664

1.82

12.65

1.5

2.03

2.20

g/l

1.28

182

1080

Additional codes for the location of defect, injury or illness

627

4746

1.43

12.60

1.5

2.34

2.37

g/l

0.17

402

2955

Other and unspecified bullous disorders

149

841

2.20

12.57

1.9

1.5

2.20

2.44

g/l

0.78

495

Other and unspecified abdominal hernia

393

2746

1.56

12.56

1.5

2.47

2.52

g/l

0.19

238

1665

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

181

1059

1.95

12.53

1.5

2.48

2.64

g/l

0.42

608

Fluid overload

190

4.05

12.52

2.4

1.4

2.94

2.61

g/l

0.40

111

Scar conditions and fibrosis of skin

495

3631

1.51

12.50

1.7

1.5

2.27

g/l

0.02

295

2301

Infection of intervertebral disc (pyogenic)

143

782

2.14

12.50

1.5

3.31

2.73

g/l

2.13

105

479

Congenital malformations and deformations of the musculoskeletal system

1194

9777

1.30

12.49

1.7

1.5

1.99

2.06

g/l

0.76

747

6160

Pyoderma gangrenosum

119

629

2.46

12.49

2.3

1.4

2.92

2.45

g/l

1.24

392

Urethritis and urethral syndrome

254

1632

1.77

12.49

1.6

1.5

2.12

2.35

g/l

1.68

168

1020

Symptoms and signs involving emotional state

382

2683

1.60

12.48

1.7

1.5

2.19

2.22

g/l

0.10

219

1739

Heterophoria

990

7974

1.33

12.48

1.6

1.5

2.10

2.19

g/l

0.96

671

4988

Inguinal hernia, bilateral

823

6410

1.34

12.47

1.5

1.6

2.60

2.75

g/l

1.18

479

4027

Hypogonadotropic hypogonadism

328

2224

1.64

12.47

1.8

1.5

2.54

2.56

g/l

0.06

233

1562

Other specific arthropathies, wide

236

1489

1.80

12.46

1.6

1.5

2.50

2.41

g/l

0.18

146

916

Helminthiases, including avohilmo

539

4023

1.49

12.45

1.8

1.5

2.07

2.16

g/l

0.64

335

2545

Other mycoses, not elsewhere classified/unspecified, including avohilmo

229

1448

1.85

12.44

1.7

1.4

2.11

2.40

g/l

1.73

130

900

Lung diseases due to external agents

1121

9053

1.29

12.43

1.7

1.5

2.81

2.62

g/l

1.70

715

5406

Injury of eye and orbit

1573

13206

1.24

12.43

1.5

2.29

2.36

g/l

0.71

986

8706

Tubulo-interstitial nephritis, not specified as acute or chronic

650

4925

1.40

12.40

1.7

1.4

2.48

2.40

g/l

0.33

418

2996

Lupus nephritis

291

3.47

12.38

1.9

1.4

2.33

2.26

g/l

0.14

190

Dronedarone medication

264

1705

1.72

12.34

1.5

2.65

2.72

g/l

0.17

130

934

Foreign body in respiratory tract

576

4328

1.45

12.33

1.5

2.20

2.29

g/l

0.47

342

2699

Impetigo

592

4481

1.45

12.32

1.7

1.5

2.11

2.16

g/l

0.30

391

2871

Residual foreign body in soft tissue

538

3981

1.46

12.30

1.5

2.44

2.41

g/l

0.13

357

2617

Use of donepezil

1059

12533

0.78

12.30

1.4

1.5

2.82

2.77

g/l

0.16

494

6756

Peritonsillar abscess

2376

20633

1.19

12.28

1.5

1.4

2.24

2.35

g/l

2.52

1554

13678

Mental and behavioural disorders due to opioids

461

3351

1.52

12.28

1.6

1.5

2.25

2.27

g/l

0.07

291

2316

Follicular cysts of skin and subcutaneous tissue

1892

16148

1.22

12.25

1.6

1.5

2.39

2.44

g/l

0.53

1174

10235

Prolonged pregnancy

1714

17139

0.81

12.25

1.3

1.4

2.08

2.07

g/l

0.07

1129

11620

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1933

16070

1.22

12.22

1.6

2.10

2.23

g/l

2.97

1270

9989

Tracheo-bronchomalasia

278

3.14

12.16

1.5

1.3

2.20

2.11

g/l

0.19

188

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

781

6111

1.36

12.13

1.8

1.5

2.50

2.41

g/l

0.48

488

3777

All dysplastic lesions of the cervix uteri, vagina or vulva

3911

34304

1.15

12.12

1.4

2.15

2.13

g/l

0.43

2475

22551

Erythema nodosum

340

2348

1.63

12.11

1.9

1.5

2.66

2.30

g/l

1.50

217

1453

Bitten or struck by other mammals

1424

11924

1.26

12.10

1.5

2.22

2.21

g/l

0.01

879

7795

ILD medications: nintedanib

286

3.12

12.06

1.9

1.3

3.17

2.88

g/l

0.51

152

Essential (haemorrhagic) thrombocythaemia

359

2489

1.58

12.01

1.5

1.3

2.38

2.57

g/l

0.80

221

1435

Other and unspecified erythematous conditions

354

2464

1.60

11.95

1.6

1.5

2.23

2.39

g/l

0.96

225

1517

Muscle strain

375

2634

1.57

11.89

1.5

2.48

2.33

g/l

0.22

230

1721

Entropion and trichiasis of eyelid

663

5051

1.38

11.85

1.4

1.5

2.83

2.71

g/l

0.53

371

2856

ILD medications: pirfenidone

108

549

2.35

11.79

2.4

1.3

3.10

2.76

g/l

1.06

288

Pyothorax

385

2707

1.54

11.77

1.9

1.5

3.00

2.68

g/l

1.42

250

1676

Anxious personality disorder

273

1829

1.74

11.76

1.5

1.4

2.09

2.16

g/l

0.32

157

1210

Unspecified misadventure during surgical and medical care

568

4275

1.43

11.76

1.7

1.5

2.48

g/l

0.00

387

2659

Other congenital malformations, including avohilmo

1607

13638

1.24

11.74

1.6

1.5

2.17

2.16

g/l

0.01

971

8639

Hydronephrosis

1048

8484

1.29

11.71

1.6

1.5

2.55

2.43

g/l

0.94

692

5021

Other disorders of optic [2nd] nerve and visual pathways

682

5279

1.39

11.71

1.7

1.5

2.15

2.33

g/l

2.09

429

3239

Mixed disorders of conduct and emotions, excluding more controls

332

2311

1.64

11.71

1.6

1.5

1.93

g/l

0.01

167

1539

Calcific tendinitis of shoulder

577

4351

1.42

11.65

1.5

2.25

2.39

g/l

1.52

419

2792

Leukaemia of unspecified cell type

124

676

2.28

11.58

2.1

1.4

1.85

2.59

g/l

5.13

106

381

Pustular psoriasis

494

3661

1.47

11.53

1.5

2.81

2.35

g/l

4.59

285

2276

False labour

4275

23981

1.14

11.48

1.4

2.03

2.08

g/l

1.71

2915

16221

Implicit parasitic Sepsis, including avohilmo

450

2.68

11.47

2.1

1.4

2.41

2.46

g/l

0.06

264

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1068

8769

1.30

11.46

1.5

2.10

2.13

g/l

0.30

696

5702

Other neurotic disorders

447

3246

1.49

11.45

1.5

2.51

g/l

0.01

228

2045

Myocardial infarction

4304

27059

1.13

11.44

1.6

1.5

2.77

2.64

g/l

2.78

2557

15643

Chronic myeloid leukaemia, including Hilmo

109

567

2.34

11.40

1.4

1.3

2.03

2.70

g/l

5.57

342

Benign neoplasm: Rectosigmoid junction

372

2622

1.55

11.40

1.5

2.70

2.60

g/l

0.34

211

1569

Acute nasopharyngitis (common cold)

1171

9550

1.27

11.38

1.7

1.5

2.47

2.49

g/l

0.12

804

6390

Vitiligo

166

996

2.02

11.36

1.6

1.4

2.21

2.26

g/l

0.17

635

Myopia

1645

14027

1.23

11.34

1.6

1.5

2.17

2.20

g/l

0.31

1086

9179

Other salmonella infections

358

2511

1.56

11.30

1.8

1.5

2.39

2.43

g/l

0.13

223

1588

Retinal vascular occlusion

947

7600

1.30

11.27

1.6

1.5

2.58

2.64

g/l

0.41

551

4333

Sequelae of injuries of lower limb

969

7844

1.31

11.27

1.5

2.43

2.40

g/l

0.15

595

5062

Periapical abscess

5236

47834

1.12

11.26

1.5

2.49

2.41

g/l

2.07

3165

30551

Pediculosis, acariasis and other infestations

653

5050

1.39

11.26

1.6

1.5

2.47

2.36

g/l

0.57

414

3273

Granulomatous disorders of skin and subcutaneous tissue

321

2232

1.62

11.19

1.7

1.5

2.29

2.28

g/l

0.04

188

1374

Malignant neoplasm of bronchus and lung, including Hilmo

1176

11920

0.80

11.17

1.5

1.3

2.69

2.73

g/l

0.23

681

6560

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

306

3.21

11.10

2.3

1.3

2.25

2.56

g/l

0.72

182

Retinal vascular disorders

957

7701

1.29

11.10

1.6

1.5

2.58

2.65

g/l

0.41

557

4392

Bullous pemphigoid

195

1201

1.82

11.09

1.5

3.01

2.69

g/l

1.08

121

680

Renal tubulo-interstitial disorders in diseases classified elsewhere

122

670

2.24

11.08

3.9

1.4

2.53

2.54

g/l

0.01

401

Exfoliative dermatitis

121

657

2.19

11.02

1.7

1.5

2.96

2.65

g/l

0.75

399

Syphilis, including avohilmo

268

1791

1.67

11.00

1.7

1.5

2.79

2.50

g/l

1.39

151

1172

Syphilis

268

1791

1.67

11.00

1.7

1.5

2.79

2.50

g/l

1.39

151

1172

Amoebiasis, including avohilmo

124

695

2.28

10.98

1.9

1.4

2.05

2.28

g/l

0.74

435

Other nonscarring hair loss

171

1053

2.01

10.97

1.7

1.5

2.15

2.12

g/l

0.10

115

656

Protein-energy malnutrition of moderate and mild degree

130

737

2.21

10.94

1.9

1.6

2.39

2.23

g/l

0.37

398

Polycystic ovarian syndrome

854

6912

1.34

10.90

1.5

1.4

1.97

2.01

g/l

0.47

563

4622

All dysplastic lesions of the vulva

494

3710

1.46

10.88

1.5

2.12

2.22

g/l

0.64

297

2318

Other bursitis of hip

222

1427

1.75

10.83

1.7

1.5

2.24

2.40

g/l

0.59

124

862

Other and unspecified nail disorders

277

1883

1.67

10.80

1.5

2.12

2.38

g/l

2.25

193

1186

Injury of muscle and tendon at hip and thigh level

1069

8783

1.28

10.80

1.5

2.32

2.42

g/l

0.99

706

5662

Polymyositis

106

562

2.35

10.76

2.2

1.4

2.27

2.55

g/l

0.54

326

Maltreatment syndromes

660

5164

1.39

10.76

1.6

1.5

2.39

2.20

g/l

1.87

402

3490

Other disorders of cornea

964

7838

1.29

10.68

1.5

2.55

2.44

g/l

0.89

584

4834

Other or ill-defined heart diseases

501

3734

1.43

10.67

1.5

2.51

2.45

g/l

0.35

334

2352

Spasmodic torticollis

358

2559

1.56

10.65

1.5

2.13

2.33

g/l

1.70

215

1581

Acute peritonitis

561

4261

1.40

10.64

1.8

1.5

3.16

2.56

g/l

5.38

384

2624

Lack of expected normal physiological development

382

2453

1.59

10.61

2.0

1.5

1.68

1.75

g/l

0.56

218

1337

Other disorders of pigmentation

470

3498

1.46

10.60

1.7

1.5

2.36

2.39

g/l

0.11

311

2107

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

298

3.36

10.56

3.2

1.5

2.02

2.59

g/l

1.15

161

Viral conjunctivitis, including avohilmo

477

3582

1.46

10.53

1.5

2.13

2.24

g/l

0.78

279

2283

Parkinson's disease, strict definition, excluding more controls

908

6790

1.29

10.51

1.4

1.5

2.42

2.70

g/l

2.00

459

3895

Scabies

530

4031

1.43

10.47

1.7

1.5

2.41

2.35

g/l

0.29

346

2636

Pustulosis palmaris et plantaris

446

3307

1.47

10.42

1.5

2.79

2.37

g/l

4.02

254

2069

Graves ophthalmopathy

290

2008

1.64

10.42

1.5

2.21

2.34

g/l

0.64

172

1225

Use of interferon beta-1a

285

1974

1.65

10.39

2.3

1.4

1.98

2.21

g/l

2.14

208

1335

Systemic disorders of connective tissue in diseases classified elsewhere

303

3.16

10.39

4.9

1.5

2.39

2.38

g/l

0.01

178

Burns and corrosions

1512

12873

1.23

10.38

1.6

1.5

2.41

2.34

g/l

0.54

943

8352

Dyshidrosis [pompholyx]

207

1337

1.80

10.38

1.6

1.5

2.47

2.28

g/l

0.51

123

850

Manic episode

340

2412

1.56

10.37

1.7

1.5

2.21

2.32

g/l

0.53

184

1601

Conductive hearing loss, unspecified

847

6823

1.31

10.34

1.7

1.5

2.46

2.38

g/l

0.45

531

4222

Benign neoplasm: Pancreas

277

1893

1.63

10.29

2.0

1.5

2.49

2.56

g/l

0.25

211

1101

Contusion of other and unspecified parts of foot

671

5291

1.37

10.27

1.6

1.5

2.20

2.19

g/l

0.06

411

3453

Contraceptive management

5101

32640

1.12

10.24

1.5

2.21

2.31

g/l

2.82

3419

21758

Arthropathy in ulcerative colitis

169

1047

1.92

10.21

1.8

1.4

2.61

2.27

g/l

1.69

126

677

Unstable angina pectoris

3000

20931

1.15

10.18

1.6

1.5

2.72

2.69

g/l

0.23

1780

11846

LSIL lesion of the cervix uteri, vagina or vulva

1788

15504

1.21

10.14

1.5

2.16

2.14

g/l

0.35

1132

10186

Endometriosis diagnosis and infertility diagnosis occurring together

1333

11305

1.25

10.12

1.4

1.5

2.11

2.14

g/l

0.27

893

7454

Other and unspecified glaucoma

570

4361

1.38

10.12

1.5

2.57

2.67

g/l

0.43

292

2479

Bacterial, viral and other infectious agents

877

7113

1.30

10.10

1.7

1.5

2.40

2.41

g/l

0.02

584

4680

Leiomyoma of uterus

7554

39385

1.10

10.10

1.5

2.17

2.26

g/l

3.65

4524

24328

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

164

1011

1.93

10.09

1.7

1.4

2.34

2.38

g/l

0.11

113

610

Viral meningitis, including avohilmo

445

3329

1.47

10.08

1.7

1.5

2.15

2.26

g/l

0.96

306

2168

Gestational diabetes (for exclusion)

5237

33110

1.12

10.04

1.4

2.14

2.07

g/l

3.79

3362

22331

Malignant neoplasm of respiratory system and intrathoracic organs

1199

11936

0.81

10.02

1.5

1.3

2.65

2.72

g/l

0.45

710

6633

Gilbert syndrome

102

548

2.32

10.01

1.8

1.4

1.83

2.48

g/l

4.60

342

Late syphilis, including avohilmo

185

1169

1.82

9.99

1.8

1.4

2.97

2.54

g/l

1.29

102

736

Colorectal cancer

1994

16596

1.18

9.97

1.5

1.4

2.64

2.67

g/l

0.27

1129

9388

Abscess of tendon sheath

429

2.48

9.86

1.6

1.5

2.61

2.56

g/l

0.07

269

Benign leiomyoma with endometriosis

1575

13522

1.22

9.85

1.4

1.5

2.24

2.32

g/l

0.97

871

7967

Benign mammary dysplasia

1442

12294

1.23

9.84

1.4

1.5

2.07

2.31

g/l

7.28

808

7214

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgA [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS